Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3017044	s-tshrab	— (—)	8171	12621	100.00%	Distribution not available
3017044	s-tshrab	iu/l (iu/l)	3360	5788	0.59%
3017044	s-tshrab	u/l (iu/l)	695	1185	0.00%
3017044	s-tshrab	iu/ml (iu/l)	16	16	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Disorders of lacrimal system and orbit in diseases classified elsewhere

457

200

44.80

307.65

5.1

1.7

5.98

4.78

iu/l

0.68

322

Thyrotoxicosis with toxic multinodular goitre

892

255

58.24

307.65

1.8

1.2

24.91

2.83

iu/l

0.84

299

Endocrine, nutritional and metabolic diseases

2693

2120

6.72

307.65

2.2

1.2

7.17

8.65

iu/l

0.08

1203

477

Graves disease, strict definition

2433

808

72.02

307.65

3.5

1.4

25.61

2.80

iu/l

1.09

1688

219

Thyroiditis, ILD-related definition

682

1134

6.81

307.65

2.0

1.9

3.69

4.61

iu/l

1.16

270

412

Disorders of the thyroid gland

5490

3236

12.14

307.65

2.3

1.2

21.66

7.01

iu/l

0.83

2502

704

Graves ophthalmopathy

455

230

39.25

307.65

5.1

1.7

6.01

4.93

iu/l

0.63

320

Graves ophthalmopathy, strict

423

207

43.08

307.65

5.2

1.7

5.96

5.18

iu/l

0.35

299

Thyroiditis

484

379

15.20

307.65

2.2

1.2

3.65

2.71

iu/l

0.99

195

Thyrotoxicosis, other and/or unspecified

4419

856

100.61

307.65

2.8

1.2

20.51

2.64

iu/l

1.24

2370

185

Nontoxic multinodular goitre

592

800

7.87

307.65

1.5

1.2

23.49

2.25

iu/l

0.55

162

163

Disorders of thyroid, IBD co-morbidities

4444

636

84.45

307.65

2.6

1.2

22.08

2.44

iu/l

1.36

2312

169

Disorders of orbit

547

348

22.75

307.65

4.5

1.8

5.64

4.70

iu/l

0.73

354

123

Hypothyroidism, levothyroxine purchases

1443

1178

7.56

307.65

2.3

2.1

33.88

3.64

iu/l

0.53

697

508

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

3894

2309

22.15

307.65

2.5

1.5

14.92

4.14

iu/l

1.70

1795

754

Carbimazole or st.post thyroidectomy, condition for graves disease

3549

1524

37.47

307.65

2.9

1.3

23.08

10.51

iu/l

0.47

2067

414

Hypothyroidism, drug reimbursement

886

734

9.48

307.65

2.7

2.0

12.75

3.35

iu/l

0.76

466

324

Hypothyroidism, strict autoimmune

1559

3365

3.14

307.65

1.5

51.65

3.36

iu/l

0.73

587

1016

Hypothyroidism (congenital or acquired)

1477

1180

7.73

307.65

2.3

2.1

33.40

3.65

iu/l

0.53

708

509

Hypothyroidism and >3 levothyroxin purchases

1443

1178

7.56

307.65

2.3

2.1

33.88

3.64

iu/l

0.53

697

508

Thyrotoxicosis with diffuse goitre

2963

608

92.17

307.65

3.3

1.2

22.71

2.70

iu/l

1.12

1960

126

Thyrotoxicosis

4987

1375

63.77

307.65

2.6

1.2

21.77

12.04

iu/l

0.34

2566

328

Used for control exclusion in common control thyroid runs

3684

2789

7.00

307.65

2.2

1.2

6.52

7.45

iu/l

0.07

1582

618

Other metabolic disorders

1046

1189

10.55

307.65

3.0

1.8

11.50

4.12

iu/l

0.80

613

427

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1032

1093

11.52

307.65

3.0

1.8

11.54

4.01

iu/l

0.81

608

391

Autoimmune hyperthyroidism

1242

391

60.56

307.65

3.8

1.3

5.86

2.57

iu/l

9.45

840

Hypothyreosis and Thyroxine purchase for inclusion criteria

3311

5969

3.83

307.65

2.2

1.7

33.16

5.19

iu/l

1.19

1515

1938

Hypothyroidism, other/unspecified

3220

3107

7.21

307.65

2.2

1.2

33.75

2.62

iu/l

1.38

1486

682

Metabolic disorders

2228

5788

2.45

289.61

2.2

1.7

11.61

12.55

iu/l

0.05

953

2002

Autoimmune diseases

2594

5868

2.30

280.01

2.2

1.6

28.20

11.52

iu/l

0.43

1132

1874

Subacute thyroiditis

203

133

17.73

238.09

1.9

1.2

2.85

2.15

iu/l

0.51

Amiodarone users

334

508

7.12

211.95

1.4

1.7

2.81

4.46

iu/l

2.05

155

Nontoxic goitre/thyroid nodule

883

2939

3.15

203.69

1.6

1.9

16.26

10.49

iu/l

0.17

249

1086

Other and/or unspecified nontoxic goitre

234

304

8.21

170.49

1.5

1.2

2.50

2.30

iu/l

0.17

Autoimmune thyroiditis

138

20.42

170.23

2.2

1.2

4.21

1.73

iu/l

2.40

Disorders of eyelid, lacrimal system and orbit

1805

6961

2.07

168.27

2.6

1.7

4.91

13.37

iu/l

1.24

778

2445

Neurological diseases, wide definition

631

867

3.72

155.50

2.0

1.2

3.96

2.57

iu/l

2.68

245

220

Antihypertensive medication - note that there are other indications

1515

3823

2.21

152.42

2.3

1.8

4.68

18.09

iu/l

0.47

641

1436

Hypothyroidism due to medicaments and other exogenous substances

30.78

139.07

2.8

1.2

6.41

0.96

iu/l

—

Autoimmune diseases related-to ILD

1769

8272

1.91

134.50

1.8

1.9

3.88

21.28

iu/l

1.65

641

3069

Thyrotoxicosis with toxic single thyroid nodule

34.00

132.13

2.1

1.2

4.19

3.72

iu/l

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1627

5809

1.94

123.22

1.5

1.7

50.40

5.22

iu/l

0.69

604

1896

Anaemias

490

1051

3.17

105.76

1.9

2.1

21.98

3.71

iu/l

0.53

177

454

Thyroiditis, unspecified

16.38

102.90

2.4

1.2

2.23

2.19

iu/l

0.01

Depression medications

642

1225

2.68

95.34

1.9

2.1

3.95

3.64

iu/l

0.40

255

525

Cardiac arrhythmias

1341

4735

1.90

95.29

1.9

2.0

11.12

14.48

iu/l

0.16

479

1916

Atrial fibrillation and flutter

658

1752

2.51

91.98

1.7

1.9

4.41

20.81

iu/l

0.73

220

667

Atrial fibrillation and flutter with reimbursement

526

1274

2.71

85.34

1.7

1.9

4.12

11.34

iu/l

0.54

172

459

Abnormalities of heart beat

721

3314

2.20

82.48

2.1

1.9

3.99

10.76

iu/l

0.56

277

1238

Exophthalmic conditions

13.63

80.86

2.8

1.6

3.02

5.29

iu/l

0.79

Other heart diseases, wide

1769

6683

1.66

79.00

1.8

1.9

14.58

14.25

iu/l

0.01

615

2583

General symptoms and signs

2120

6709

1.60

77.91

1.8

1.9

12.45

20.25

iu/l

0.34

754

2551

Other heart diseases

1002

3448

1.95

76.91

1.9

2.0

13.47

12.28

iu/l

0.04

350

1400

Nontoxic diffuse goitre

104

9.62

76.71

1.8

1.2

2.95

2.29

iu/l

0.28

Symptoms and signs involving the circulatory and respiratory systems

2005

6313

1.61

75.41

1.9

19.20

17.27

iu/l

0.06

782

2377

Medical observation and evaluation for suspected diseases and conditions

1303

3745

1.80

74.49

1.8

1.9

4.45

23.76

iu/l

0.70

471

1423

Other disorders of lacrimal gland

681

3264

2.14

71.97

2.4

1.7

4.57

13.70

iu/l

0.68

283

1138

Nontoxic single thyroid nodule

142

275

5.38

69.87

1.5

1.2

3.87

2.25

iu/l

0.76

Cardiodefibrillation

538

2374

2.31

69.34

1.7

1.6

3.95

4.68

iu/l

0.76

170

713

Pain in joint

1098

4067

1.81

67.47

2.0

1.9

4.05

21.13

iu/l

0.72

393

1570

Examination and observation for other reasons

1099

3730

1.81

66.74

1.9

21.32

23.84

iu/l

0.04

320

1418

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

873

2977

1.95

65.99

2.5

2.0

3.61

13.50

iu/l

1.16

375

1290

Abnormalities of breathing

1682

6292

1.61

65.22

1.8

1.9

18.99

17.30

iu/l

0.05

624

2372

Headache

1270

6342

1.70

64.75

1.9

2.0

10.92

18.42

iu/l

0.29

434

2449

Other obstetric conditions, not elsewhere classified

885

3055

1.93

64.65

2.5

2.0

3.61

13.25

iu/l

1.17

378

1330

Disorders of lacrimal system

782

4107

1.94

63.77

2.3

1.7

4.64

16.32

iu/l

1.11

315

1433

Diseases of the eye and adnexa

1607

5033

1.62

61.68

2.1

1.8

4.36

17.48

iu/l

1.59

630

1912

Oral corticosteroids

1909

7607

1.53

61.00

1.9

26.50

17.14

iu/l

0.34

706

2821

Other soft tissue disorders, not elsewhere classified

1702

6763

1.57

60.78

1.8

1.9

3.94

20.95

iu/l

1.26

569

2568

Heart failure and antihypertensive medication

389

999

2.62

60.25

1.7

3.93

4.67

iu/l

0.61

123

318

First line medication for Crohn's disease

2034

7414

1.51

59.38

1.9

21.56

17.18

iu/l

0.15

725

2798

Malaise and fatigue

847

3858

1.86

58.92

1.8

1.9

14.83

10.23

iu/l

0.15

287

1399

ILD medications: prednisolone, methylprednisolone, prednisone

1989

7502

1.51

58.85

1.9

21.55

17.16

iu/l

0.15

722

2802

Infections, IBD-co-morbidities

211

431

3.63

58.15

1.6

1.1

3.33

2.55

iu/l

0.63

110

Visual disturbances

848

4729

1.82

57.15

2.2

1.8

4.31

6.30

iu/l

0.55

320

1706

Anxiety disorders, excluding more controls

1551

6606

1.57

56.58

1.8

1.9

16.01

21.06

iu/l

0.17

532

2556

ILD medications

2057

7649

1.49

56.31

1.9

21.11

16.91

iu/l

0.15

743

2853

Visual disturbances and blindness

888

5049

1.79

55.98

2.2

1.8

4.34

7.97

iu/l

0.84

330

1812

Mood disorders, excluding more controls

1719

6881

1.54

55.39

1.8

1.9

9.21

20.55

iu/l

0.58

597

2631

Mood [affective] disorders

1852

8171

1.51

55.23

1.9

8.69

19.20

iu/l

0.63

652

3081

Mood disorders

1854

8177

1.50

55.00

1.9

8.69

19.19

iu/l

0.63

652

3084

Diplopia

282

1034

2.82

54.81

2.7

1.9

4.10

4.73

iu/l

0.45

126

370

Inflammatory bowel disease treatment related agents

2049

7941

1.48

54.56

1.9

20.81

16.55

iu/l

0.15

750

2951

Episodal and paroxysmal disorders

2048

7133

1.48

54.37

1.8

1.9

19.32

18.37

iu/l

0.02

703

2719

Any reimbursement code in KELA

1202

3614

1.69

54.35

2.0

4.45

17.20

iu/l

1.15

480

1464

Disorders of calcium metabolism

157

409

4.04

53.66

2.1

1.7

4.43

4.17

iu/l

0.13

126

Other arrhythmias

1117

5176

1.67

53.52

1.8

1.9

12.64

13.01

iu/l

0.01

372

1982

Pain in throat and chest

1484

5826

1.57

53.25

1.8

1.9

25.75

9.29

iu/l

0.65

535

2192

Disorders of mineral metabolism

185

543

3.55

52.88

2.0

1.7

4.97

4.36

iu/l

0.33

181

Depression

1733

7991

1.51

52.57

1.9

9.06

19.43

iu/l

0.59

608

3037

Parasetamol

1489

4883

1.57

51.32

1.9

2.0

3.83

16.59

iu/l

0.64

550

1900

Asthma, excluding more controls

1382

4680

1.59

50.56

1.8

1.9

88.02

7.71

iu/l

1.08

482

1844

Anxiety disorders

1652

7852

1.51

50.12

1.9

15.05

18.50

iu/l

0.13

576

3010

Neurotic, stress-related and somatoform disorders

1638

7812

1.51

49.64

1.9

15.15

18.58

iu/l

0.12

571

2993

Lower back pain or/and sciatica

1783

8450

1.48

49.06

1.9

30.90

15.43

iu/l

0.46

632

3141

Anxiety (asthma-related co-morbidities)

1176

5832

1.61

48.67

1.9

2.0

11.71

19.89

iu/l

0.30

408

2355

Other antidepressants

1802

6379

1.49

48.52

1.8

1.9

14.03

19.82

iu/l

0.21

623

2400

Disorders of other endocrine glands

802

4553

1.76

48.04

1.7

1.9

15.63

4.36

iu/l

0.49

273

1690

Non-small cell lung cancer

240

872

2.82

47.22

1.5

1.7

3.13

4.56

iu/l

1.49

262

Persons encountering health services in other circumstances, wide

2074

7553

1.44

46.79

1.9

4.30

21.07

iu/l

1.38

757

2770

Asthma

1408

4911

1.55

46.67

1.8

1.9

87.67

7.57

iu/l

1.08

484

1917

Dyspnoea

1459

7461

1.51

45.82

1.8

1.9

10.05

13.68

iu/l

0.21

508

2748

Asthma (mode)

1383

4963

1.54

45.12

1.9

80.79

10.32

iu/l

0.91

487

1942

All anxiety disorders

1195

6198

1.57

44.79

1.9

2.0

11.60

17.85

iu/l

0.23

413

2467

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

240

842

2.75

44.53

1.4

1.6

3.13

4.26

iu/l

1.42

249

Codeine

1732

6535

1.47

44.52

1.8

1.9

14.33

18.70

iu/l

0.15

611

2527

Disorders of lipoprotein metabolism and other lipidaemias

1147

4556

1.60

44.49

1.7

12.82

15.39

iu/l

0.09

351

1495

Low back pain

1290

6510

1.54

44.37

1.8

1.9

28.55

18.40

iu/l

0.20

440

2491

Strabismus

507

2614

1.98

43.74

2.4

1.9

4.71

4.22

iu/l

0.48

231

995

Vocal cord dysfunction

282

1068

2.51

43.41

2.2

2.0

5.38

4.27

iu/l

0.88

119

440

Neurological diseases

1646

5641

1.48

43.38

1.9

2.0

9.29

18.84

iu/l

0.41

600

2184

Pure hypercholesterolaemia

990

4088

1.64

43.34

1.7

4.11

16.92

iu/l

1.15

306

1324

Pain in limb

1349

6481

1.52

43.07

1.8

1.9

3.84

21.71

iu/l

1.27

425

2462

Cardiovascular diseases

1258

4433

1.56

42.99

1.9

2.0

4.50

23.88

iu/l

0.96

471

1847

Paroxysmal tachycardia

418

1694

2.13

42.96

1.8

1.9

4.55

9.27

iu/l

0.51

140

670

Dorsalgia

1786

6727

1.45

42.80

1.9

30.25

17.96

iu/l

0.33

642

2566

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1878

7531

1.43

42.76

1.9

3.97

21.10

iu/l

1.43

681

2764

Other headache syndromes

812

4869

1.69

42.44

1.8

1.9

15.55

10.63

iu/l

0.16

269

1936

Oxycodone

527

2687

1.92

42.32

1.5

1.8

4.12

4.27

iu/l

0.09

133

943

Other disorders of fluid, electrolyte and acid-base balance

426

2017

2.07

41.99

1.7

1.6

3.43

4.19

iu/l

1.18

127

641

Benzodiazepine use

1691

8399

1.44

41.86

1.8

1.9

15.33

18.82

iu/l

0.13

559

3148

Codeine or tramadol medication

1994

7876

1.41

41.81

1.8

1.9

17.73

16.58

iu/l

0.04

692

2962

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

721

2022

1.81

41.80

1.9

2.0

4.18

42.09

iu/l

0.82

271

819

Depression or dysthymia

1186

4279

1.57

41.29

1.8

1.9

12.01

14.88

iu/l

0.12

408

1631

Lung cancer and mesothelioma

291

1047

2.42

41.03

1.5

1.7

3.14

5.03

iu/l

2.89

344

Disorder of thyroid, unspecified

10.97

40.43

2.2

1.2

2.62

0.73

iu/l

—

Opioids

1791

6623

1.43

39.87

1.8

1.9

13.97

18.48

iu/l

0.16

640

2561

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

929

5404

1.61

39.80

1.7

1.8

14.54

12.04

iu/l

0.08

296

1865

Other special examinations and investigations of persons without complaint or reported diagnosis

1150

3745

1.57

39.47

1.9

4.28

23.76

iu/l

0.71

426

1423

Other dorsopathies, not elsewhere classified

1808

6748

1.42

39.31

1.8

1.9

13.35

17.92

iu/l

0.17

655

2574

Other pulmonary diagnosis

1458

4951

1.49

39.24

1.9

10.19

7.58

iu/l

0.17

535

1933

Asthma (only as main-diagnosis), excluding more controls

1197

4680

1.54

39.03

1.8

1.9

99.47

7.71

iu/l

1.09

424

1844

Disorders of ocular muscles, binocular movement, accommodation and refraction

847

5214

1.63

38.57

2.2

1.9

4.47

11.47

iu/l

0.92

350

1975

Recurrent or chronic depression

768

3318

1.69

38.39

1.9

2.0

15.50

10.20

iu/l

0.17

268

1355

Cardiovascular diseases (excluding rheumatic etc)

1264

4861

1.52

38.37

1.9

2.0

10.74

22.61

iu/l

0.45

495

1986

Excluding asthma or asthma-COPD overlap

1452

4951

1.48

38.30

1.9

10.04

7.58

iu/l

0.16

538

1933

Fever of other and unknown origin

862

5009

1.61

37.20

1.7

1.9

3.91

11.97

iu/l

1.05

306

1883

Vertical strabismus

106

273

4.15

37.19

3.4

1.9

6.47

4.91

iu/l

0.57

101

Other disorders of thyroid

9.21

37.10

2.2

1.1

2.52

2.63

iu/l

—

Other strabismus

427

2202

1.97

36.85

2.6

1.9

4.91

4.18

iu/l

0.74

200

866

General examination and investigation of persons without complaint and reported diagnosis

1086

3742

1.56

36.80

1.8

1.9

11.82

23.79

iu/l

0.32

400

1421

Pain, not elsewhere classified

483

2608

1.88

36.44

1.6

1.9

57.61

4.72

iu/l

0.74

157

1002

Other specific joint derangements/joint disorders

1319

6048

1.48

36.16

2.0

1.9

4.07

20.51

iu/l

1.12

485

2333

Asthma (only as main-diagnosis)

1215

4911

1.51

36.10

1.8

1.9

98.79

7.57

iu/l

1.09

427

1917

Migraine

982

5449

1.55

35.36

1.9

2.0

34.81

18.68

iu/l

0.28

352

2224

Hypertension, essential

1264

4921

1.48

34.00

1.8

1.9

3.89

10.21

iu/l

0.83

431

1898

COPD differential diagnosis

1427

4967

1.45

33.93

1.9

10.20

10.31

iu/l

0.01

525

1944

Cystitis

1546

6718

1.42

33.90

1.9

15.53

19.58

iu/l

0.14

562

2582

ILD differential diagnosis

1425

4963

1.45

33.77

1.9

10.21

10.32

iu/l

0.01

524

1942

Hypertensive diseases (excluding secondary)

927

3452

1.58

33.66

1.8

1.9

13.69

12.22

iu/l

0.05

327

1406

Dysphagia

377

1932

1.98

33.37

1.6

1.7

30.17

4.49

iu/l

0.47

116

683

Asthma, including avohilmo

1955

8399

1.36

33.34

1.8

1.9

64.13

7.97

iu/l

1.04

673

3135

Asthma, unspecified (mode), excluding more controls

843

4217

1.59

33.17

1.8

1.9

55.24

6.32

iu/l

0.88

274

1663

Abdominal and pelvic pain

1665

6005

1.40

33.17

1.8

1.9

9.85

19.42

iu/l

0.41

578

2248

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

235

1009

2.38

32.93

1.5

1.8

3.70

4.60

iu/l

0.43

334

Heart failure, not strict

1045

4803

1.51

32.68

1.7

1.8

12.88

14.72

iu/l

0.06

330

1662

GASTRO-related operations

1519

5415

1.42

32.06

1.9

3.83

21.76

iu/l

1.09

536

2142

Any gastric operation

1519

5415

1.42

32.06

1.9

3.83

21.76

iu/l

1.09

536

2142

Symptoms and signs involving the digestive system and abdomen

1661

6005

1.40

32.01

1.8

1.9

9.38

19.42

iu/l

0.44

587

2248

Pain (limb, back, neck, head abdominally)

1214

4148

1.48

31.81

1.9

3.91

20.90

iu/l

0.73

426

1586

Malignant neoplasm of bronchus and lung

232

939

2.35

31.38

1.4

1.6

2.97

4.46

iu/l

1.90

279

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

282

1094

2.18

31.34

1.4

1.7

3.09

4.41

iu/l

2.25

335

Symptoms and signs involving the skin and subcutaneous tissue

1103

7562

1.47

31.05

1.8

1.9

21.89

11.12

iu/l

0.41

369

2839

Selective serotonin reuptake inhibitors

1672

6406

1.38

30.94

1.8

1.9

9.30

19.76

iu/l

0.49

589

2412

Autoimmune diseases excluding thyroid diseases

1289

4986

1.44

30.76

1.4

32.26

10.14

iu/l

0.69

318

1273

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

317

1308

2.06

30.47

1.5

1.7

3.06

4.52

iu/l

2.90

406

Malignant melanoma, excluding all cancers (controls excluding all cancers)

263

1224

2.19

30.36

1.5

1.8

3.72

4.42

iu/l

0.37

408

Diseases of oesophagus, stomach and duodenum

1710

7646

1.37

30.35

1.8

1.9

19.43

12.30

iu/l

0.33

593

2871

Insulin, fast-acting

543

3202

1.72

30.28

1.9

1.8

4.02

4.36

iu/l

0.41

199

1135

1908

7515

1.35

30.26

1.9

13.94

12.29

iu/l

0.08

668

2798

Malignant neoplasm of respiratory system and intrathoracic organs

259

1096

2.21

30.19

1.5

1.6

2.97

4.45

iu/l

2.18

326

Acute upper respiratory infections

1726

7986

1.36

30.15

1.9

14.62

19.84

iu/l

0.20

613

2940

Asthma, unspecified (mode)

854

4424

1.54

30.12

1.8

1.9

55.04

6.24

iu/l

0.88

275

1725

Exclusions for E4_PCOS_BROAD

310

1541

2.05

30.07

1.7

1.9

34.01

4.54

iu/l

0.48

102

577

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

110

337

3.38

29.53

1.4

1.7

3.37

4.28

iu/l

0.42

102

Tramadol

1240

5595

1.44

29.49

1.7

1.9

19.19

10.56

iu/l

0.34

402

2148

Malignant melanoma of skin

188

770

2.51

29.37

1.5

1.8

3.83

4.41

iu/l

0.20

260

Migraine, single triptan purchase ok & required. ICD-code if available is included

1413

6894

1.40

29.25

1.9

26.29

18.10

iu/l

0.26

567

2633

Triptan medication for migraine, single purchase ok

1413

6894

1.40

29.25

1.9

26.29

18.10

iu/l

0.26

567

2633

COPD/asthma related infections

1822

6784

1.35

29.21

1.9

9.14

13.03

iu/l

0.26

641

2575

COPD/asthma/ILD related infections

1822

6784

1.35

29.21

1.9

9.14

13.03

iu/l

0.26

641

2575

Insulin, fast-acting or short human

546

3257

1.70

29.18

1.9

1.8

4.01

4.29

iu/l

0.33

200

1149

Type 1 diabetes, wide definition, subgroup 1

365

1939

1.91

29.03

2.0

4.20

4.31

iu/l

0.08

135

745

Gastro-oesophageal reflux disease

1031

6298

1.46

28.43

1.8

12.22

11.93

iu/l

0.01

364

2307

Other diseases of urinary system

1721

7201

1.35

28.25

1.9

14.85

18.60

iu/l

0.13

600

2747

Type 1 diabetes

416

2321

1.82

28.20

1.9

4.24

4.23

iu/l

0.00

146

872

Dermatitis and eczema

1754

8621

1.34

28.03

1.8

1.9

14.22

18.59

iu/l

0.18

632

3182

Sciatica+with lumbago

817

5144

1.52

27.75

1.9

35.02

10.51

iu/l

0.74

300

1970

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

172

698

2.55

27.64

1.9

2.0

4.93

4.44

iu/l

0.24

260

Any mental disorder

1847

6952

1.34

27.56

1.8

1.9

13.73

20.51

iu/l

0.27

640

2638

Other diseases of intestines

1769

7715

1.34

27.54

1.8

1.9

9.18

20.81

iu/l

0.66

613

2955

Hypertensive diseases

1266

5092

1.42

27.47

1.8

1.9

11.17

10.05

iu/l

0.05

430

1970

Follow-up examination after treatment for conditions other than malignant neoplasms

780

3322

1.55

27.33

1.9

15.49

25.81

iu/l

0.22

281

1294

Psychiatric diseases

1824

6863

1.34

27.31

1.8

1.9

13.72

20.63

iu/l

0.27

637

2621

Hypertension

1264

5088

1.42

27.27

1.8

1.9

11.19

10.05

iu/l

0.05

429

1969

Other anxiety disorders

838

4969

1.51

27.18

1.8

2.0

4.16

20.82

iu/l

0.89

269

2022

Persons encountering health services for specific procedures and health care

1749

8150

1.34

27.05

1.7

1.9

4.03

14.59

iu/l

2.17

559

3113

Non-small cell lung cancer, adenocarcinoma

110

356

3.19

27.03

1.4

1.8

3.37

4.39

iu/l

0.50

115

Non-small cell lung cancer, adenocarcinoma, helper endpoint

110

356

3.19

27.03

1.4

1.7

3.37

4.39

iu/l

0.50

115

Asthma (diagnoses ohter than nonallergic)

1388

8694

1.38

26.95

1.8

1.9

91.87

6.94

iu/l

1.10

460

3249

Bronchitis

1729

8551

1.33

26.57

1.9

9.37

19.63

iu/l

0.60

609

3176

Chronic lower respiratory diseases

1986

8226

1.31

26.43

1.8

1.9

62.72

8.06

iu/l

1.03

689

3082

Nausea and vomiting

423

2384

1.77

26.26

1.7

1.9

4.14

4.43

iu/l

0.23

126

894

Other diseases of upper respiratory tract

1799

7086

1.33

26.21

1.9

9.26

19.42

iu/l

0.52

650

2602

Type 1 diabetes, wide definition

371

2050

1.83

26.07

2.0

4.18

4.26

iu/l

0.06

137

779

Acute upper respiratory infections of multiple and unspecified sites

1232

6657

1.40

25.85

2.0

1.9

10.80

22.40

iu/l

0.51

456

2520

Malignant melanoma

222

1032

2.20

25.83

1.5

1.8

3.80

4.64

iu/l

0.37

350

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

179

764

2.42

25.74

1.9

5.19

4.45

iu/l

0.39

285

Cardiomyopathy

222

1033

2.18

25.63

1.6

1.7

52.17

4.13

iu/l

0.48

338

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

779

5111

1.51

25.31

2.0

1.8

4.58

12.79

iu/l

0.94

304

1907

Asthma-related infections

895

6068

1.46

25.23

1.8

1.9

104.88

6.75

iu/l

0.78

293

2275

Asthma, hospital admission 2, infections

895

6068

1.46

25.23

1.8

1.9

104.88

6.75

iu/l

0.78

293

2275

Hypo-osmolality and hyponatraemia

230

1094

2.13

24.94

1.7

1.6

3.72

4.32

iu/l

0.49

338

Sleep disorders (combined)

1539

7568

1.34

24.57

1.7

1.9

9.94

12.34

iu/l

0.13

518

2840

Disturbances of skin sensation

480

2907

1.68

24.51

1.9

4.16

6.99

iu/l

0.53

177

1165

Other functional intestinal disorders

672

4187

1.54

24.41

1.6

1.8

4.09

13.63

iu/l

1.01

219

1553

Symptoms and signs concerning food and fluid intake

175

755

2.37

24.35

1.7

1.9

3.26

4.87

iu/l

1.50

255

Type 1 diabetes, strict definition, subgroup 1

173

744

2.38

24.27

1.9

2.1

3.92

4.33

iu/l

0.31

305

Other disorders of eye and adnexa

257

1294

2.03

24.26

2.1

1.9

5.11

4.49

iu/l

0.26

484

Heart failure,strict

625

2878

1.58

24.23

1.6

1.7

4.16

4.78

iu/l

0.63

191

903

Insulin, intermediate and long-acting

728

4774

1.51

23.93

1.8

3.87

8.07

iu/l

0.94

240

1659

Oedema, not elsewhere classified

443

2633

1.69

23.71

1.7

1.8

3.85

4.72

iu/l

1.24

151

940

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

228

3.24

23.51

1.9

1.1

4.67

2.33

iu/l

1.48

Dorsopathies

1736

6774

1.32

23.21

1.8

1.9

8.65

17.90

iu/l

0.47

623

2580

Autoimmune diseases excluding thyroid diseases, strict definition

991

3871

1.43

23.08

1.3

16.75

9.36

iu/l

0.21

223

913

Sleep apnoea, including avohilmo

1447

7051

1.34

22.98

1.7

1.9

10.27

13.07

iu/l

0.15

515

2595

Bipolar affective disorders

347

1960

1.80

22.90

1.7

2.1

29.23

4.38

iu/l

0.48

121

822

Persons encountering health services for examination and investigation

1055

3745

1.42

22.88

1.8

1.9

4.27

23.76

iu/l

0.71

372

1423

Irritable bowel syndrome

494

3069

1.63

22.82

1.9

23.33

13.68

iu/l

0.19

163

1207

Haemorrhage from respiratory passages

428

2368

1.69

22.81

1.6

1.7

4.51

4.67

iu/l

0.09

131

789

Ocular pain

171

757

2.33

22.67

2.2

2.0

5.05

4.81

iu/l

0.07

281

Gastrointestinal diseases

1128

4058

1.40

22.65

2.0

4.20

25.33

iu/l

0.94

431

1631

Sub-endpoint used in defining T1D endpoints

427

2517

1.69

22.55

1.9

4.17

4.25

iu/l

0.06

151

915

Factors influencing health status and contact with health services

464

1377

1.70

22.49

1.9

1.8

5.17

4.64

iu/l

0.36

160

515

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

301

1636

1.87

22.49

1.4

1.7

2.90

4.43

iu/l

4.40

557

Dental caries 3 and operation codes

1403

5363

1.35

22.48

1.8

1.9

4.12

17.49

iu/l

1.66

496

1929

694

4630

1.50

22.32

1.9

31.82

4.39

iu/l

0.79

231

1785

Soft tissue disorders

1713

6834

1.31

22.25

1.8

1.9

3.81

20.80

iu/l

1.27

613

2591

Dental pulpitis 1, only avohilmo

1807

7301

1.30

22.23

1.9

4.66

22.44

iu/l

1.39

667

2671

Any operation in hilmo

104

3.98

22.20

2.0

1.8

5.34

5.03

iu/l

0.10

Type 1 diabetes, strict definition

174

780

2.28

22.16

2.0

2.1

3.90

4.33

iu/l

0.34

317

Dental pulpitis 4, only avohilmo

1802

7286

1.30

22.03

1.9

4.67

22.45

iu/l

1.39

661

2669

Symptoms and signs involving cognition, perception, emotional state and behaviour

1475

7853

1.32

21.91

1.8

1.9

17.02

13.02

iu/l

0.16

484

2950

Cardiomyopathies, Primary/intrinsic

151

640

2.40

21.89

1.6

1.7

73.60

4.72

iu/l

0.48

207

Congenital iodine-deficiency syndrome/hypothyroidism

105

4.83

21.65

1.9

1.2

3.81

2.17

iu/l

0.83

Dental caries 1 and operation codes

1319

5026

1.35

21.58

1.8

1.9

4.31

14.04

iu/l

1.51

459

1824

Disorders of parathyroid gland

318

1761

1.81

21.47

1.6

1.7

4.13

4.90

iu/l

0.76

106

582

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1471

8035

1.32

21.44

1.8

1.9

10.20

14.05

iu/l

0.23

526

2957

Diseases of pulp and periapical tissues, including avohilmo

1766

7111

1.30

21.44

1.9

4.75

21.67

iu/l

1.27

652

2617

Abnormal results of function studies

158

694

2.34

21.30

1.8

1.9

4.33

4.48

iu/l

0.06

248

Dental pulpitis 1

1766

7119

1.30

21.28

1.9

4.75

21.65

iu/l

1.27

652

2619

Dental pulpitis 4

1766

7120

1.30

21.23

1.9

4.75

21.65

iu/l

1.27

652

2619

Viral hepatitis, IBD co-morbidity

157

3.95

21.18

1.9

1.1

3.19

2.82

iu/l

0.13

Other disorders of eyelid

568

3576

1.55

21.15

2.3

1.6

4.71

16.60

iu/l

0.89

207

1134

Adjustment and management of implanted device

233

1188

1.99

21.15

1.6

1.7

2.66

4.53

iu/l

4.15

376

Malignant neoplasm of thyroid gland

143

605

2.44

21.11

1.7

1.9

4.26

4.65

iu/l

0.20

209

Cardiomyopathy (excluding other)

155

676

2.33

21.07

1.6

1.8

72.03

4.81

iu/l

0.48

216

Heart failure, strict

658

3155

1.51

21.06

1.6

1.7

4.24

4.57

iu/l

0.28

200

966

Malignant neoplasm of endocrine gland

148

637

2.40

21.00

1.7

1.9

4.58

4.52

iu/l

0.02

219

Other joint disorders

1512

6136

1.32

20.99

1.8

1.9

4.55

20.37

iu/l

1.07

573

2355

False labour

647

2694

1.53

20.97

2.1

3.67

9.79

iu/l

1.02

252

1196

Other specified and unspecified strabismus

5.34

20.88

3.5

1.9

6.29

6.38

iu/l

0.01

Diseases of the musculoskeletal system and connective tissue

1003

3594

1.41

20.82

1.9

2.0

3.92

26.16

iu/l

0.89

377

1450

Pregnancy examination and test

364

1308

1.77

20.81

2.5

2.0

4.19

15.52

iu/l

0.87

152

587

Insulin, combination of fast acting with intermediate-acting or long-acting

808

5227

1.44

20.58

1.8

3.81

7.77

iu/l

1.00

269

1833

Diarrhoea and gastroenteritis of presumed infectious origin

1082

7244

1.37

20.58

1.8

1.9

20.83

12.60

iu/l

0.29

365

2724

Diseases of the respiratory system

1122

4103

1.38

20.48

1.9

4.49

9.73

iu/l

0.74

410

1596

Migraine with aura

459

2880

1.62

20.44

1.9

2.0

21.83

7.09

iu/l

0.36

171

1225

Symptoms and signs involving speech and voice

497

3176

1.58

20.42

1.9

1.8

3.97

7.28

iu/l

0.65

188

1145

Intestinal infectious diseases

1449

8654

1.31

20.37

1.8

1.9

16.18

18.55

iu/l

0.08

502

3213

Diabetes mellitus in pregnancy

713

3150

1.49

20.37

2.2

2.1

4.23

15.19

iu/l

1.31

306

1380

Abnormal findings on diagnostic imaging of lung

570

3653

1.53

20.30

1.6

1.7

3.82

4.54

iu/l

0.93

160

1214

Type 1 diabetes, definitions combined

197

960

2.09

20.28

1.9

2.1

3.75

4.34

iu/l

0.58

380

Type 1 diabetes, strict (exclude DM2)

196

955

2.09

20.19

1.9

2.1

3.76

4.36

iu/l

0.57

376

Disorders of conjunctiva

1324

8430

1.32

20.14

2.0

1.9

52.17

11.44

iu/l

0.48

484

3165

Use of hypnotics and sedatives

1638

7369

1.29

19.79

1.9

14.93

13.64

iu/l

0.06

575

2763

241

1275

1.93

19.77

2.1

1.9

3.28

4.31

iu/l

1.35

484

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

234

3.32

19.72

1.4

1.9

2.14

4.40

iu/l

2.82

Subjective visual disturbances

388

2361

1.67

19.59

2.0

1.8

4.32

4.51

iu/l

0.11

134

851

Constipation

1255

6795

1.33

19.44

1.7

1.8

4.37

12.54

iu/l

1.37

421

2475

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

140

611

2.37

19.31

2.0

5.16

4.56

iu/l

0.26

226

Insulin medication

806

4890

1.42

19.15

1.8

3.81

12.30

iu/l

1.04

269

1755

Other maternal disorders predominantly related to pregnancy

1133

5310

1.35

19.12

2.1

2.0

4.42

16.54

iu/l

1.63

469

2117

Panic disorder

291

1650

1.80

19.11

1.9

2.1

3.60

4.52

iu/l

1.37

703

Diseases of the skin and subcutaneous tissue

1683

6599

1.29

19.05

1.8

1.9

4.17

21.31

iu/l

1.22

580

2493

Dizziness and giddiness

1093

6614

1.35

19.02

1.8

1.9

13.40

10.07

iu/l

0.13

343

2462

Type 2 diabetes, wide definition

1094

5289

1.36

19.00

1.7

1.8

13.12

13.46

iu/l

0.01

343

1874

Sleep apnoea

1310

6782

1.32

18.82

1.7

1.8

10.95

11.39

iu/l

0.02

452

2469

Nerve, nerve root and plexus disorders

1601

7869

1.28

18.81

1.8

1.9

21.42

12.00

iu/l

0.44

561

2913

Other and unspecified disorders of orbit

8.97

18.80

1.8

1.7

2.08

2.89

iu/l

—

Other nutritional deficiencies

1032

7500

1.36

18.78

1.9

3.83

20.35

iu/l

1.40

378

2861

Non-invasive ventilation

320

1752

1.74

18.76

1.7

1.9

4.84

4.48

iu/l

0.11

125

724

All-cause Heart Failure

636

3108

1.49

18.74

1.6

1.7

4.33

4.56

iu/l

0.17

193

952

Voice disturbances

419

2629

1.62

18.71

1.9

4.07

7.79

iu/l

0.60

167

969

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

486

3155

1.56

18.66

1.9

2.0

3.91

23.96

iu/l

0.69

171

1311

Diseases of the digestive system

587

3955

1.49

18.58

1.9

1.8

4.46

6.53

iu/l

0.44

207

1379

Other systemic involvement of connective tissue (FG)

413

2575

1.61

18.38

1.7

1.9

50.89

7.66

iu/l

0.72

135

967

Certain infectious and parasitic diseases

1685

6650

1.28

17.95

1.8

1.9

23.05

19.12

iu/l

0.09

582

2571

Dental caries 1

1158

4447

1.34

17.68

1.8

1.9

4.55

13.52

iu/l

1.21

403

1592

Other disorders of urethra and urinary system

1111

6285

1.33

17.62

1.8

1.9

12.81

12.36

iu/l

0.02

364

2423

Maternal care for other known or suspected fetal problems

514

2168

1.54

17.50

2.1

18.02

7.66

iu/l

0.33

230

978

Other intervertebral disc disorders

1253

5866

1.31

17.49

1.7

1.9

10.78

11.14

iu/l

0.02

439

2224

Clear cell adenocarcinoma of kidney

252

3.08

17.47

1.4

1.8

2.14

4.97

iu/l

3.46

Care involving use of rehabilitation procedures

915

6412

1.36

17.43

1.7

1.9

3.63

12.97

iu/l

1.60

297

2389

Fibromyalgia

188

958

2.01

17.41

1.9

2.0

3.48

4.77

iu/l

1.24

408

Dental caries 3

1241

4825

1.32

17.41

1.8

1.9

4.36

17.40

iu/l

1.40

449

1707

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

143

655

2.22

17.41

1.4

1.8

2.32

4.58

iu/l

5.04

194

Maternal care for other conditions predominantly related to pregnancy

441

2814

1.57

17.38

2.0

2.1

3.82

16.68

iu/l

1.39

176

1218

Diseases of oral cavity, salivary glands and jaws

1406

5585

1.30

17.30

1.8

1.9

4.15

11.39

iu/l

1.33

493

2104

Dental caries, including avohilmo

1154

4446

1.33

17.27

1.8

1.9

4.55

13.53

iu/l

1.21

403

1591

Other diseases of hard tissues of teeth

967

5365

1.35

16.91

1.9

66.53

11.56

iu/l

0.42

322

2058

Generalized anxiety disorder

289

1696

1.73

16.87

1.9

2.1

3.31

4.48

iu/l

1.95

724

Chronic sinusitis

661

4659

1.43

16.77

1.9

3.72

11.65

iu/l

0.86

231

1766

Osteoporosis

352

2071

1.64

16.77

1.8

1.7

34.51

4.72

iu/l

0.50

105

674

Chronic rhinitis, nasopharyngitis and pharyngitis

494

3299

1.51

16.68

1.9

3.56

10.54

iu/l

0.59

153

1254

Symptoms and signs involving the nervous and musculoskeletal systems

820

6001

1.38

16.62

1.8

14.68

10.73

iu/l

0.14

292

2221

Non-ischemic cardiomyopathy

361

1832

1.63

16.60

1.7

4.80

4.86

iu/l

0.02

107

578

Myalgia

387

2460

1.59

16.43

2.0

4.12

8.03

iu/l

0.66

130

987

Dental caries 1, only avohilmo

1168

4543

1.32

16.43

1.8

1.9

4.54

13.39

iu/l

1.22

410

1618

1381

6766

1.29

16.41

1.7

1.9

63.44

13.06

iu/l

0.56

443

2567

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1381

6766

1.29

16.41

1.7

1.9

63.44

13.06

iu/l

0.56

443

2567

Implicit Sepsis

974

5671

1.34

16.40

1.7

1.8

13.32

9.91

iu/l

0.12

307

1999

Gingivitis and periodontal diseases

1384

5564

1.29

16.38

1.9

4.50

11.40

iu/l

1.23

478

2099

Other/unspecified dorsalgia

565

3870

1.47

16.33

1.8

1.9

3.94

4.79

iu/l

1.26

188

1492

Hypokalaemia

160

786

2.07

16.31

1.7

3.68

4.13

iu/l

0.28

259

Dental caries 3, only avohilmo

1250

4917

1.31

16.22

1.8

4.34

17.20

iu/l

1.40

451

1734

Syncope and collapse

579

3544

1.46

16.13

1.7

1.9

3.51

4.64

iu/l

2.74

199

1267

Exclusions for E4_PCOS_CONSORTIUM

1312

6410

1.29

16.07

1.8

2.0

10.59

13.44

iu/l

0.15

485

2510

Cardiomyopathy, other and unspecified

109

463

2.40

15.93

1.4

1.8

3.57

4.66

iu/l

0.53

151

Osteopathies and chondropathies

761

5264

1.38

15.73

1.8

18.53

11.91

iu/l

0.20

238

1881

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

127

580

2.23

15.64

1.4

1.7

2.38

4.60

iu/l

4.32

176

Other and unspecified iron deficiency

450

2991

1.52

15.55

1.7

1.8

4.47

7.26

iu/l

0.47

153

1074

Abnormal findings on examination of blood, without diagnosis

525

3361

1.47

15.52

1.7

3.52

7.13

iu/l

0.72

163

1136

Neoplasms

1275

5317

1.29

15.35

1.8

2.0

4.79

19.93

iu/l

0.87

443

2156

Conjunctivitis

1200

8159

1.29

15.31

2.0

1.9

56.68

11.64

iu/l

0.48

441

3080

Spondylopathies

1101

5120

1.31

15.30

1.7

1.8

28.85

7.90

iu/l

0.82

376

1893

Asthma/COPD (KELA code 203)

1460

8193

1.26

15.25

1.8

1.9

60.60

8.06

iu/l

0.73

522

3073

Finngen Rheumatological endpoints

1542

7021

1.26

15.15

1.7

1.9

24.91

17.06

iu/l

0.18

530

2719

Allergic asthma (mode), excluding more controls

401

2568

1.55

15.12

1.9

2.0

164.30

4.47

iu/l

0.60

145

1065

Nutritional anaemias

642

4462

1.41

15.10

1.7

1.8

4.48

6.48

iu/l

0.50

218

1586

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

502

3006

1.48

15.03

1.4

1.8

3.41

7.31

iu/l

0.73

122

1056

Malignant neoplasm of urinary organs

120

546

2.24

14.94

1.4

1.8

2.34

4.55

iu/l

3.96

166

Cough

567

3813

1.44

14.85

1.8

1.9

3.99

9.87

iu/l

0.55

181

1414

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1438

7788

1.26

14.84

1.7

1.9

11.05

14.08

iu/l

0.16

491

2924

Personality disorders, excluding more controls

423

2811

1.52

14.72

1.9

2.1

3.36

4.55

iu/l

2.60

140

1171

Malignant neoplasm of kidney, except renal pelvis

113

505

2.28

14.71

1.5

1.8

2.42

4.49

iu/l

3.42

158

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

501

3412

1.47

14.59

1.9

2.0

21.46

10.48

iu/l

0.25

171

1441

Iron deficiency anaemia

555

3856

1.44

14.55

1.7

1.8

4.32

6.68

iu/l

0.51

191

1376

Asthma, hospital admissions , main diagnosis only

1245

8798

1.27

14.54

1.8

1.9

96.62

6.89

iu/l

1.10

437

3277

Benign neoplasms

1518

6789

1.25

14.49

1.8

1.9

20.36

20.82

iu/l

0.01

522

2625

Persons encountering health services in other circumstances

557

3912

1.43

14.48

1.7

1.9

5.02

13.78

iu/l

0.82

222

1468

Triptan medication for migraine, min. 3 purchases

1017

6169

1.31

14.47

1.8

2.0

20.15

20.19

iu/l

0.00

395

2488

Allergic asthma (mode)

401

2594

1.53

14.47

1.9

2.0

164.30

4.42

iu/l

0.60

145

1068

Migraine with aura and triptan purchases

300

1855

1.64

14.46

1.9

2.1

29.90

4.37

iu/l

0.47

120

790

Diabetes mellitus

1570

7547

1.25

14.45

1.8

1.9

9.87

13.39

iu/l

0.20

529

2851

Diabetes, varying definitions

1557

7492

1.25

14.37

1.7

1.9

9.90

12.37

iu/l

0.14

524

2829

Gestational diabetes (for exclusion)

762

3975

1.37

14.33

2.2

2.1

64.98

12.95

iu/l

0.40

329

1708

Other inflammation of eyelid

189

1029

1.87

14.32

2.2

1.7

5.52

4.53

iu/l

0.45

374

Systemic connective tissue disorders

518

3603

1.45

14.31

1.7

1.8

42.27

6.87

iu/l

0.73

167

1301

Arthropathies

1508

6143

1.26

14.27

1.9

4.21

20.35

iu/l

1.10

561

2357

Coxibs

410

1415

1.55

14.26

1.9

3.92

4.09

iu/l

0.12

141

530

Pain in thoracic spine

238

1389

1.74

14.24

1.8

1.9

3.44

4.95

iu/l

2.22

542

Weight loss

147

738

2.03

14.23

1.7

1.9

3.37

4.52

iu/l

1.04

248

COPD (mode)

349

1764

1.58

14.18

1.7

34.41

5.00

iu/l

0.47

101

596

Dental pulpitis 2, only avohilmo

1035

4048

1.32

14.17

1.8

1.9

4.24

14.49

iu/l

1.29

367

1450

Dronedarone medication

150

3.45

14.11

1.2

1.6

3.56

4.29

iu/l

0.23

Hyperlipidaemia, other/unspecified

396

2473

1.53

14.07

1.5

1.6

34.92

8.14

iu/l

0.41

101

757

Hyperparathyroidism

254

1497

1.70

14.00

1.6

1.8

3.37

4.98

iu/l

2.43

495

Other systemic involvement of connective tissue

417

2797

1.51

13.93

1.7

1.8

50.19

7.59

iu/l

0.72

137

1015

Acetic acid derivatives and related substances

411

1399

1.54

13.75

1.8

1.9

3.97

4.11

iu/l

0.10

147

523

Chronic gastritis

353

2290

1.56

13.74

1.8

1.7

4.48

4.64

iu/l

0.10

109

765

Cerebrovascular diseases (FINNGEN)

429

2053

1.51

13.73

1.8

1.9

4.12

17.89

iu/l

0.75

146

814

Chronic inflammatory disorders of orbit

8.88

13.66

2.8

1.6

1.41

7.15

iu/l

—

Special screening examination for infectious and parasitic diseases

405

2007

1.52

13.65

2.1

4.25

28.48

iu/l

0.50

137

824

Contraceptive management

636

3223

1.40

13.64

2.1

1.9

56.72

9.52

iu/l

0.79

263

1277

Temporomandibular joint disorders

280

1729

1.64

13.54

1.7

2.0

36.70

4.66

iu/l

0.48

722

Continuous positive airway pressure

223

1110

1.75

13.51

1.7

1.9

3.59

4.47

iu/l

1.01

415

Abnormal weight loss

131

644

2.08

13.47

1.7

1.9

3.59

4.49

iu/l

0.65

215

Type1 diabetes, definitions combined, early onset

135

669

2.06

13.46

2.0

2.1

3.63

4.61

iu/l

0.85

267

Dental pulpitis 2

1011

3977

1.31

13.37

1.8

1.9

4.33

12.54

iu/l

1.03

361

1430

Supervision of high-risk pregnancy

415

1671

1.52

13.30

2.3

2.0

44.14

13.42

iu/l

0.34

190

724

Chronic diseases of tonsils and adenoids

1266

6370

1.26

13.30

1.9

17.62

20.61

iu/l

0.08

467

2416

Heart failure and bmi 25plus

373

1681

1.54

13.21

1.7

1.6

4.06

4.63

iu/l

0.39

118

543

Benign neoplasms

1233

5524

1.27

13.12

1.8

2.0

23.72

22.25

iu/l

0.03

436

2223

Postpartum care and examination

294

1162

1.64

13.07

2.1

2.0

3.28

16.75

iu/l

0.95

142

525

Osteoporosis with pathological fracture (FG)

109

507

2.20

13.00

1.9

1.6

4.52

4.14

iu/l

0.14

162

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

486

3405

1.44

12.99

1.9

2.0

3.91

6.66

iu/l

0.64

171

1381

Maternal care related to the fetus and amniotic cavity and possible delivery problems

850

3789

1.33

12.96

2.1

2.0

3.96

13.25

iu/l

1.01

343

1582

Paracetamol of NSAID medication

289

887

1.65

12.86

1.8

2.0

4.95

4.10

iu/l

0.55

105

348

Other reaction to severe stress, and adjustment disorders

605

4414

1.38

12.75

1.9

2.0

4.23

11.73

iu/l

0.82

223

1812

Diseases of pulp and periapical tissues

473

3307

1.44

12.74

1.8

1.9

23.84

6.74

iu/l

0.40

150

1262

Adrenocortical insufficiency

288

2.63

12.73

2.2

1.8

105.84

5.42

iu/l

0.49

Insulin, fast-acting (human)

225

1335

1.71

12.72

1.9

2.0

4.43

4.26

iu/l

0.10

506

Spondylosis

680

4318

1.36

12.71

1.8

28.88

8.67

iu/l

0.59

248

1547

Problems related to lifestyle

162

874

1.88

12.70

2.0

1.9

92.22

4.74

iu/l

0.49

319

Non-rheumatic valve diseases

529

2737

1.42

12.57

1.8

22.43

11.17

iu/l

0.26

168

951

Other specified and unspecified disorders of eyelid

4.12

12.50

3.3

1.5

5.29

7.56

iu/l

0.35

Dental caries

336

2182

1.54

12.49

2.0

1.9

4.71

8.08

iu/l

0.42

116

818

Inflammatory diseases of female pelvic organs

1132

6773

1.27

12.49

1.9

2.0

3.92

21.54

iu/l

1.39

409

2672

Benign neoplasm: Colon

585

3242

1.39

12.49

1.7

1.8

4.96

13.39

iu/l

0.64

158

1190

Influenza and pneumonia

1581

8535

1.22

12.42

1.8

1.9

56.33

12.21

iu/l

0.55

504

3244

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

157

3.18

12.38

1.6

1.7

2.43

4.02

iu/l

1.62

Diverticular disease of intestine

895

4571

1.31

12.38

1.7

1.8

3.85

14.86

iu/l

1.26

271

1645

Excessive, frequent and irregular menstruation

797

3345

1.34

12.37

1.9

2.0

82.63

12.62

iu/l

0.51

294

1340

Functional dyspepsia

394

2680

1.49

12.33

1.9

3.88

7.79

iu/l

0.67

126

994

Obesity related asthma

457

3198

1.44

12.30

1.6

1.8

26.23

4.44

iu/l

0.49

145

1192

Migraine without aura

361

2416

1.51

12.29

1.9

2.1

4.13

7.44

iu/l

0.57

130

1055

Complications of surgical and medical care, not elsewhere classified

1409

8220

1.23

12.29

1.8

1.9

10.44

13.78

iu/l

0.18

469

3057

Asthma and allergy, excluding more controls

231

1377

1.68

12.25

1.9

2.1

242.61

4.33

iu/l

0.50

613

Concussion

718

4667

1.34

12.23

1.8

2.0

5.53

10.66

iu/l

0.74

249

1853

Asthma, hospital admissions 3, pneumonia

446

3105

1.45

12.21

1.6

1.8

208.28

4.36

iu/l

0.70

129

1106

Asthma-related pneumonia or sepsis

446

3105

1.45

12.21

1.6

1.8

208.28

4.36

iu/l

0.70

129

1106

Asthma-related pneumonia

445

3101

1.44

12.13

1.6

1.8

208.28

4.36

iu/l

0.70

129

1104

Dentinal caries

292

1862

1.58

12.06

1.9

1.8

4.51

8.60

iu/l

0.44

103

693

Conduction disorders

319

1723

1.55

12.04

1.6

1.7

3.35

4.60

iu/l

2.48

584

Covid-19 confirmed case

380

2578

1.49

12.04

1.8

1.9

4.20

4.32

iu/l

0.08

136

963

ILD medications: immunosuppressive drugs

871

6471

1.30

12.03

2.2

1.8

4.70

9.67

iu/l

0.70

315

2447

Hypopituitarism

103

483

2.18

12.03

1.6

1.9

96.02

5.40

iu/l

0.47

174

Asthma and allergy

231

1385

1.67

11.99

1.9

2.0

242.61

4.37

iu/l

0.50

606

Undetermined asthma, excluding more controls

184

1050

1.77

11.96

1.7

1.9

3.94

4.36

iu/l

0.23

405

Valvular heart disease excluding rheumatic fever

528

2760

1.41

11.93

1.8

22.31

11.15

iu/l

0.26

169

958

Paralytic strabismus

103

485

2.17

11.93

1.6

1.8

3.34

4.84

iu/l

0.92

162

Other disorders affecting eyelid function

5.09

11.90

6.1

1.5

6.21

5.79

iu/l

0.05

Lumbar disc prolapse

890

5487

1.30

11.87

1.7

1.9

13.67

10.13

iu/l

0.13

310

2086

Urticaria

475

3372

1.42

11.85

1.8

2.0

3.85

6.72

iu/l

0.64

164

1324

Genitourinary diseases

862

3304

1.31

11.83

1.9

4.19

6.76

iu/l

0.54

312

1250

Other and unspecified dermatitis

720

5455

1.33

11.83

1.7

1.9

16.87

11.27

iu/l

0.16

244

2046

Coeliac disease

196

1145

1.74

11.82

2.2

1.9

5.35

4.51

iu/l

0.47

426

Ptosis of eyelid

138

725

1.93

11.78

2.3

1.6

5.21

4.84

iu/l

0.13

230

Other symptoms and signs involving the nervous and musculoskeletal systems

592

4364

1.37

11.70

1.8

1.9

3.86

13.11

iu/l

1.05

221

1637

Phobic anxiety disorders

229

1397

1.66

11.70

2.0

2.1

44.28

4.33

iu/l

0.50

599

Diseases of the myoneural junction and muscle

154

840

1.86

11.69

1.7

1.8

5.22

4.92

iu/l

0.09

280

Somatoform disorder

259

1631

1.61

11.65

1.7

2.0

83.59

4.46

iu/l

0.78

654

Benign neoplasm of colon, rectum, anus and anal canal

674

3597

1.35

11.62

1.7

1.8

4.93

17.09

iu/l

1.08

186

1341

Disorders of choroid and retina

1007

5784

1.27

11.60

1.8

13.68

14.50

iu/l

0.03

342

1996

Other gastritis (incl. Duodenitis)

283

1819

1.57

11.59

1.7

1.8

34.84

4.79

iu/l

0.48

100

623

Dermatitis

839

6514

1.30

11.49

1.7

1.9

15.16

12.32

iu/l

0.09

285

2437

Pacemaker

325

2097

1.52

11.40

1.6

3.54

4.52

iu/l

1.02

100

609

Adenomyosis (Endometriosis of uterus)

240

1496

1.63

11.32

1.8

3.23

18.25

iu/l

0.57

568

Non-selective monoamine reuptake inhibitors

529

3735

1.38

11.30

1.8

3.80

12.48

iu/l

0.81

190

1365

Dentofacial anomalies [including malocclusion]

446

3124

1.43

11.28

1.8

2.0

24.85

11.04

iu/l

0.29

155

1273

Other noninfective gastroenteritis and colitis

340

2286

1.50

11.27

1.8

4.13

4.25

iu/l

0.07

108

831

Heartburn

155

858

1.84

11.26

1.9

1.8

2.74

4.81

iu/l

5.37

327

Other medical care

500

3524

1.40

11.25

1.5

1.8

3.67

6.92

iu/l

0.72

132

1263

Obesity and other hyperalimentation

937

7329

1.27

11.14

1.9

3.61

20.59

iu/l

1.43

334

2818

L01XE Protein kinase inhibitors

388

2.27

11.13

1.3

1.9

2.47

4.56

iu/l

2.79

133

Excessive vomiting in pregnancy

168

959

1.79

11.10

1.8

2.1

3.61

4.46

iu/l

0.47

396

Chronic periapical parodontitis

265

1696

1.58

11.09

1.8

40.29

9.56

iu/l

0.39

632

Urticaria and erythema

560

4132

1.37

11.07

1.8

1.9

3.94

8.43

iu/l

0.97

193

1616

Undetermined asthma

184

1076

1.73

11.02

1.7

1.9

3.94

4.34

iu/l

0.23

416

Obesity

932

7302

1.27

11.01

1.9

3.62

20.63

iu/l

1.43

332

2812

Single delivery by caesarean section

362

1411

1.50

10.99

2.0

2.1

3.75

15.05

iu/l

0.90

150

593

Provisional assignment of new diseases of uncertain etiology

642

4840

1.34

10.96

1.7

1.9

4.20

14.55

iu/l

1.20

206

1879

Diseases of arteries, arterioles and capillaries (FINNGEN)

282

1266

1.57

10.94

1.6

1.9

4.80

11.26

iu/l

0.49

475

Symptoms and signs involving the urinary system

977

5990

1.27

10.89

1.7

1.8

13.91

12.52

iu/l

0.05

319

2123

Codes for special purposes

642

4845

1.33

10.89

1.7

1.9

4.20

14.54

iu/l

1.20

206

1881

Diaphragmatic hernia

454

3249

1.41

10.82

1.9

1.8

4.55

7.26

iu/l

0.48

151

1136

Other chronic obstructive pulmonary disease, including avohilmo

572

3518

1.36

10.82

1.7

53.50

7.24

iu/l

0.70

173

1133

Nonorganic sleeping disorders, excluding more controls

271

1756

1.56

10.78

1.7

2.0

3.31

4.34

iu/l

1.22

740

Diabetes medication

1521

7674

1.21

10.65

1.8

1.9

9.92

13.24

iu/l

0.19

520

2896

Diseases of the ear and mastoid process

1845

7865

1.19

10.64

1.8

1.9

42.83

13.24

iu/l

0.46

659

2959

Later onset COPD, excluding more controls

206

967

1.68

10.63

1.7

1.6

3.76

4.90

iu/l

0.76

286

Shoulder lesions

1056

5170

1.26

10.61

1.7

1.8

3.79

11.88

iu/l

1.09

348

1917

Dental operations

897

3597

1.29

10.56

1.8

1.9

4.63

15.29

iu/l

1.20

312

1331

Other and unspecified urticaria

308

2062

1.51

10.55

1.9

4.26

4.51

iu/l

0.13

100

796

Other retinal disorders

740

4576

1.31

10.55

1.8

4.99

8.43

iu/l

0.62

238

1537

Benign neoplasm of colon, rectum, anus and anal canal

708

4900

1.31

10.55

1.7

4.88

12.69

iu/l

0.85

191

1683

STROKE

754

4026

1.31

10.55

1.8

3.64

14.08

iu/l

1.08

240

1464

Hypoparathyroidism

297

2.44

10.53

1.7

1.8

6.56

4.89

iu/l

0.62

Presence of cardiac and vascular implants and grafts

452

2440

1.41

10.52

1.5

1.6

3.57

4.48

iu/l

1.46

125

755

Benign neoplasm of other and unspecified endocrine glands

174

1017

1.74

10.52

1.9

3.39

4.49

iu/l

0.98

363

Pre-eclampsia or poor fetal growth

584

4367

1.35

10.49

2.0

40.75

24.93

iu/l

0.23

238

1804

Condition for Implicit Sepsis (Organ dysfunction codes)

1143

6728

1.24

10.46

1.7

1.9

11.72

11.36

iu/l

0.01

377

2460

Medical abortion

1182

5204

1.24

10.45

2.0

1.9

11.78

15.54

iu/l

0.17

451

2028

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1351

6784

1.22

10.45

1.7

1.9

10.67

11.15

iu/l

0.02

465

2536

Complications of procedures, not elsewhere classified

1130

7926

1.24

10.43

1.8

1.9

11.45

13.13

iu/l

0.07

391

2955

Benign neoplasm: Colon

589

4325

1.34

10.43

1.7

4.96

8.75

iu/l

0.65

158

1463

Abnormal involuntary movements

182

1081

1.71

10.37

1.8

55.34

4.71

iu/l

0.49

386

Non-small cell lung cancer, squamous, helper endpoint

175

2.85

10.31

1.6

2.43

5.52

iu/l

2.07

Non-small cell lung cancer, squamous

175

2.85

10.31

1.6

2.43

5.52

iu/l

2.07

All pneumoniae

1454

8345

1.21

10.21

1.7

1.9

60.94

12.46

iu/l

0.56

462

3159

Other disorders of adrenal gland

371

2.24

10.18

2.2

2.0

94.27

5.05

iu/l

0.49

132

Complications of the puerperium, not elsewhere classified

101

506

2.06

10.12

2.2

2.1

3.55

4.29

iu/l

0.63

219

Poisoning by drugs, medicaments and biological substances

364

2539

1.45

10.10

1.9

2.0

3.89

7.31

iu/l

0.57

131

1012

All influenza

299

2008

1.50

10.05

1.9

1.8

4.55

4.33

iu/l

0.13

727

Viral Sepsis

228

1445

1.59

10.01

1.6

1.8

2.99

4.59

iu/l

3.25

499

Fenamates

239

1020

1.60

9.92

1.7

1.9

4.12

iu/l

0.00

386

Oxicams

305

1151

1.52

9.87

1.5

1.9

4.01

4.23

iu/l

0.13

418

Pneumonias (Asthma/COPD co-morbidities)

1439

8310

1.20

9.87

1.7

1.9

61.82

12.51

iu/l

0.56

455

3143

Bleeding

1018

5969

1.25

9.82

1.7

1.8

4.50

15.58

iu/l

1.57

320

2082

Implicit viral Sepsis

226

1439

1.59

9.74

1.6

1.8

3.03

4.62

iu/l

3.18

494

Dental operations, only avohilmo

946

3852

1.26

9.73

1.8

4.41

14.64

iu/l

1.24

327

1415

Spinal stenosis

583

3444

1.33

9.69

1.7

39.55

7.43

iu/l

0.69

178

1173

Behavioural syndromes associated with physiological disturbances and physical factors

498

3687

1.36

9.68

1.8

2.0

2.93

6.42

iu/l

1.01

154

1485

Presence of other functional implants

661

3584

1.31

9.68

1.6

1.7

19.06

7.16

iu/l

0.39

226

1178

Other neurological diseases

889

5695

1.26

9.66

1.7

1.8

3.92

13.04

iu/l

1.27

268

2000

Early onset COPD, excluding more controls

223

1418

1.58

9.62

1.9

1.8

46.41

4.57

iu/l

0.49

529

Polycystic ovarian syndrome, consortium definition

1322

6611

1.21

9.53

1.8

2.0

63.40

10.98

iu/l

0.64

482

2606

Acute pharyngitis

213

1342

1.59

9.35

1.8

2.0

5.07

4.43

iu/l

0.32

536

Poisoning by medicine

331

2304

1.45

9.34

1.8

2.0

3.36

7.62

iu/l

0.69

120

927

Polyuria

246

1613

1.54

9.32

1.9

1.7

42.45

4.38

iu/l

0.49

554

Propionic acid derivatives

416

1485

1.42

9.28

1.9

4.58

4.11

iu/l

0.36

154

553

Persons encountering health services for specific procedures, not carried out

116

626

1.89

9.25

1.9

4.19

5.13

iu/l

0.41

240

Personality disorders

423

3078

1.39

9.25

1.9

2.0

3.36

6.80

iu/l

0.77

140

1251

Heterophoria

135

764

1.80

9.24

2.4

2.0

4.99

4.17

iu/l

0.36

287

Bacterial infection, other or unspecified

606

4184

1.31

9.23

1.6

1.8

4.39

6.45

iu/l

0.46

164

1447

Other and unspecified visual disturbances

138

786

1.78

9.23

2.1

1.9

4.20

4.96

iu/l

0.34

277

Endometriosis

668

3065

1.31

9.14

1.9

2.0

3.93

13.47

iu/l

0.79

254

1223

Menorrhagia

656

2788

1.31

9.10

1.9

16.63

14.50

iu/l

0.05

251

1100

Complications of medical and surgical care

979

7563

1.23

9.02

1.7

1.9

14.01

12.37

iu/l

0.06

308

2822

Hyperkalaemia

248

2.42

9.01

1.5

1.7

3.02

4.55

iu/l

0.79

355

0.14

9.01

1.4

1.7

—

4.60

—

110

Other and unspecified effects of external causes

405

2940

1.39

9.00

1.8

1.9

3.10

6.94

iu/l

0.82

142

1163

Delivery, wide proxy

559

2236

1.34

8.97

1.9

4.34

8.22

iu/l

0.51

208

816

Other CVD (FINNGEN)

125

541

1.84

8.97

1.8

3.56

5.04

iu/l

1.39

184

Myocarditis

305

2.27

8.96

1.6

1.9

2.86

4.69

iu/l

1.24

125

Soft tissue disorders related to use, overuse and pressure

347

2455

1.43

8.95

1.7

1.8

29.36

16.79

iu/l

0.19

124

896

Benign neoplasm of other and unspecified endocrine glands

174

1065

1.66

8.93

1.9

1.8

3.39

4.59

iu/l

1.02

380

Disorders of refraction and accommodation

380

2723

1.40

8.92

2.0

1.9

4.02

7.13

iu/l

0.53

130

1065

Benign neoplasm: Colon, unspecified

254

1685

1.51

8.91

1.7

4.50

4.51

iu/l

0.00

564

Diseases of salivary glands

265

1785

1.50

8.88

1.6

1.9

3.02

9.11

iu/l

0.75

690

Falls/tendency to fall

1754

7488

1.18

8.87

1.9

8.92

21.60

iu/l

0.74

646

2826

Abnormal findings on antenatal screening of mother

172

1054

1.66

8.85

2.1

2.2

3.54

4.07

iu/l

0.59

470

Diabetes, insulin treatment (Kela reimbursement)

1392

7140

1.20

8.85

1.7

1.9

10.48

10.93

iu/l

0.02

479

2622

Papillary adenocarcinoma of thyroid gland

468

2.01

8.83

1.6

2.0

4.24

4.87

iu/l

0.26

165

Implicit bacterial Sepsis

403

2685

1.38

8.75

1.5

1.7

3.10

4.69

iu/l

4.48

122

858

Persistent mood disorders

275

1874

1.48

8.71

2.0

1.9

3.42

4.44

iu/l

1.80

731

Adverse effects, not elsewhere classified

299

2072

1.46

8.70

1.8

1.9

2.97

4.47

iu/l

4.47

107

813

Temporomandibular joint disorders, including avohilmo

692

5445

1.28

8.63

1.9

2.0

96.76

11.89

iu/l

0.53

250

2180

Rheumatism, unspecified

232

1534

1.53

8.57

1.9

4.81

23.30

iu/l

0.72

589

Other and unspecified anaemias

442

3169

1.36

8.55

1.7

3.96

4.58

iu/l

0.62

144

1030

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1380

8169

1.19

8.52

1.7

1.9

64.44

12.69

iu/l

0.56

435

3081

Other acute lower respiratory infections

671

5027

1.28

8.52

1.8

4.44

6.01

iu/l

0.43

214

1836

Disorders of adult personality and behaviour

438

3250

1.36

8.50

1.9

2.0

3.37

6.61

iu/l

0.77

153

1323

Disorders of sclera, cornea, iris and ciliary body

720

5713

1.27

8.45

1.9

1.8

4.25

11.05

iu/l

0.96

262

2094

Acute sinusitis

772

5751

1.26

8.44

2.0

1.9

15.82

24.68

iu/l

0.25

277

2234

Other and unspecified polyneuropathies, also in other diseases

196

1252

1.58

8.41

1.6

1.7

3.83

4.66

iu/l

0.48

407

Other arthrosis

654

3651

1.29

8.39

1.8

5.40

11.35

iu/l

0.82

197

1338

Maternal care for known or suspected abnormality of pelvic organs

462

2378

1.35

8.27

2.0

2.1

3.55

10.66

iu/l

1.04

188

1045

Hypothyroidism, autoimmune, DX-based

4.81

8.25

2.0

1.7

3.89

9.99

iu/l

—

Special screening examination for other diseases and disorders

116

649

1.81

8.25

1.6

1.9

3.64

4.58

iu/l

0.60

254

Migraine without aura and triptan purchases

288

2006

1.45

8.22

1.9

2.1

4.26

4.34

iu/l

0.05

103

863

Dental caries 2 and operation codes

1153

7635

1.20

8.21

2.0

1.9

53.27

13.01

iu/l

0.39

412

2940

Convulsions, not elsewhere classified

284

1944

1.45

8.20

1.9

3.49

4.61

iu/l

1.61

732

Deforming dorsopathies

385

2822

1.37

8.10

1.7

1.9

4.34

4.84

iu/l

0.44

131

1065

Cervical disc disorders

456

3429

1.34

8.09

1.9

1.8

4.21

7.31

iu/l

0.64

163

1263

Third [oculomotor] nerve palsy

104

3.19

8.09

1.5

1.7

4.87

6.11

iu/l

0.21

Postmenopausal osteoporosis with pathological fracture

448

1.98

8.08

1.9

1.6

4.86

4.42

iu/l

0.13

128

Malignant neoplasm, wide definition for exclusion

1260

6242

1.20

8.08

1.7

1.9

5.04

14.85

iu/l

1.43

424

2405

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

1260

6242

1.20

8.08

1.7

1.9

5.04

14.85

iu/l

1.43

424

2405

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

642

3429

1.29

8.07

1.5

1.8

5.38

13.27

iu/l

0.60

158

1216

Irregular menses

875

5776

1.24

8.05

1.9

2.0

87.39

10.26

iu/l

0.68

343

2352

Other specified/unspecified arthritis

358

2597

1.39

8.04

1.8

31.58

10.89

iu/l

0.34

113

986

Persons encountering health services in circumstances related to reproduction

774

4197

1.26

8.03

2.0

1.8

24.59

8.60

iu/l

0.55

300

1573

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

1259

6241

1.20

8.02

1.7

1.9

5.05

14.86

iu/l

1.43

423

2403

Other anaemias

444

3210

1.34

8.02

1.7

3.96

4.60

iu/l

0.64

144

1051

Polyneuropathies and other disorders of the peripheral nervous system

222

1474

1.52

8.01

1.6

1.7

4.30

4.47

iu/l

0.07

488

Other diseases of the digestive system

320

2278

1.41

8.00

1.7

3.79

4.44

iu/l

0.84

743

Nonischemic cardiomyopathy

347

2.11

7.99

1.5

1.8

210.50

5.71

iu/l

0.47

116

Sleep disorders

305

2158

1.43

7.95

1.7

2.0

3.28

4.35

iu/l

1.44

852

Inflammatory disease of uterus

262

1808

1.47

7.90

1.8

2.0

4.05

8.46

iu/l

0.54

756

Left bundle-branch block

410

2.00

7.86

1.4

1.7

2.45

4.77

iu/l

3.11

136

Delirium, not induced by alcohol and other psychoactive substances

113

636

1.79

7.85

1.4

1.7

4.31

4.24

iu/l

0.02

193

Disorder of lipoprotein metabolism, unspecified

133

785

1.71

7.85

1.9

1.6

3.15

4.18

iu/l

0.91

238

Pneumonia, organism unspecified

1233

7506

1.19

7.78

1.7

1.9

65.01

12.37

iu/l

0.49

380

2813

Retention of urine

318

1914

1.41

7.77

1.6

1.7

3.92

4.35

iu/l

0.32

106

610

Other arthritis (FG)

404

3007

1.35

7.72

1.8

1.9

28.26

7.13

iu/l

0.42

129

1137

Bacterial Sepsis

464

3127

1.33

7.71

1.6

1.7

3.43

4.63

iu/l

2.40

142

1012

Disorders of vitreous body and globe

597

4569

1.28

7.70

1.8

4.16

13.38

iu/l

0.98

190

1573

Unspecified mental disorder

569

4442

1.29

7.68

1.6

1.9

20.35

6.26

iu/l

0.39

182

1706

Allergic conjunctivitis

892

7212

1.22

7.66

1.9

73.49

12.45

iu/l

0.50

334

2797

Acute bronchitis

500

3761

1.31

7.65

1.8

3.96

6.69

iu/l

0.61

163

1354

Other disorders of amniotic fluid and membranes

252

1723

1.47

7.60

1.9

2.2

3.42

8.49

iu/l

0.69

782

COPD

448

2787

1.33

7.59

1.8

1.7

27.12

4.62

iu/l

0.47

133

895

Gonarthrosis [arthrosis of knee](FG)

969

4692

1.22

7.59

1.7

1.8

27.67

7.88

iu/l

0.41

338

1738

Ovarian cyst

700

3220

1.27

7.56

2.1

2.0

3.96

13.00

iu/l

0.79

283

1286

GI-bleeding

316

2268

1.40

7.55

1.7

3.60

4.42

iu/l

1.29

100

734

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

656

3287

1.27

7.54

1.8

1.9

4.35

12.56

iu/l

0.73

262

1337

Transient ischemic attack

566

3657

1.29

7.54

1.7

3.30

7.32

iu/l

0.90

165

1188

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

296

2104

1.42

7.54

1.7

1.8

3.86

8.53

iu/l

0.62

785

Other chronic obstructive pulmonary disease

431

2692

1.34

7.52

1.8

1.7

27.90

4.64

iu/l

0.48

129

860

Dental caries 2

1162

7682

1.19

7.50

2.0

1.9

53.47

12.96

iu/l

0.39

410

2956

Obesity due to excess calories

659

5257

1.26

7.47

1.8

1.9

3.92

14.00

iu/l

1.32

221

2047

Trochanteric bursitis

204

1354

1.53

7.47

1.9

45.81

11.24

iu/l

0.37

508

Noninfective enteritis and colitis

615

4861

1.27

7.45

1.8

1.9

3.95

12.12

iu/l

1.02

208

1818

Premature rupture of membranes

394

2149

1.36

7.44

2.1

137.69

7.85

iu/l

0.48

150

953

Aplastic and other anaemias

476

3456

1.31

7.40

1.7

4.10

4.61

iu/l

0.50

154

1138

Disorders of vitreous body

580

4466

1.28

7.37

1.8

4.02

13.61

iu/l

1.01

184

1535

Elevated blood glucose level

108

615

1.78

7.32

2.0

1.9

3.19

4.81

iu/l

2.00

220

Anti-inflammatory and antirheumatic products, non-steroids

401

1485

1.36

7.31

1.8

1.9

4.57

4.11

iu/l

0.35

146

553

Need for other prophylactic measures

436

1.94

7.31

2.5

1.8

4.02

4.99

iu/l

0.54

152

Insomnia

229

1564

1.48

7.28

1.8

2.0

3.46

4.40

iu/l

0.88

612

Nonorganic sleeping disorders

271

1910

1.43

7.28

1.7

2.0

3.31

4.34

iu/l

1.22

757

Other external causes of accidental injury

1367

5823

1.18

7.25

1.8

1.9

10.40

24.78

iu/l

0.64

508

2238

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

849

6864

1.22

7.23

2.0

1.9

76.52

12.88

iu/l

0.50

320

2660

Enlarged lymph nodes

199

1323

1.52

7.21

1.6

1.9

3.85

4.70

iu/l

0.68

491

Cholelithiasis

1161

6867

1.19

7.19

1.9

1.8

4.30

13.19

iu/l

1.44

387

2566

Noninflammatory disorders of female genital tract

834

3416

1.24

7.14

2.0

4.08

12.48

iu/l

0.77

321

1362

DVT of lower extremities and pulmonary embolism

456

3483

1.31

7.13

1.7

1.8

4.18

7.04

iu/l

0.55

150

1184

Chronic laryngitis and laryngotracheitis

177

1151

1.55

7.12

2.1

1.8

4.75

4.40

iu/l

0.16

415

Dislocation, sprain and strain of joints and ligaments at neck level

224

1531

1.48

7.11

1.9

2.0

4.27

4.19

iu/l

0.04

616

Antenatal screening

418

1764

1.35

7.08

2.1

2.0

49.32

12.88

iu/l

0.37

170

771

Cholecystectomy

946

6956

1.21

7.07

1.9

1.8

4.23

11.05

iu/l

1.20

316

2583

Other and unspecified myopathies

534

1.82

7.04

1.7

1.8

6.11

4.51

iu/l

0.39

180

Pain and other conditions associated with female genital organs and menstrual cycle

373

2674

1.35

6.99

1.9

2.0

3.84

11.35

iu/l

0.55

127

1112

Extrapyramidal and movement disorders

410

3106

1.33

6.99

1.7

1.8

55.64

4.57

iu/l

0.80

121

1069

Other symptoms and signs involving cognitive functions and awareness

481

3489

1.30

6.97

1.6

1.7

25.06

4.51

iu/l

0.49

149

1193

Disorders of gallbladder, biliary tract and pancreas

1336

7359

1.17

6.96

1.9

1.8

10.99

12.62

iu/l

0.08

461

2730

Other symptoms and signs involving the circulatory and respiratory systems

457

1.89

6.96

1.7

1.9

5.51

4.90

iu/l

0.14

146

Procreative management

428

2745

1.32

6.96

1.9

52.41

10.58

iu/l

0.41

159

1084

Gonarthrosis

829

3887

1.23

6.94

1.7

1.8

31.14

10.98

iu/l

0.35

295

1432

Other disorders of skin and subcutaneous tissue

859

6500

1.22

6.94

1.8

15.37

10.30

iu/l

0.18

291

2347

Substance use, excluding alcohol

254

1785

1.43

6.94

1.8

1.9

4.61

4.38

iu/l

0.14

692

Disorders of synovium and tendon

737

5400

1.23

6.92

1.8

1.9

15.56

13.80

iu/l

0.05

273

2086

Agoraphobia

300

2.12

6.92

2.2

2.1

6.89

5.14

iu/l

0.29

133

AV-block

151

863

1.60

6.87

1.5

1.7

3.55

4.38

iu/l

0.62

260

Other extrapyramidal and movement disorders in other diseases

269

1914

1.42

6.87

1.8

82.09

4.48

iu/l

0.80

674

Pulmonary heart disease, diseases of pulmonary circulation

336

2478

1.36

6.85

1.7

4.22

8.39

iu/l

0.55

108

810

Carpal tunnel syndrome

820

6095

1.22

6.85

1.8

1.9

26.62

9.24

iu/l

0.55

279

2239

Other disorders of teeth and supporting structures

253

1781

1.43

6.85

2.0

1.9

3.28

9.20

iu/l

0.69

666

Statin medication

1033

4846

1.20

6.80

1.9

4.09

12.00

iu/l

1.03

368

1887

Gonarthrosis,primary

1082

5726

1.19

6.79

1.7

1.8

25.71

12.13

iu/l

0.28

362

2005

Excessive attrition of teeth

581

2482

1.28

6.79

1.9

5.00

7.63

iu/l

0.36

181

963

conjunctival haemorrhage

519

1.82

6.79

1.9

1.8

5.67

4.39

iu/l

0.34

161

Disorders of vestibular function (Vertigo)

575

4538

1.27

6.78

1.8

3.73

15.37

iu/l

1.31

186

1604

Cervicobrachial syndrome

310

2265

1.38

6.76

1.8

1.9

34.19

5.11

iu/l

0.47

103

869

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

778

6368

1.22

6.73

1.7

1.8

16.36

11.80

iu/l

0.14

247

2337

Injuries to the thorax

489

3813

1.29

6.72

1.7

1.8

23.65

4.38

iu/l

0.48

157

1333

Maternal care for known or suspected fetal abnormality and damage

285

1828

1.40

6.69

2.0

2.2

3.62

12.00

iu/l

0.94

831

Follicular adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

3.40

6.68

1.8

2.0

5.14

7.41

iu/l

—

Pregnancy, childbirth and the puerperium

469

1882

1.31

6.68

1.9

1.8

4.23

9.25

iu/l

0.56

174

675

Infections of the skin and subcutaneous tissue

730

5939

1.23

6.67

1.8

1.9

3.66

12.15

iu/l

1.34

261

2224

Hypermobility syndrome

104

605

1.75

6.65

1.6

2.1

86.75

4.57

iu/l

0.47

257

Benign neoplasm: Colon, unspecified

254

1800

1.42

6.64

1.7

4.50

4.70

iu/l

0.08

586

Specific personality disorders

358

2684

1.34

6.62

1.8

2.0

3.48

4.35

iu/l

1.41

119

1106

Pain associated with micturition

158

1020

1.57

6.62

1.7

1.8

4.56

4.55

iu/l

0.00

362

Poor fetal growth

241

1697

1.44

6.62

2.1

2.2

53.54

4.08

iu/l

0.49

109

745

Type 2 diabetes

1375

7018

1.17

6.61

1.7

1.9

10.85

12.87

iu/l

0.09

454

2646

Malignant neoplasm

1224

6187

1.18

6.58

1.6

1.9

5.10

12.76

iu/l

1.16

404

2357

Cervicalgia

268

1921

1.41

6.57

1.9

1.8

3.24

5.08

iu/l

3.94

714

Pregnancy hypertension

741

5477

1.23

6.53

2.0

14.65

23.63

iu/l

0.27

304

2215

Any event in cancer register

1346

6859

1.17

6.53

1.7

1.9

16.62

12.98

iu/l

0.12

466

2643

Fentanyl

107

628

1.72

6.52

1.5

1.8

4.13

4.50

iu/l

0.12

213

Renal tubulo-interstitial diseases

1174

7675

1.18

6.52

1.7

1.9

12.23

12.33

iu/l

0.00

377

2835

Dental caries 2, only avohilmo

1134

7610

1.18

6.49

2.0

1.9

54.62

13.06

iu/l

0.39

400

2933

Accidents

1354

5823

1.17

6.45

1.8

1.9

10.44

24.78

iu/l

0.64

505

2238

Polyarthropathies

909

5051

1.20

6.41

1.8

1.9

15.10

11.91

iu/l

0.11

288

1938

COPD-related respiratory insufficiency

104

609

1.72

6.41

1.9

1.8

3.68

4.17

iu/l

0.28

178

Abnormal findings on diagnostic imaging of other body structures

164

1076

1.54

6.40

1.8

54.86

4.68

iu/l

0.50

376

Other problems related to primary support group, including family circumstances

185

1213

1.50

6.40

1.8

2.0

46.98

4.16

iu/l

0.48

496

Bacterial pneumonia, not elsewhere classified

441

3020

1.30

6.37

1.6

1.8

29.07

7.42

iu/l

0.41

124

1044

Oral lichen ruber planus wide, hypothyreosis or thyroxin

465

1.84

6.36

2.0

1.8

6.88

4.60

iu/l

0.63

150

Arthrosis

957

4398

1.20

6.36

1.7

1.8

5.22

10.13

iu/l

0.82

323

1638

Other diseases of jaws

552

1.76

6.36

1.9

3.78

4.42

iu/l

0.36

209

Disorders of skin appendages

667

5428

1.23

6.36

1.9

3.80

11.07

iu/l

1.06

223

2103

Tobacco use

429

1.88

6.35

2.5

2.0

177.14

4.81

iu/l

0.48

168

Acute tubulo-interstitial nephritis

822

6051

1.21

6.35

1.7

1.9

15.85

14.53

iu/l

0.04

266

2249

Emotionally unstable personality disorder

207

1428

1.47

6.34

1.9

2.1

3.63

4.28

iu/l

0.54

587

Bacterial pneumoniae

463

3194

1.29

6.34

1.6

1.8

27.05

7.18

iu/l

0.41

135

1115

Diagnoses used for exclusion with ILD

267

1926

1.40

6.31

1.7

4.28

4.49

iu/l

0.12

670

Other disorders of bladder

124

765

1.64

6.29

1.5

1.8

96.08

4.64

iu/l

0.49

253

Pregnancy with abortive outcome

1180

5259

1.18

6.28

2.0

1.9

4.13

15.39

iu/l

1.48

458

2054

Cervicocranial syndrome

149

963

1.57

6.24

2.1

1.9

3.13

4.85

iu/l

3.11

369

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

293

2156

1.37

6.21

2.1

2.0

3.43

4.22

iu/l

1.61

107

892

Hyperfunction of pituitary gland

476

1.82

6.20

1.5

2.0

1.90

4.62

iu/l

7.20

186

Kela-code for severe mental illness

488

3848

1.28

6.20

1.5

1.9

23.05

4.39

iu/l

0.46

156

1471

Glucagon-like peptide-1 (GLP-1) analogues

589

3893

1.25

6.19

1.6

1.8

20.96

9.35

iu/l

0.29

178

1308

Other diseases of anus and rectum

344

2588

1.34

6.18

1.8

3.97

7.98

iu/l

0.63

111

925

Spondylolisthesis/Spondylolysis

233

1651

1.42

6.15

1.7

1.8

5.02

5.42

iu/l

0.20

613

Internal derangement of knee

487

3833

1.27

6.14

1.9

49.82

10.72

iu/l

0.42

173

1458

Unspecified haematuria

405

2667

1.31

6.14

1.6

1.7

4.38

4.57

iu/l

0.12

119

874

Localized swelling, mass and lump of skin and subcutaneous tissue

383

2935

1.31

6.09

1.8

57.53

7.31

iu/l

0.77

122

1079

Other and unspecified tonsillitis

473

3151

1.28

6.09

1.9

2.0

4.11

31.72

iu/l

0.99

180

1265

Meniscus derangement

702

3930

1.23

6.08

1.7

1.8

32.80

10.85

iu/l

0.35

271

1442

Injuries to the abdomen, lower back, lumbar spine and pelvis

456

3550

1.28

6.07

1.8

24.19

4.40

iu/l

0.48

152

1259

Supervision of normal pregnancy

394

1715

1.32

6.07

2.2

2.0

49.89

13.17

iu/l

0.36

166

746

Viral pneumonia

145

937

1.56

6.07

2.1

1.9

3.77

4.78

iu/l

0.62

331

COPD, hospital admissions

434

2853

1.29

6.07

1.8

1.7

27.90

4.66

iu/l

0.48

129

872

Hyperkinetic disorders, excluding more controls

155

989

1.54

6.07

1.9

2.2

3.51

4.14

iu/l

0.34

438

Other specified/unspecified soft tissue disorders

393

1.89

6.04

1.8

2.35

4.54

iu/l

3.21

153

Intracranial trauma

788

4882

1.21

6.03

1.8

2.0

5.48

20.66

iu/l

0.78

263

1938

Cardiac murmurs and other cardiac sounds

127

788

1.61

6.02

1.8

1.9

3.32

4.95

iu/l

1.66

275

Congenital malformations, deformations and chromosomal abnormalities

861

6919

1.20

6.01

2.0

1.9

4.30

20.17

iu/l

1.21

325

2681

Tonsillectomy and adenotomy

914

5351

1.19

6.01

2.0

4.09

23.63

iu/l

1.23

341

2197

COPD, early/later onset

437

2873

1.29

5.99

1.8

1.7

27.50

4.64

iu/l

0.47

131

877

Hypertensive Heart Disease

206

1166

1.45

5.98

1.7

1.6

3.35

4.71

iu/l

1.54

356

Other general symptoms and signs

404

1.87

5.97

1.9

2.0

3.83

4.91

iu/l

0.62

153

Congenital malformations of the circulatory system

179

1176

1.49

5.96

2.3

1.9

3.58

4.83

iu/l

1.06

434

Obsessive-compulsive disorder

106

639

1.68

5.95

2.0

2.2

3.04

4.55

iu/l

2.21

277

Delivery

643

2754

1.24

5.94

2.0

1.9

4.05

10.63

iu/l

0.89

232

1013

Primary gonarthrosis, bilateral

565

3977

1.25

5.94

1.7

45.55

9.16

iu/l

0.43

189

1327

Cholelithiasis, broad definition with cholecystitis

1179

6939

1.17

5.94

1.9

1.8

4.27

13.10

iu/l

1.44

397

2591

Other diseases of blood and blood-forming organs, wide

263

1915

1.38

5.93

1.8

4.22

4.43

iu/l

0.15

105

676

COPD related to multimorbidity

354

2261

1.32

5.91

1.8

1.6

30.89

4.62

iu/l

0.47

113

678

Pleural effusion

140

903

1.56

5.91

1.7

3.24

4.53

iu/l

1.07

275

Volume depletion

504

1.76

5.91

1.5

1.7

4.16

3.98

iu/l

0.04

151

Leiomyoma of uterus

812

3803

1.21

5.86

1.9

2.0

4.48

16.95

iu/l

1.18

321

1534

Stomatitis and related lesions

110

672

1.66

5.86

2.0

3.60

4.48

iu/l

0.78

260

Hyperhidrosis

272

2.07

5.85

1.8

2.0

3.16

5.36

iu/l

1.64

114

Venous thromboembolism

610

4821

1.23

5.82

1.7

1.8

4.71

12.80

iu/l

0.89

198

1673

Inflammatory diseases of prostate (prostatitis)

543

1.73

5.82

1.7

1.6

5.08

3.96

iu/l

0.35

167

Certain disorders involving the immune mechanism

229

1635

1.41

5.81

1.8

4.92

4.59

iu/l

0.16

605

Abnormal serum enzyme levels

244

1737

1.39

5.79

1.6

1.7

4.72

4.36

iu/l

0.15

550

Oter anti-inflammatory and antirheumatic agents, non-steroids

245

966

1.41

5.77

2.0

1.8

6.63

4.19

iu/l

0.66

348

Familial hypercholesterolemia

143

932

1.55

5.77

1.6

1.5

5.26

4.06

iu/l

0.36

283

TMD related operations

237

1708

1.40

5.72

1.8

2.0

40.15

9.08

iu/l

0.39

669

Other abnormal uterine and vaginal bleeding

368

2008

1.32

5.72

1.8

1.9

3.62

19.19

iu/l

0.79

120

751

191

1327

1.46

5.72

2.1

2.2

3.33

4.15

iu/l

0.81

600

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

242

1751

1.39

5.70

1.9

2.0

4.68

4.40

iu/l

0.14

709

Emotional disorders starting during childhood or adolecense, excluding more controls

413

1.83

5.70

2.0

2.3

3.02

4.55

iu/l

1.52

179

Other necrotizing vasculopathies

503

1.75

5.70

1.5

1.9

5.25

4.55

iu/l

0.16

164

Injuries to the neck

296

2210

1.35

5.70

2.0

4.05

4.39

iu/l

0.27

860

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

523

1.73

5.69

1.3

1.6

2.33

4.54

iu/l

3.14

144

Schizophrenia or delusion, excluding more controls

384

2949

1.30

5.69

1.6

1.9

3.40

4.42

iu/l

1.67

125

1165

Vasomotor and allergic rhinitis

551

4388

1.24

5.68

1.8

1.9

20.19

13.72

iu/l

0.16

208

1725

Hypotension

146

959

1.53

5.68

1.7

3.48

4.45

iu/l

1.04

294

Retinal detachments and breaks

369

2847

1.30

5.61

1.8

1.7

28.14

7.85

iu/l

0.40

130

948

Hypertensive heart and/or renal disease

228

1260

1.41

5.61

1.7

1.6

3.58

4.68

iu/l

1.22

388

Diseases of male genital organs

397

1541

1.31

5.60

1.6

1.7

4.71

16.59

iu/l

0.73

117

480

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

801

5883

1.20

5.57

2.0

13.89

22.55

iu/l

0.28

330

2350

Scleritis and episcleritis

560

1.71

5.56

1.7

2.0

4.49

4.54

iu/l

0.01

208

Social phobias

125

799

1.58

5.55

1.9

2.2

81.50

4.36

iu/l

0.49

350

Single delivery by forceps and vacuum extractor

263

1167

1.39

5.54

2.2

2.1

4.42

16.97

iu/l

0.82

118

503

Benign neoplasm of mouth and pharynx

129

831

1.57

5.53

1.8

1.9

3.20

4.53

iu/l

1.59

290

Bacterial pneumonia (organism specified)

481

3493

1.26

5.53

1.6

1.8

26.69

6.89

iu/l

0.41

137

1208

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

154

1031

1.51

5.52

1.4

1.8

4.85

4.65

iu/l

0.05

340

Other necrotizing vasculopathies (FG)

420

1.81

5.50

1.5

1.9

4.85

iu/l

0.00

145

Sixth [abducent] nerve palsy

218

2.16

5.48

1.7

3.33

4.39

iu/l

0.44

Benign neoplasm: Sigmoid colon

183

1270

1.45

5.46

1.6

1.7

7.51

4.69

iu/l

0.95

421

Other disorders of conjunctiva

157

1058

1.50

5.46

2.1

1.8

5.40

4.71

iu/l

0.23

357

Substance abuse, excluding more controls

645

4649

1.22

5.45

1.8

1.9

4.46

12.30

iu/l

0.92

209

1758

Follicular adenocarcinoma of thyroid gland

4.33

5.44

1.3

1.9

3.16

4.28

iu/l

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

422

1.81

5.43

2.0

2.18

4.73

iu/l

4.79

162

Non-allergic asthma (mode), excluding more controls

232

1664

1.39

5.43

1.8

45.10

4.55

iu/l

0.49

636

Haemorrhoids and perianal venous thrombosis

329

2512

1.32

5.40

1.6

1.8

3.50

8.01

iu/l

0.71

893

Entropion and trichiasis of eyelid

429

1.79

5.40

1.8

1.6

4.60

4.67

iu/l

0.02

123

Preparation and fitting of bite rail to mouth

191

1341

1.44

5.39

1.7

2.0

3.07

4.75

iu/l

3.36

528

Noninfectious colitis NAS

173

1192

1.46

5.39

1.9

4.05

4.56

iu/l

0.33

441

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

543

1.70

5.34

1.7

1.9

2.70

4.90

iu/l

3.46

182

Coxarthrosis [arthrosis of hip](FG)

608

3601

1.23

5.33

1.7

1.8

70.75

9.35

iu/l

0.64

163

1279

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

298

2048

1.33

5.29

1.9

2.2

3.81

3.93

iu/l

0.08

108

843

Other complications of surgical and medical care, not elsewhere classified

130

849

1.55

5.28

1.9

4.94

4.92

iu/l

0.00

311

Other shoulder lesions

129

841

1.55

5.28

1.7

2.0

2.66

4.97

iu/l

4.85

335

Impingement syndrome of shoulder

298

2255

1.33

5.27

1.8

4.60

17.92

iu/l

0.73

829

Pulmonary embolism

301

2281

1.33

5.24

1.7

4.00

4.61

iu/l

0.63

756

Iron deficiency

223

2.13

5.23

2.2

2.1

3.14

5.35

iu/l

1.38

Pulmonary heart disease

301

2283

1.33

5.22

1.7

4.00

4.61

iu/l

0.64

757

Other abnormal products of conception

594

3241

1.23

5.21

2.1

3.98

18.23

iu/l

1.27

242

1405

Benign neoplasm: Adrenal gland

540

1.69

5.20

2.0

1.9

4.42

4.54

iu/l

0.04

186

Other bacterial diseases

1191

7155

1.15

5.19

1.7

1.9

33.70

9.08

iu/l

0.56

371

2629

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

713

5967

1.20

5.19

1.8

17.25

10.86

iu/l

0.19

230

2190

Other and unspecified disorders of vitreous body

476

3810

1.25

5.17

1.8

1.7

3.71

15.38

iu/l

1.04

155

1293

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

145

977

1.51

5.14

2.1

3.23

4.26

iu/l

1.28

430

Intracranial injury

704

5696

1.20

5.09

1.7

1.8

4.85

9.56

iu/l

0.61

226

2074

Diseases of inner ear

645

5249

1.21

5.08

1.8

3.82

13.87

iu/l

1.30

215

1848

Aortic aneurysm

175

1200

1.44

5.07

1.6

4.06

4.26

iu/l

0.07

337

Obesity, other/unspecified

473

3816

1.25

5.04

1.8

2.0

3.20

13.72

iu/l

1.15

169

1531

Thoracic aortic aneurysm

115

738

1.57

5.03

1.6

1.7

5.03

4.34

iu/l

0.17

216

Giant cell arteritis

253

2.01

5.03

1.7

5.09

4.68

iu/l

0.04

All influenza (not pneumonia)

170

1184

1.45

5.01

2.0

1.9

5.52

4.57

iu/l

0.40

435

Coxarthrosis

565

3133

1.23

5.01

1.7

1.8

76.52

12.81

iu/l

0.60

150

1120

Malignant neoplasm of skin

645

4029

1.21

5.00

1.5

1.7

5.71

9.08

iu/l

0.48

154

1335

Mental and behavioural disorders due to sedatives or hypnotics

569

1.66

5.00

1.5

1.9

3.50

4.73

iu/l

0.98

210

Astigmatism

500

1.70

5.00

2.2

1.8

3.39

4.61

iu/l

0.95

170

Other diseases of pericardium

240

2.03

4.97

1.4

1.9

3.30

4.92

iu/l

0.83

Rotator cuff syndrome

740

4621

1.19

4.97

1.7

1.8

15.52

12.87

iu/l

0.08

254

1683

Other diseases of liver

213

1547

1.39

4.97

1.6

1.8

4.13

4.54

iu/l

0.23

574

Female infertility

565

2855

1.23

4.96

2.3

2.0

88.67

13.77

iu/l

0.42

237

1175

Mouth breathing

447

3587

1.25

4.95

1.7

1.8

41.01

12.82

iu/l

0.53

170

1280

Vitamin deficiency

383

1.80

4.94

1.9

6.36

4.84

iu/l

0.28

137

Vitamin deficiency, wide

383

1.80

4.94

1.9

6.36

4.84

iu/l

0.28

137

Horner syndrome

2.79

4.93

1.8

1.6

13.24

7.57

iu/l

—

Single spontaneous delivery

626

2750

1.22

4.91

1.9

3.98

10.63

iu/l

0.90

226

1009

Benign neoplasm: Adrenal gland

549

1.66

4.91

2.0

1.9

4.42

4.66

iu/l

0.07

188

Maternal care for known or suspected malpresentation of fetus

323

1855

1.31

4.90

1.9

2.2

151.01

8.13

iu/l

0.48

136

844

Outcome of delivery

291

1363

1.33

4.89

2.3

2.0

4.10

15.08

iu/l

0.88

117

613

External causes of morbidity and mortality

1108

4805

1.16

4.88

1.9

4.57

23.25

iu/l

0.97

444

1847

Allergic rhinitis

453

3616

1.25

4.88

1.8

2.0

23.53

8.61

iu/l

0.36

170

1454

Other and unspecified nerve root and plexus disorders, also in other diseases

222

1628

1.37

4.88

1.7

1.9

4.04

4.38

iu/l

0.26

633

Cutaneous abscess, furuncle and carbuncle

304

2335

1.31

4.87

1.9

3.89

4.34

iu/l

0.38

107

875

Post-traumatic stress disorder

136

915

1.50

4.85

2.0

2.2

4.50

4.39

iu/l

0.03

413

Hyperplasia of prostate

246

1031

1.37

4.85

1.3

1.6

4.08

23.26

iu/l

0.78

313

Follow-up examination after treatment for malignant neoplasms

115

746

1.56

4.83

1.7

8.39

4.77

iu/l

0.61

260

Schizoaffective disorder

112

724

1.57

4.81

1.4

2.0

2.87

4.38

iu/l

3.25

279

Viral infections characterized by skin and mucous membrane lesions

503

4106

1.23

4.78

1.9

4.43

6.49

iu/l

0.48

171

1511

Other diseases of intestine

127

844

1.52

4.78

1.9

1.8

6.11

4.79

iu/l

0.39

299

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

116

757

1.55

4.77

1.6

1.9

5.98

4.68

iu/l

0.26

276

Suicide or other Intentional self-harm

330

2571

1.29

4.76

1.8

2.0

4.14

7.30

iu/l

0.51

102

1012

Benign neoplasm: Pituitary gland, craniopharyngeal duct

440

1.73

4.76

2.0

1.9

2.18

4.99

iu/l

4.83

152

Rash and other nonspecific skin eruption

127

846

1.52

4.75

1.9

4.88

4.45

iu/l

0.13

316

Benign neoplasm: Sigmoid colon

183

1306

1.41

4.75

1.6

1.7

7.51

4.55

iu/l

1.01

427

Mental disorders, not otherwise specified

128

856

1.51

4.71

2.1

2.0

3.59

4.29

iu/l

0.69

326

Recurring oral aphthae, including avohilmo

171

1209

1.43

4.70

1.8

1.9

4.88

4.29

iu/l

0.25

439

Atopic dermatitis

838

6117

1.17

4.69

1.9

2.0

14.76

20.58

iu/l

0.17

308

2422

Restless leg syndrome

149

1028

1.46

4.68

1.7

1.8

4.38

4.76

iu/l

0.15

366

Other disorders of patella

245

1839

1.34

4.65

1.9

6.61

13.17

iu/l

0.51

101

720

Benign neoplasm of mouth and pharynx

129

866

1.50

4.65

1.8

1.9

3.20

4.78

iu/l

1.71

302

Fall on same level

1678

8379

1.12

4.61

1.9

4.06

20.87

iu/l

1.61

604

3134

Endometriosis of pelvic peritoneum

274

2066

1.32

4.61

2.0

3.44

17.46

iu/l

0.82

112

851

Parodontitis and operation codes

1072

7265

1.15

4.60

1.8

12.78

12.08

iu/l

0.03

353

2644

Temporal arteritis

227

2.02

4.60

1.7

5.41

4.91

iu/l

0.05

Sarcoidosis

158

1106

1.44

4.59

1.8

4.93

4.71

iu/l

0.09

407

Papulosquamous disorders

467

3804

1.23

4.59

1.7

1.8

3.75

12.38

iu/l

0.81

153

1372

Hyperprolactinaemia

356

1.81

4.59

1.6

2.1

1.81

4.93

iu/l

6.56

143

Pre-eclampsia or eclampsia

372

2959

1.27

4.58

1.9

2.0

27.41

16.05

iu/l

0.20

143

1209

Hard cardiovascular diseases

901

4970

1.17

4.57

1.6

1.8

24.71

12.59

iu/l

0.36

304

1712

Other diseases of pleura

416

2961

1.25

4.56

1.7

3.73

4.55

iu/l

1.03

127

931

Early onset COPD

223

1655

1.36

4.56

1.9

1.7

46.41

4.45

iu/l

0.49

543

Atopic conjunctivitis

401

1.75

4.55

1.6

1.9

3.43

5.33

iu/l

0.86

149

Drug-induced osteoporosis with pathological fracture

2.60

4.53

1.8

1.6

3.44

6.45

iu/l

—

Non-allergic asthma (mode)

232

1718

1.35

4.52

1.8

45.10

4.50

iu/l

0.49

654

Collagenous colitis

115

759

1.53

4.52

1.8

1.9

3.90

4.36

iu/l

0.27

256

Acute renal failure

178

1276

1.40

4.51

1.4

1.7

2.43

4.77

iu/l

7.05

412

Other cataract

461

2901

1.24

4.48

1.8

1.7

3.92

7.85

iu/l

0.66

146

978

Monoamine oxidase A inhibitors

144

996

1.46

4.47

1.6

1.9

4.46

4.92

iu/l

0.21

374

Senile cataract

683

3564

1.19

4.47

1.7

4.04

15.96

iu/l

0.99

211

1219

Other bacterial intestinal infections

191

1388

1.39

4.47

1.6

1.8

3.05

4.53

iu/l

2.67

497

Complications predominantly related to the puerperium

445

3621

1.24

4.47

2.3

2.0

4.09

13.99

iu/l

0.99

185

1474

Lichen simplex chronicus and prurigo

486

1.67

4.47

1.8

1.9

2.75

4.72

iu/l

2.43

165

Superficial injury of head

262

1997

1.32

4.47

1.6

1.8

3.47

4.30

iu/l

0.63

731

Blepharochalasis

312

2435

1.29

4.46

2.1

1.6

4.92

18.23

iu/l

0.66

101

771

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

603

1.60

4.45

1.8

2.0

2.74

4.80

iu/l

3.51

223

Female infertility, cervigal, vaginal, other or unspecified origin

507

2785

1.23

4.45

2.3

2.0

97.86

13.98

iu/l

0.43

214

1146

Benign neoplasm of eye and adnexa

115

762

1.52

4.44

1.6

1.9

3.14

4.66

iu/l

1.46

262

Fracture of rib(s), sternum and thoracic spine

282

2174

1.30

4.42

1.5

1.7

41.06

4.35

iu/l

0.50

718

Disorders of lens

769

4130

1.18

4.40

1.7

1.8

3.87

14.00

iu/l

1.01

243

1451

Septal defects

515

1.64

4.40

2.4

1.9

3.41

4.80

iu/l

1.25

187

Renal failure

391

2866

1.25

4.38

1.4

1.6

3.37

4.54

iu/l

1.32

111

886

Secondary right heart disease

224

1.99

4.38

1.8

1.7

6.27

5.41

iu/l

0.15

Unspecified kidney failure

527

1.63

4.36

1.6

1.7

3.15

4.64

iu/l

1.05

162

Disorders of myoneural junction and muscle in diseases classified elsewhere

3.17

4.32

2.3

1.6

10.32

5.67

iu/l

—

Other symptoms and signs involving general sensations and perceptions

282

1.87

4.32

1.8

2.71

5.62

iu/l

2.55

Benign neoplasm of other and ill-defined parts of digestive system

194

1423

1.37

4.32

1.8

80.90

4.63

iu/l

0.50

501

Ischaemic heart disease, wide definition

879

4742

1.16

4.31

1.6

1.8

26.47

12.95

iu/l

0.37

278

1627

Later onset COPD

214

1245

1.36

4.30

1.7

1.5

3.70

4.18

iu/l

0.30

322

Giant cell arteritis with polymyalgia rheumatica

233

1.97

4.30

1.7

5.41

5.32

iu/l

0.01

Diseases of liver

369

2953

1.26

4.29

1.8

4.36

7.50

iu/l

0.53

114

1049

Benign neoplasm: Cerebral meninges

112

744

1.52

4.29

1.8

4.02

4.61

iu/l

0.23

267

Nonalcoholic fatty liver disease

118

793

1.50

4.28

1.8

1.9

3.74

4.91

iu/l

0.84

295

Heart failure and hypertrophic cardiomyopathy

2.62

4.27

1.9

1.6

1.52

5.83

iu/l

—

Unspecified acute lower respiratory infection

158

1122

1.42

4.26

1.9

5.87

4.57

iu/l

0.47

408

Erosion of teeth, including avohilmo

273

2036

1.30

4.26

1.8

1.9

230.98

8.16

iu/l

0.48

827

Other CVD

166

1189

1.40

4.25

1.7

3.67

4.40

iu/l

0.72

377

Congenital malformations of cardiac septa

544

1.60

4.24

2.4

1.9

4.52

4.95

iu/l

0.13

200

Polymyalgia rheumatica

131

902

1.46

4.19

1.6

1.7

90.78

4.62

iu/l

0.49

281

Keratitis

427

3484

1.23

4.18

1.9

1.8

4.17

6.76

iu/l

0.53

162

1284

Benign paroxysmal vertigo

340

2707

1.26

4.17

1.9

1.8

4.30

7.95

iu/l

0.56

115

944

Vitamin A deficiency

3.72

4.14

2.2

1.8

17.20

7.27

iu/l

—

Presbycusis

106

697

1.52

4.13

1.6

4.03

4.12

iu/l

0.05

195

Mycoses

305

2401

1.28

4.11

1.7

1.8

3.66

4.34

iu/l

1.02

870

Dental pulpitis 3

203

1082

1.36

4.10

2.3

2.1

4.37

3.90

iu/l

0.32

434

Myopia

176

1284

1.38

4.09

2.0

4.25

4.23

iu/l

0.01

518

Other disorders of bone

248

1903

1.31

4.09

1.8

1.9

5.71

4.39

iu/l

0.31

734

Otitis externa

263

2036

1.30

4.06

1.8

1.9

4.21

4.41

iu/l

0.14

762

Sequelae of external causes of morbidity and mortality

276

2150

1.29

4.05

1.8

3.38

4.51

iu/l

1.24

756

Neuromuscular dysfunction of bladder

102

673

1.53

4.05

1.9

3.12

4.31

iu/l

0.75

240

Vitreous haemorrhage

105

697

1.52

4.05

1.8

5.24

4.94

iu/l

0.09

238

Diseases of appendix

1010

8082

1.14

4.03

1.9

32.57

17.76

iu/l

0.36

397

3024

Parodontitis

1130

7357

1.13

4.02

1.8

12.28

11.92

iu/l

0.01

375

2693

Postpartum haemorrhage

434

3101

1.23

3.99

2.2

2.0

4.00

16.69

iu/l

1.04

174

1317

Chronic periodontitis, including avohilmo

1124

7348

1.13

3.98

1.8

12.41

11.93

iu/l

0.02

370

2687

Persons with potential health hazards related to communicable diseases

551

4594

1.19

3.97

2.1

2.0

3.64

21.77

iu/l

0.92

277

1820

Malignant neoplasm of digestive organs

211

2736

0.76

3.96

1.6

5.82

4.42

iu/l

0.55

841

Lactose intolerance, other/unspecified

198

2.01

3.96

2.1

1.7

4.49

5.56

iu/l

0.28

Conjunctivitis (acute, non atopic)

350

2804

1.25

3.96

2.0

1.9

4.23

7.21

iu/l

0.51

127

1083

Benign neoplasm: Cerebral meninges

112

758

1.49

3.96

1.8

4.02

4.93

iu/l

0.37

258

Cushing syndrome

2.59

3.95

1.8

1.9

3.49

5.99

iu/l

—

Parodontitis or operation codes

1130

7361

1.13

3.94

1.8

12.28

11.91

iu/l

0.01

375

2694

Brachial plexus disorders

134

940

1.44

3.93

1.6

2.0

3.57

4.82

iu/l

1.49

395

Type 2 diabetes, definitions combined

1243

6589

1.13

3.92

1.7

1.9

11.31

11.30

iu/l

0.00

415

2472

Other pulmonary heart/vessel disease

255

1.87

3.92

1.7

6.27

5.44

iu/l

0.15

Secondary polycythaemia

132

2.24

3.90

1.7

1.8

3.07

5.83

iu/l

1.27

Wet age-related macular degeneration

137

947

1.43

3.89

1.7

1.6

6.22

4.13

iu/l

0.81

269

Other and unspecified disorders of binocular movement

3.22

3.89

1.5

2.1

2.04

4.93

iu/l

—

Abnormal findings on diagnostic imaging of central nervous system

382

1.70

3.89

2.0

1.9

4.22

5.34

iu/l

0.54

130

Appendectomy

910

7670

1.15

3.88

1.8

1.9

27.88

17.23

iu/l

0.24

350

2896

Hyperkinetic disorders

157

1120

1.40

3.88

1.9

2.2

3.64

4.14

iu/l

0.25

465

Fracture of foot, except ankle

302

2394

1.27

3.88

1.9

4.06

7.71

iu/l

0.55

113

922

Dissociative [conversion] disorders

375

1.71

3.87

1.9

2.0

3.02

5.08

iu/l

1.94

156

Congenital malformations of heart and great arteries

149

1033

1.41

3.87

2.2

1.9

3.43

4.71

iu/l

1.72

375

Complications of labour and delivery

1062

5215

1.14

3.86

2.1

1.9

11.68

14.07

iu/l

0.11

439

2010

Radiculopathy

177

1305

1.36

3.85

1.8

49.17

4.96

iu/l

0.48

455

Hernia of abdominal wall, postoperative

188

1399

1.35

3.85

1.8

4.57

10.77

iu/l

0.53

533

Glaucoma

586

4354

1.19

3.84

1.7

4.25

8.83

iu/l

0.87

168

1473

Dental pulpitis 3, only avohilmo

185

998

1.36

3.83

2.3

2.1

4.17

3.74

iu/l

0.28

397

Episcleritis

484

1.61

3.83

1.9

2.0

4.86

4.92

iu/l

0.01

171

Other specified/unspecified systemic involvement of connective tissue

539

1.58

3.82

1.5

1.9

116.12

4.55

iu/l

0.49

196

TMD related pain

362

1.72

3.81

2.0

4.57

5.29

iu/l

0.23

139

Cardiac arrest

270

1.77

3.81

1.7

2.37

4.67

iu/l

1.78

Benign neoplasm of eye and adnexa

115

789

1.47

3.80

1.6

1.9

3.14

4.78

iu/l

1.39

275

Deviated nasal septum

328

2628

1.25

3.80

1.8

29.72

7.60

iu/l

0.40

117

921

Tinnitus

271

2126

1.28

3.80

2.1

1.8

61.65

8.51

iu/l

0.45

771

Manic episode

244

1.88

3.79

1.4

1.9

5.82

5.26

iu/l

0.10

Ovarian dysfunction

136

965

1.43

3.79

1.8

2.2

5.43

4.00

iu/l

0.59

406

Artrosis, including avohilmo

1114

5404

1.13

3.77

1.8

12.81

9.97

iu/l

0.13

395

2040

Melanocytic naevi

368

2994

1.24

3.76

1.7

2.0

3.54

7.16

iu/l

0.76

110

1181

Psoriasis

325

2609

1.25

3.75

1.6

1.8

2.98

7.76

iu/l

0.86

106

966

Anosmia

107

2.34

3.75

1.3

1.9

2.29

2.44

iu/l

—

Mental and behavioural disorders due to psychoactive substance use

669

5417

1.17

3.74

1.8

4.48

14.41

iu/l

1.33

220

1989

Chronic kidney disease

239

1839

1.30

3.74

1.5

1.6

3.95

4.40

iu/l

0.21

567

Convergent concomitant strabismus

542

1.57

3.74

3.4

1.9

7.68

4.29

iu/l

1.35

201

Missing teeth due to accident, extraction or parodontitis

124

866

1.44

3.73

2.0

1.8

3.18

4.53

iu/l

1.68

312

Cerebrovascular diseases

794

4934

1.16

3.72

1.7

3.96

14.62

iu/l

1.25

236

1688

Appendicitis, broad definition

997

8046

1.14

3.72

1.9

32.72

17.79

iu/l

0.37

395

3017

Recurrent dislocation of patella

567

1.55

3.71

2.0

2.1

7.38

4.64

iu/l

0.39

239

Substance abuse

645

5279

1.17

3.71

1.8

4.46

14.64

iu/l

1.34

209

1943

Viral and other specified intestinal infections

273

2100

1.28

3.70

1.8

2.0

4.12

3.98

iu/l

0.12

104

832

Deposits [accretions] on teeth

478

1.59

3.69

1.5

1.9

5.45

4.89

iu/l

0.08

166

Other specified and unspecified personality disorders

128

902

1.43

3.69

1.7

2.0

2.73

4.49

iu/l

2.58

353

Sequelae with surgical and medical care as external cause

214

1635

1.32

3.69

1.7

1.8

3.55

4.51

iu/l

0.66

569

Polyhydramnios

505

1.59

3.68

2.1

2.2

5.98

3.77

iu/l

0.71

224

Disturbance of activity and attention

149

1065

1.39

3.67

1.9

2.2

3.67

4.10

iu/l

0.21

446

Leiomyoma of uterus

988

4945

1.14

3.66

1.9

4.53

13.48

iu/l

1.14

381

1903

Polyarthrosis

236

1752

1.30

3.66

1.7

1.8

7.93

14.55

iu/l

0.43

631

Acute appendicitis, no complications

745

6445

1.16

3.66

1.9

40.96

11.48

iu/l

0.71

308

2457

Disorders of muscles

121

845

1.44

3.66

1.7

2.0

4.51

4.99

iu/l

0.16

340

Lactose intolerance

233

1.88

3.64

2.1

1.7

4.38

5.28

iu/l

0.27

Other and unspecified mood [affective] disorders

104

707

1.49

3.63

1.8

2.1

80.59

4.19

iu/l

0.48

291

Fracture of lumbar spine and pelvis

214

1636

1.31

3.63

1.6

1.8

3.43

4.60

iu/l

1.77

540

Other noninflammatory disorders of uterus, except cervix

316

1724

1.26

3.62

1.7

1.8

5.01

21.71

iu/l

0.69

637

Sicca syndrome [Sjögren]

121

848

1.44

3.61

1.9

1.8

4.19

4.56

iu/l

0.17

310

Other diseases of oesophagus

642

1.51

3.61

1.5

1.8

121.88

4.55

iu/l

0.48

210

Other disorders of glucose regulation and pancreatic internal secretion

643

1.51

3.59

1.9

5.14

4.85

iu/l

0.08

235

Other coagulation defects

660

1.50

3.59

1.6

1.9

2.36

4.44

iu/l

5.82

256

Other disorders of ear

1156

6860

1.13

3.59

1.8

18.15

13.75

iu/l

0.12

396

2485

Dermatographic urticaria

661

1.50

3.57

1.7

2.0

3.70

4.26

iu/l

0.35

256

Other diseases of lip and oral mucosa

181

1357

1.34

3.57

2.0

1.8

4.32

10.66

iu/l

0.52

508

Ischemic heart diseases

886

4859

1.14

3.57

1.6

1.8

25.41

12.76

iu/l

0.36

293

1665

Pyoderma gangrenosum

2.82

3.57

2.4

1.9

2.59

7.66

iu/l

—

Oral leukoplakia and related diseases, including avohilmo

100

677

1.49

3.56

1.7

1.8

3.72

4.58

iu/l

0.55

229

Other or ill-defined heart diseases

330

1.71

3.56

1.8

3.02

5.28

iu/l

2.00

122

Malignant neoplasm of bladder

285

1.77

3.56

1.3

1.7

2.56

4.54

iu/l

—

Acute appendicitis

932

7755

1.14

3.56

1.9

34.33

17.17

iu/l

0.41

375

2919

Labour and delivery complicated by fetal stress [distress]

436

2411

1.21

3.56

2.3

2.1

128.01

12.33

iu/l

0.54

187

1064

Acute laryngitis and tracheitis

159

1151

1.37

3.55

1.9

2.0

3.11

4.36

iu/l

2.29

451

Other predominantly sexually transmitted diseases, not elsewhere classified

263

2078

1.27

3.53

2.0

2.1

4.30

4.48

iu/l

0.11

100

871

Benign neoplasm of meninges

118

827

1.44

3.52

1.8

4.09

4.70

iu/l

0.26

293

Otitis externa, unspecified

137

986

1.40

3.52

2.0

1.9

3.96

4.49

iu/l

0.37

380

Other and unspecified drugs and medicaments

102

696

1.48

3.51

1.5

2.0

7.03

4.91

iu/l

0.34

250

Toxic liver disease

106

2.32

3.50

2.1

1.9

2.96

6.56

iu/l

—

Type 2 diabetes, strict (exclude DM1)

1241

6632

1.12

3.49

1.7

1.9

11.40

11.25

iu/l

0.01

412

2488

Benign neoplasm of major salivary glands

101

689

1.48

3.47

1.6

1.8

3.57

4.87

iu/l

0.60

237

Diabetic retinopathy, strict definition

184

1218

1.34

3.46

2.0

1.7

4.12

18.85

iu/l

0.77

417

Failed induction of labour

103

708

1.48

3.45

2.3

2.1

3.75

4.05

iu/l

0.16

301

Vascular disorders of the intestines

356

1.67

3.45

1.4

1.7

3.02

4.44

iu/l

0.66

112

Benign neoplasm of meninges

118

831

1.43

3.44

1.8

4.09

4.71

iu/l

0.25

287

Car occupant injured in other and unspecified transport accidents

240

1881

1.28

3.44

1.9

2.0

4.05

4.39

iu/l

0.27

744

Implicit fungal Sepsis

216

1.88

3.43

1.8

1.87

5.57

iu/l

3.26

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

281

2736

0.80

3.42

1.6

1.8

5.52

7.74

iu/l

0.28

931

Correction of physiology of bite - demanding therapy visit

104

717

1.47

3.42

1.7

2.0

89.14

4.32

iu/l

0.48

272

Cluster headache, strict

305

1.73

3.41

1.7

2.1

3.79

5.54

iu/l

0.87

117

KRA_PSY_EATING, excluding more controls

140

1016

1.39

3.38

1.8

2.3

2.18

4.28

iu/l

9.52

453

Prurigo nodularis

168

2.00

3.38

1.8

2.85

5.80

iu/l

—

Chronic periodontitis

143

1044

1.38

3.37

1.8

4.08

4.35

iu/l

0.13

373

Polyp of the female genital tract

507

2488

1.19

3.36

2.0

1.9

4.00

15.86

iu/l

0.77

191

966

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

187

1376

1.32

3.36

2.1

1.9

3.13

4.69

iu/l

3.46

514

Diseases of external ear

373

3079

1.22

3.35

1.8

4.51

7.05

iu/l

0.43

113

1103

241

1676

1.28

3.35

1.6

6.07

4.75

iu/l

0.64

477

Autonomic disorders

176

1.97

3.33

1.6

1.7

9.45

5.76

iu/l

0.44

Exposure to unspecified factor

1301

9103

1.11

3.33

1.8

1.9

19.07

17.69

iu/l

0.04

419

3405

Other skin changes

176

1330

1.33

3.32

1.7

1.8

3.67

4.28

iu/l

0.44

470

Cerebral cysts

478

1.57

3.32

1.5

2.0

2.31

4.72

iu/l

4.79

179

Intermittent heterotropia

542

1.53

3.31

2.1

2.0

4.36

4.28

iu/l

0.03

208

COPD, hospital admission 2, with asthma infections

271

1844

1.26

3.28

1.8

1.6

41.19

4.55

iu/l

0.48

567

Ulcer of lower limb, not elsewhere classified

121

863

1.41

3.28

1.4

1.7

4.11

4.60

iu/l

0.14

280

Pre-eclampsia

335

2745

1.23

3.28

1.9

2.0

30.03

9.98

iu/l

0.37

128

1124

Psychotic depression

487

1.56

3.28

1.7

2.1

150.83

4.16

iu/l

0.48

193

Other disorders of iris and ciliary body

163

2.00

3.27

2.2

1.9

4.56

6.40

iu/l

0.56

COPD, hospital admissions 3, with asthma pneumonia sepsis

210

1381

1.30

3.27

1.7

1.6

51.83

4.67

iu/l

0.48

400

Other disorders of skin and subcutaneous tissue, not elsewhere classified

154

1144

1.36

3.27

1.8

4.35

4.44

iu/l

0.04

408

Gastric ulcer

160

1195

1.35

3.26

1.7

171.51

4.83

iu/l

0.79

373

Emotional disorders starting during childhood or adolescence

500

1.55

3.26

2.1

2.0

3.24

4.44

iu/l

1.00

194

Emotional disorders and disorders of social functioning with onset specific to childhood

521

1.53

3.26

2.0

2.1

3.44

4.43

iu/l

0.73

209

Fungal Sepsis

235

1.81

3.24

1.8

1.87

5.28

iu/l

3.25

Other disorders of binocular movement

221

1.85

3.24

2.0

2.17

4.90

iu/l

2.83

Barrett oesophagus

272

1.75

3.23

2.0

1.8

6.36

4.69

iu/l

0.27

Benign neoplasm of other and ill-defined parts of digestive system

194

1493

1.31

3.23

1.8

80.90

4.52

iu/l

0.50

518

Glaucoma suspect

377

3128

1.21

3.23

1.7

1.8

5.02

7.50

iu/l

0.39

109

1070

Pericarditis

199

1.88

3.22

1.6

1.8

5.81

4.83

iu/l

—

TMD muscular pain linked with fibromyalgia

2.44

3.22

2.1

2.0

1.83

5.88

iu/l

—

Other abnormal findings in urine

2.36

3.21

2.0

1.6

2.67

8.34

iu/l

—

Other noninflammatory disorders of vagina

119

852

1.41

3.20

2.0

1.8

4.59

4.64

iu/l

0.02

322

Carcinoma in situ of breast, lobular

2.74

3.20

2.3

1.5

4.32

6.18

iu/l

—

Schizophrenia, schizotypal and delusional disorders

388

3231

1.21

3.20

1.6

1.9

3.43

6.84

iu/l

0.74

124

1226

Antepartum haemorrhage, not elsewhere classified

140

1031

1.37

3.18

2.2

4.66

4.15

iu/l

0.25

476

Female genital prolapse

454

2201

1.20

3.18

1.8

1.9

4.00

17.75

iu/l

0.77

156

833

Mixed connective tissue disease

613

1.49

3.17

1.6

1.9

105.02

4.61

iu/l

0.49

220

Degeneration of macula and posterior pole

436

3021

1.19

3.17

1.7

5.88

4.53

iu/l

1.02

121

898

Melanocytic naevi

368

3053

1.21

3.17

1.7

1.9

3.54

7.06

iu/l

0.73

110

1181

Oral lichen ruber planus, hypothyreosis or thyroxin

138

2.09

3.17

1.3

1.7

2.35

4.74

iu/l

—

Other and unspecified nonorganic psychotic disorders

242

1920

1.27

3.17

1.6

2.0

3.46

4.42

iu/l

1.01

764

Valvular operations

105

735

1.44

3.17

1.7

3.54

4.47

iu/l

0.38

228

L04AA Selective immunosuppressants

261

2090

1.26

3.16

1.8

1.9

5.23

8.37

iu/l

0.36

788

Use of glatiramer acetate

180

1.94

3.16

2.7

2.0

11.54

5.51

iu/l

1.03

Other symptoms and signs involving the digestive system and abdomen

210

1639

1.29

3.15

1.7

1.8

4.04

4.63

iu/l

0.47

623

Other diseases of blood and blood-forming organs

484

1.54

3.15

1.5

1.9

2.84

4.88

iu/l

2.36

164

Respiratory insufficiency

404

1.59

3.13

1.4

1.8

3.59

5.23

iu/l

0.78

134

Gonarthrosis, primary, with knee surgery

574

4035

1.17

3.13

1.7

47.75

9.14

iu/l

0.43

178

1327

Spermatocele

282

1.71

3.12

1.5

1.6

2.83

3.95

iu/l

0.61

Cluster headache, wide

321

1.67

3.11

1.7

2.1

3.79

5.54

iu/l

0.88

121

Postviral fatigue syndrome

2.35

3.11

1.4

2.2

2.38

5.84

iu/l

—

Injuries to the elbow and forearm

905

7269

1.13

3.11

1.8

1.9

3.96

10.75

iu/l

1.27

307

2702

Injury, poisoning and certain other consequences of external causes

896

3968

1.13

3.10

2.0

1.9

4.57

25.24

iu/l

0.86

348

1523

Pustulosis palmaris et plantaris

376

1.62

3.09

2.0

1.9

4.44

4.79

iu/l

0.08

129

Twin gestation

146

1088

1.36

3.09

2.0

2.1

3.55

4.49

iu/l

0.69

504

Impotence

202

1.85

3.08

2.0

1.8

3.72

4.64

iu/l

0.44

Nasal polyp

186

1433

1.30

3.08

2.0

1.8

4.71

4.33

iu/l

0.20

493

Other disorders of binocular vision

133

2.09

3.07

2.2

1.9

2.32

5.11

iu/l

1.82

Benign lipomatous neoplasm

319

2619

1.22

3.06

1.6

1.8

4.30

7.36

iu/l

0.47

102

985

Dental caries 1 and operation codes, only avohilmo

375

1557

1.22

3.06

1.9

4.76

10.19

iu/l

0.46

136

537

Other menopausal disorders

418

2017

1.20

3.05

1.9

3.65

18.34

iu/l

0.79

161

796

Personal history of other diseases and conditions

162

1222

1.33

3.05

2.0

5.08

3.92

iu/l

0.43

475

Budesonide

162

1227

1.33

3.05

2.0

1.9

3.87

4.47

iu/l

0.38

471

Vitamin D deficiency

147

2.02

3.04

1.9

1.8

3.46

5.34

iu/l

0.58

Speech therapy

303

2478

1.23

3.03

1.6

1.8

4.42

8.11

iu/l

0.52

889

Other blood glucose lowering drugs, excl. Insulins

168

1280

1.32

3.03

1.7

3.83

4.74

iu/l

0.81

406

Infections with a predominantly sexual mode of transmission

455

3862

1.18

3.03

2.0

4.15

13.57

iu/l

1.30

163

1598

Benign neoplasm: Ascending colon

117

844

1.40

3.01

1.9

1.8

5.76

4.64

iu/l

0.32

271

Cluster headache, strict, including avohilmo

450

1.55

3.01

1.7

2.0

4.79

4.73

iu/l

0.02

170

Retinal vascular occlusion

106

752

1.42

3.00

1.7

2.73

4.17

iu/l

2.48

217

Macular pucker

133

981

1.36

2.99

1.6

1.7

5.75

4.73

iu/l

0.23

284

Dysplasia of cervi uteri

411

2674

1.20

2.99

2.2

2.0

34.85

11.56

iu/l

0.34

179

1098

Assault by bodily force

662

1.45

2.99

1.8

1.9

2.91

4.92

iu/l

3.48

259

Coxarthrosis, primary

598

4503

1.16

2.97

1.7

55.43

8.57

iu/l

0.46

154

1493

Multiple gestation

149

1122

1.34

2.96

2.1

3.47

4.43

iu/l

0.74

516

Epilepsy

326

2686

1.21

2.94

1.7

1.8

4.19

7.58

iu/l

0.55

110

1003

Schizophrenia or delusion

384

3223

1.20

2.94

1.6

1.9

3.40

6.83

iu/l

0.74

125

1225

Preterm labour and delivery

398

3353

1.19

2.94

2.0

4.25

14.24

iu/l

0.80

162

1331

Carcinoma in situ of breast, lobular

2.61

2.94

2.3

1.6

4.32

5.63

iu/l

—

Melanocytic naevi of other and unspecified parts of face

534

1.50

2.92

2.0

2.81

4.56

iu/l

1.99

202

Benign neoplasm: Parotid gland

558

1.48

2.92

1.7

1.9

4.17

4.78

iu/l

0.18

191

Herpesviral [herpes simplex] infections

143

1072

1.34

2.91

1.9

2.0

3.58

4.48

iu/l

0.82

409

Gout, unspecified

142

1062

1.34

2.91

1.6

5.47

4.22

iu/l

0.34

307

Direct fill therapy

152

1149

1.33

2.91

1.9

3.73

4.72

iu/l

0.91

433

Atypical facial pain

470

1.53

2.91

1.8

1.9

126.83

4.64

iu/l

0.51

172

Premature separation of placenta [abruptio placentae]

252

1.74

2.90

2.1

2.2

2.27

4.06

iu/l

3.22

120

Drug-induced adrenocortical insufficiency

143

2.01

2.90

2.4

1.9

6.94

6.45

iu/l

0.07

Benign neoplasm of urinary organs

305

1.66

2.88

1.4

1.8

4.34

5.23

iu/l

0.23

Myositis

193

1.84

2.87

1.6

2.0

3.56

5.24

iu/l

0.55

Paralytic ileus and intestinal obstruction

248

1998

1.25

2.86

1.4

1.7

3.64

8.97

iu/l

0.62

684

Pustular psoriasis

400

1.57

2.85

2.0

1.9

4.54

4.93

iu/l

0.10

139

Anomalies of pupillary function

172

1.90

2.85

1.8

1.9

4.69

5.02

iu/l

0.05

Candidiasis

164

1258

1.31

2.85

1.6

1.9

3.72

4.48

iu/l

0.68

465

Dental caries 3 and operation codes, only avohilmo

446

1895

1.19

2.85

1.9

1.8

4.14

21.14

iu/l

0.73

175

643

Other eating disorders

587

1.47

2.84

1.7

2.1

1.95

4.46

iu/l

6.57

243

Injuries to the ankle and foot

942

7692

1.12

2.83

1.9

4.23

19.78

iu/l

1.33

343

2946

Zoster [herpes zoster]

182

1417

1.29

2.82

1.9

1.8

5.11

4.59

iu/l

0.20

480

Other pleural conditions

570

1.47

2.82

1.8

1.7

4.54

4.11

iu/l

0.12

177

Amenorrhoea

117

856

1.38

2.82

2.0

2.1

184.13

4.32

iu/l

0.75

377

Mixed hyperlipidaemia

209

1.79

2.80

1.6

1.7

3.98

3.95

iu/l

—

Perineal laceration during delivery

281

2051

1.23

2.80

2.2

2.1

3.53

13.80

iu/l

0.85

119

893

Type 2 diabetes, definitions combined, including avohilmo

1241

6665

1.10

2.80

1.7

1.9

11.25

11.21

iu/l

0.00

418

2503

Explicit Sepsis

433

3535

1.18

2.80

1.6

1.8

25.79

4.53

iu/l

0.48

143

1217

Retinal vascular disorders

106

763

1.40

2.79

1.7

2.73

4.22

iu/l

2.62

219

Chronic Coagulation defects

240

1.74

2.78

1.9

2.58

5.12

iu/l

2.74

Bacterial intestinal infections, IBD co-morbidities

186

1455

1.28

2.78

1.6

1.8

3.03

4.54

iu/l

2.72

518

Total colectomy

324

1.63

2.77

1.6

2.0

4.23

5.36

iu/l

0.45

117

Total colectomy operation

324

1.63

2.77

1.6

2.0

4.23

5.36

iu/l

0.45

117

Separation of retinal layers (serosa)

270

1.69

2.77

1.5

1.9

3.98

5.30

iu/l

0.32

Other (not insulin) diabetes medications

1243

6804

1.10

2.77

1.7

1.9

11.63

11.09

iu/l

0.02

407

2543

Polycystic ovarian syndrome

100

716

1.41

2.76

1.8

2.2

4.34

3.98

iu/l

0.19

303

Benign neoplasm: Bronchus and lung

2.41

2.75

1.6

2.48

4.80

iu/l

—

Spondyloarthritis

191

1501

1.28

2.75

1.6

1.9

3.74

4.50

iu/l

0.57

560

Degenerative macular diseases

112

816

1.38

2.75

2.1

1.7

6.07

4.27

iu/l

0.83

250

Superficial injury of lower leg

304

2516

1.21

2.75

1.9

3.91

7.57

iu/l

0.57

113

948

Dislocation, sprain and strain of joints and ligaments of thorax

256

1.70

2.74

1.8

1.9

2.03

4.85

iu/l

3.63

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

118

2.06

2.74

1.8

2.0

8.30

4.97

iu/l

—

Salpingitis and oophoritis

263

2148

1.23

2.73

1.8

1.9

4.39

17.38

iu/l

0.73

844

Divergent concomitant strabismus

101

725

1.41

2.73

2.0

1.9

4.00

4.28

iu/l

0.11

271

Other or unspecified paralytic strabismus

3.06

2.72

1.5

1.6

1.26

6.73

iu/l

—

Chondropathies

181

1416

1.29

2.72

1.9

2.0

6.13

4.63

iu/l

0.27

552

Benign neoplasm of urinary organs

310

1.63

2.72

1.4

1.9

4.35

4.65

iu/l

0.07

108

Torsion of ovary, ovarian pedicle and fallopian tube

250

1.71

2.70

1.6

2.0

3.41

4.06

iu/l

0.48

111

Superficial injury of wrist and hand

244

1979

1.24

2.70

1.9

2.0

3.35

4.33

iu/l

1.73

774

Osteonecrosis due to drugs

2.39

2.69

1.6

1.5

5.76

6.54

iu/l

—

Artificial joint operation, meniscal resection

1055

6337

1.11

2.69

1.7

1.8

26.31

11.42

iu/l

0.30

350

2213

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

594

1.44

2.67

1.8

1.9

4.45

4.67

iu/l

0.06

222

Other symptoms and signs involving the urinary system

677

1.41

2.67

1.7

1.8

4.32

4.39

iu/l

0.03

219

Other diseases of the respiratory system

167

1296

1.29

2.67

1.6

1.7

3.26

4.62

iu/l

1.95

406

Other respiratory disorders and diseases

167

1296

1.29

2.67

1.6

1.7

3.26

4.62

iu/l

1.95

406

Gout, strict definition

119

881

1.36

2.65

1.5

1.6

4.13

4.15

iu/l

0.01

250

Diabetic retinopathy, excluding more controls

273

1254

1.23

2.65

1.9

1.7

4.20

18.59

iu/l

0.77

426

Melanocytic naevi of other and unspecified parts of face

546

1.46

2.65

2.0

1.9

2.81

4.95

iu/l

2.42

202

Carcinoma in situ of colon

2.51

2.64

1.3

1.5

2.05

5.02

iu/l

—

Myasthenia gravis

120

2.04

2.64

2.2

1.7

4.87

4.99

iu/l

—

Benign neoplasm: Tongue

184

1.82

2.64

1.4

1.9

2.73

4.45

iu/l

—

Cluster headache, wide,, including avohilmo

473

1.50

2.63

1.7

2.0

4.79

4.67

iu/l

0.04

177

Viral pneumonia (known virus, not influenza)

141

1.95

2.63

1.9

1.7

3.96

5.49

iu/l

—

Intestinal stricture

291

2409

1.21

2.63

1.4

1.7

3.98

4.53

iu/l

0.34

805

Benign neoplasm of major salivary glands

101

730

1.39

2.63

1.6

1.9

3.57

4.53

iu/l

0.41

255

Faecal incontinence

110

807

1.37

2.62

1.6

1.7

5.86

4.81

iu/l

0.27

284

Seborrhoeic dermatitis

688

1.41

2.62

1.5

1.8

3.70

4.49

iu/l

0.44

239

Anankastic personality disorder

369

1.57

2.62

1.7

2.1

3.69

4.59

iu/l

0.53

151

Glaucoma-related operations

329

1.60

2.61

1.7

4.55

4.77

iu/l

0.04

101

Coagulation defects, purpura and other haemorrhagic conditions

209

1673

1.26

2.61

1.7

1.9

3.32

4.50

iu/l

1.41

622

Other diseases of stomach and duodenum

449

1.51

2.61

1.6

1.9

3.31

4.84

iu/l

1.40

145

Covid-19 suspected case

275

2268

1.22

2.60

1.6

2.0

4.25

7.54

iu/l

0.47

928

Myocardial infarction, without ST-elevation

315

2424

1.20

2.60

1.5

1.6

33.63

4.49

iu/l

0.48

103

705

Benign neoplasm: Kidney

230

1.72

2.58

1.4

1.9

2.81

4.77

iu/l

1.32

Postprocedural disorders of digestive system, not elsewhere classified

230

1.72

2.58

1.4

1.9

2.72

5.61

iu/l

2.49

Erectile dysfunction

314

1.60

2.58

1.4

1.7

4.70

4.26

iu/l

0.06

Endometriosis ASRM stages 1,2

279

2308

1.22

2.58

2.0

3.41

7.53

iu/l

0.67

114

941

Seropositive rheumatoid arthritis, strict definition

107

1446

0.74

2.58

1.8

4.70

4.60

iu/l

0.03

525

Acute inflammation of orbit

2.69

2.57

2.1

1.5

1.31

5.81

iu/l

—

Gastroduodenal ulcer

223

1796

1.24

2.57

1.6

1.7

116.54

4.88

iu/l

0.79

573

Benign leiomyoma with endometriosis

211

1696

1.25

2.57

1.8

1.9

5.15

9.37

iu/l

0.41

637

Arthropathies in other diseases classified elsewhere

269

1.66

2.55

1.7

1.9

3.45

4.55

iu/l

0.65

101

Postpartum hemorraghe, all women as controls

434

3717

1.17

2.55

2.2

2.1

4.00

26.04

iu/l

1.01

174

1607

Postmenopausal bleeding

376

1745

1.19

2.54

1.8

3.68

21.64

iu/l

0.79

124

647

Mixed and other personality disorders

108

795

1.37

2.54

1.9

2.0

2.38

4.51

iu/l

5.45

317

165

1218

1.29

2.54

1.6

6.22

4.80

iu/l

0.54

350

Otitis media, unspecified

140

984

1.32

2.53

2.1

1.9

4.64

4.26

iu/l

0.17

380

Intrahepatic Cholestasis of Pregnancy (ICP)

120

899

1.35

2.53

1.7

2.1

3.28

4.09

iu/l

1.07

379

Endometriosis of ovary

263

2163

1.22

2.52

2.1

1.9

4.86

17.20

iu/l

0.70

107

865

Haemorrhage in early pregnancy

443

3729

1.16

2.51

2.1

2.0

4.17

19.30

iu/l

1.46

175

1521

Glucosamine medication

523

3636

1.15

2.50

1.7

5.67

9.90

iu/l

0.54

141

1173

Smoking dependency

670

1.40

2.49

1.9

2.0

5.06

4.91

iu/l

0.06

239

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

271

1.64

2.49

1.7

2.0

4.99

4.84

iu/l

0.03

L04AX Other immunosuppressants

691

6143

1.13

2.48

2.2

1.8

4.45

11.80

iu/l

1.13

243

2312

Acute and transient psychotic disorders

139

1066

1.31

2.47

1.5

1.9

4.42

4.76

iu/l

0.12

405

Other noninflammatory disorders of vulva and perineum

135

1032

1.32

2.47

2.0

1.9

3.23

4.71

iu/l

2.73

406

Injuries to the knee and lower leg

1650

8732

1.08

2.47

1.8

1.9

4.36

20.40

iu/l

1.56

603

3214

Hypoglycaemia, other or unspecified

504

1.46

2.47

1.8

1.9

3.53

5.06

iu/l

0.68

184

Retinal breaks without detachment

164

1286

1.28

2.46

1.8

1.7

52.87

4.51

iu/l

0.49

445

Other septicaemia

348

2892

1.18

2.46

1.6

1.7

32.11

4.47

iu/l

0.49

111

955

Other misadventures during surgical and medical care

152

1.88

2.46

2.3

1.8

3.37

5.56

iu/l

0.74

Speech and linguistic disorders, excluding more controls

616

1.40

2.45

1.7

2.2

4.68

4.45

iu/l

0.06

257

Benign neoplasm: Tongue

189

1.77

2.44

1.4

1.7

2.73

4.74

iu/l

—

Use of antiglaucoma preparations and miotics

489

1.46

2.43

1.7

2.77

4.53

iu/l

2.31

155

Disorders of psychological development

139

989

1.31

2.43

1.8

2.1

5.17

4.20

iu/l

0.35

383

Other neurotic disorders

368

1.54

2.42

1.6

1.9

4.21

4.71

iu/l

0.18

126

Benign neoplasm: Ascending colon

117

879

1.34

2.41

1.9

1.7

5.76

4.67

iu/l

0.30

287

Arterial embolism and thrombosis

320

1.57

2.41

1.5

1.7

3.09

5.22

iu/l

1.65

101

Second line medication for Crohn's disease

710

6336

1.12

2.40

2.2

1.8

4.47

11.53

iu/l

1.12

249

2386

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

498

4340

1.15

2.40

2.0

4.07

15.59

iu/l

1.25

190

1730

Acute pancreatitis

178

1414

1.26

2.40

1.7

1.8

3.89

4.56

iu/l

0.39

488

Benign neoplasm: Bronchus and lung

2.25

2.40

1.6

1.7

2.48

4.50

iu/l

—

Corneal ulcer

200

1611

1.25

2.40

2.1

1.9

4.56

4.52

iu/l

0.02

615

Nail disorders

692

1.38

2.40

1.8

1.9

4.56

4.66

iu/l

0.03

251

DVT of lower extremities

188

1504

1.26

2.39

1.6

1.8

4.20

4.63

iu/l

0.17

519

Benign neoplasm of middle ear and respiratory system

524

1.44

2.39

1.8

1.9

3.87

4.97

iu/l

0.39

168

Dental caries 2 and operation codes, only avohilmo

993

5585

1.11

2.39

2.0

1.9

4.76

12.53

iu/l

1.05

352

2071

Melanoma in situ

228

1.69

2.38

1.4

1.8

3.80

3.95

iu/l

—

Assault

149

1160

1.29

2.38

1.8

2.0

3.07

4.55

iu/l

3.32

454

Mental and behavioural disorders due to tobacco

676

1.39

2.38

1.9

2.0

5.06

4.85

iu/l

0.09

240

Superficial injury of abdomen, lower back and pelvis

166

1310

1.27

2.38

1.9

59.36

4.32

iu/l

0.49

498

Osteonecrosis

410

1.50

2.38

1.6

1.8

6.10

5.05

iu/l

0.17

132

Atrial septal defect

304

1.59

2.37

2.1

1.8

5.23

5.31

iu/l

0.01

105

Other disorders of breast

183

1463

1.26

2.37

1.9

3.70

4.23

iu/l

0.37

561

Benign neoplasm: Rectum

156

1222

1.28

2.37

1.7

4.90

4.71

iu/l

0.06

399

Secondary parkinsonism, excluding more controls

125

1.94

2.37

1.6

1.8

2.65

4.09

iu/l

—

Urolithiasis

285

2383

1.20

2.36

1.8

1.7

4.09

4.41

iu/l

0.22

799

Peritonsillar abscess

255

2111

1.21

2.36

2.1

2.0

3.89

4.11

iu/l

0.19

113

864

Coronary atherosclerosis

699

4011

1.13

2.35

1.6

1.7

19.29

15.11

iu/l

0.10

204

1312

Chronic conjunctivitis

260

1.64

2.35

2.6

1.8

3.21

5.16

iu/l

0.67

Hypermetropia

576

1.42

2.35

2.1

1.9

4.64

4.39

iu/l

0.09

205

Dialysis, with operation codes

113

848

1.34

2.35

1.6

1.8

3.40

4.65

iu/l

0.89

287

Sequelae of cerebrovascular disease

301

2217

1.20

2.35

1.6

3.72

4.67

iu/l

0.93

698

Chondrocostal junction syndrome [Tietze]

323

1.57

2.35

1.7

2.0

3.25

4.62

iu/l

0.79

117

Follicular cysts of skin and subcutaneous tissue

191

1535

1.25

2.35

1.7

1.8

4.53

4.44

iu/l

0.04

570

Demyelinating diseases of the central nervous system

120

910

1.33

2.35

2.2

2.0

7.08

4.17

iu/l

1.35

360

Cardiomyopathy, Hypertrophic obstructive

2.07

2.33

1.7

1.8

1.88

5.26

iu/l

—

Causalgia

155

1.84

2.33

1.5

1.9

2.82

5.16

iu/l

1.56

Unknown and unspecified causes of morbidity

594

1.41

2.33

1.9

3.70

4.14

iu/l

0.31

215

Benign neoplasm: Parotid gland

586

1.41

2.32

1.7

1.9

4.17

4.65

iu/l

0.14

202

Primary open-angle glaucoma, strict

233

1912

1.22

2.31

1.6

4.33

4.96

iu/l

0.36

605

Torsion of testis

2.14

2.30

1.4

1.8

1.91

3.79

iu/l

—

Benign neoplasm: Conjunctiva

254

1.64

2.30

1.4

1.8

3.04

5.14

iu/l

1.01

Other diseases of arteries and capillaries

672

1.38

2.29

1.5

1.9

4.29

4.50

iu/l

0.06

235

Abnormal findings on examination of urine, without diagnosis

309

1.57

2.29

1.8

1.9

2.34

5.20

iu/l

3.99

109

Benign leiomyoma with endometriosis

211

1721

1.23

2.29

1.8

5.15

4.76

iu/l

0.16

621

Chronic pancreatitis

103

766

1.35

2.29

1.8

89.64

5.02

iu/l

0.48

261

Misadventures to patients during surgical and medical care

151

1185

1.28

2.28

1.9

3.85

4.52

iu/l

0.35

443

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

136

1055

1.30

2.27

1.7

2.1

3.25

4.34

iu/l

1.51

429

Abnormal blood-pressure reading, without diagnosis

350

1.53

2.26

1.6

1.9

4.83

4.93

iu/l

0.02

114

Benign neoplasm: salivary glands, exclude unknown (D119)

657

1.38

2.26

1.6

1.9

3.99

4.75

iu/l

0.26

227

Trigeminal neuralgia

506

1.44

2.26

1.9

7.71

4.75

iu/l

0.36

178

Other disorders of the genitourinary system

149

1170

1.28

2.25

1.9

1.7

3.87

4.88

iu/l

1.14

403

Hordeolum and other deep inflammation of eyelid

432

1.47

2.24

1.8

4.53

4.92

iu/l

0.18

148

Diseases of arteries, arterioles and capillaries

659

4381

1.12

2.24

1.6

1.7

4.00

8.68

iu/l

0.91

199

1461

Other abnormal immunological findings in serum

172

1.78

2.24

1.8

2.71

6.76

iu/l

2.19

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

735

1.36

2.24

1.5

1.9

3.25

4.59

iu/l

0.70

259

Encephalitis

225

1.67

2.23

1.9

7.62

5.90

iu/l

0.34

Fall on same level involving ice and snow

682

6105

1.12

2.23

1.8

1.9

3.93

12.09

iu/l

1.27

248

2239

Other specified and unspecified disorders of conjunctiva

2.47

2.22

3.6

1.6

4.55

6.40

iu/l

—

Melanoma in situ

233

1.65

2.22

1.4

1.7

3.80

4.87

iu/l

—

Ganglion

277

2327

1.20

2.21

1.7

2.0

4.08

16.38

iu/l

0.78

937

Superficial injury of forearm

114

866

1.33

2.21

1.9

3.50

4.50

iu/l

0.69

328

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1209

7230

1.09

2.21

1.7

1.9

4.56

15.11

iu/l

1.78

426

2668

Iridocyclitis

246

2044

1.21

2.21

1.8

4.05

4.49

iu/l

0.30

749

Melanocytic naevi of trunk

133

1032

1.30

2.21

1.8

2.0

4.52

4.23

iu/l

0.13

398

Speech disturbances, not elsewhere classified

592

1.39

2.21

1.7

1.8

3.26

4.60

iu/l

0.74

194

Other disorders of the musculoskeletal system and connective tissue

151

1191

1.27

2.20

1.9

1.8

4.26

4.67

iu/l

0.16

430

Fall on and from stairs and steps

278

2337

1.19

2.20

1.8

43.06

4.46

iu/l

0.49

856

Carcinoma in situ of colon

2.28

2.20

1.3

1.4

2.05

5.63

iu/l

—

Other viral diseases

357

3057

1.17

2.19

1.9

4.17

4.26

iu/l

0.07

139

1203

Other benign neoplasms of skin

395

3352

1.16

2.19

1.8

4.73

13.16

iu/l

0.67

140

1228

Benign neoplasm: Kidney

242

1.63

2.18

1.4

1.8

2.81

5.69

iu/l

1.99

Inflammatory diseases of the central nervous system

670

1.37

2.18

1.7

1.9

4.78

4.62

iu/l

0.06

244

Charcot foot

108

1.98

2.18

1.7

1.9

3.00

7.18

iu/l

—

Superficial injury of thorax

148

1167

1.27

2.17

2.0

1.8

2.98

4.63

iu/l

3.40

410

Vitamin B12 deficiency anaemia

739

1.35

2.16

1.8

5.95

4.43

iu/l

0.42

240

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

159

1265

1.26

2.16

1.5

1.7

2.72

4.66

iu/l

5.93

423

Acute gastritis

544

1.41

2.16

1.6

1.9

3.46

4.54

iu/l

0.92

182

Drug-induced osteoporosis

2.15

2.16

2.1

1.7

2.14

6.08

iu/l

—

Neuralgia and neuritis, unspecified

437

1.46

2.14

1.6

1.9

2.87

4.87

iu/l

2.26

160

Benign neoplasm: Transverse colon

613

1.38

2.13

2.2

1.8

7.54

4.47

iu/l

0.84

192

Open wound of lower leg

150

1188

1.27

2.13

1.6

1.8

6.35

4.51

iu/l

0.50

432

Benign neoplasm: Caecum

656

1.37

2.12

1.7

1.8

2.73

4.73

iu/l

4.17

205

Other or unspecified ileus, impaction or obstruction

163

1303

1.26

2.12

1.3

1.7

3.29

4.80

iu/l

1.61

441

Placenta praevia

505

1.42

2.11

2.4

2.2

4.16

3.76

iu/l

0.20

236

Benign neoplasm: Conjunctiva

260

1.60

2.11

1.4

1.9

3.04

5.16

iu/l

1.08

Nephropathy related operations

108

820

1.32

2.11

1.6

1.8

3.21

4.60

iu/l

1.18

279

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

2.31

2.10

1.6

4.12

5.09

iu/l

—

Spontaneous abortion

742

4546

1.11

2.10

2.1

2.0

15.28

16.85

iu/l

0.04

281

1820

Liveborn infants according to place of birth

2.32

2.09

1.4

1.6

2.30

5.33

iu/l

—

Hypertrophic disorders of skin

565

1.39

2.09

2.0

4.87

4.91

iu/l

0.01

217

Use of amantadine

117

1.91

2.09

1.3

1.7

3.84

5.70

iu/l

—

Other sleep disorders

105

796

1.33

2.08

1.6

2.0

2.47

4.67

iu/l

5.13

294

Benign lipomatous neoplasm

319

2729

1.17

2.08

1.6

1.8

4.30

7.61

iu/l

0.53

102

991

Dermatopolymyositis

2.02

2.08

1.4

1.6

4.41

6.15

iu/l

—

Other and unspecified coagulation defects

465

1.43

2.08

1.6

2.0

2.42

4.89

iu/l

4.81

172

Other specified/unspecified dorsopathies

277

1.57

2.07

2.3

2.0

3.21

5.66

iu/l

1.36

Lesion of ulnar nerve

138

1086

1.28

2.07

1.4

1.9

5.21

4.53

iu/l

0.18

419

Hypertrophic cardiomyopathy

238

1.61

2.06

1.8

1.74

5.46

iu/l

4.08

Other/unspecified rheumatoid arthritis

135

1061

1.28

2.06

1.7

1.8

5.12

4.63

iu/l

0.16

364

Benign neoplasm: Rectum

156

1247

1.26

2.06

1.7

4.90

4.65

iu/l

0.08

405

Sleep disorders, other/unspecified

302

1.54

2.05

1.8

2.08

5.84

iu/l

—

109

Enterocolitis due to Clostridium difficile

746

1.33

2.05

1.5

1.8

3.36

4.69

iu/l

1.27

244

Ventral hernia

243

2034

1.20

2.05

1.8

4.58

8.82

iu/l

0.48

715

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

351

1.50

2.04

1.9

2.0

4.93

4.97

iu/l

0.01

140

Ankylosing spondylitis, strict definition

391

0.56

2.03

1.4

2.0

7.50

4.82

iu/l

—

152

Gastrointestinal stromal tumor and sarcoma

2.27

2.03

1.6

4.12

5.96

iu/l

—

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

162

1.74

2.03

1.6

1.8

2.95

4.32

iu/l

—

Fibroblastic disorders

228

1899

1.20

2.03

1.6

1.8

4.97

9.47

iu/l

0.47

679

Adhesive capsulitis of shoulder

189

1546

1.23

2.03

1.8

3.55

10.66

iu/l

0.72

575

Ischaemic Stroke, excluding all haemorrhages

523

3501

1.13

2.01

1.7

4.29

7.44

iu/l

0.58

146

1128

Paranoid personality disorder

163

1.75

2.01

2.1

1.9

2.65

5.40

iu/l

—

Septicaemia

385

3220

1.15

2.00

1.6

1.8

29.65

7.25

iu/l

0.43

124

1088

Benign neoplasm of thyroid gland

280

1.56

2.00

1.8

1.9

2.24

5.01

iu/l

3.65

106

Benign neoplasm of middle ear and respiratory system

544

1.39

1.99

1.8

1.9

3.87

4.85

iu/l

0.34

183

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

569

1.38

1.99

1.5

1.7

4.73

4.71

iu/l

0.00

174

Hereditary deficiency of other clotting factors

2.08

1.99

1.8

2.98

5.53

iu/l

—

Mixed disorders of conduct and emotions, excluding more controls

217

1.63

1.99

1.9

2.1

4.76

4.55

iu/l

0.05

Other and unspecified glaucoma

410

1.45

1.99

1.7

1.8

2.21

4.67

iu/l

2.56

135

Allergic contact dermatitis

180

1469

1.23

1.99

1.9

3.76

4.52

iu/l

0.70

588

Pneumothorax

419

1.44

1.97

2.0

1.8

3.15

4.43

iu/l

0.39

140

Benign neoplasm: Stomach

743

1.33

1.97

1.9

1.8

152.25

4.78

iu/l

0.50

246

Poisoning by narcotics and psychodysleptics [hallucinogens]

142

1.79

1.95

1.4

2.0

2.55

5.45

iu/l

—

Viral pneumonia (unknown virus, not influenza)

521

1.39

1.95

2.1

2.0

3.90

5.26

iu/l

0.50

192

FESS (DNB20)

139

1105

1.26

1.95

2.0

1.9

4.61

4.67

iu/l

0.03

422

Other peripheral vertigo

100

762

1.32

1.95

1.7

1.8

2.81

4.63

iu/l

3.39

264

Biomechanical lesions, not elsewhere classified

363

1.47

1.94

2.2

1.8

2.83

4.96

iu/l

2.43

128

Agranulocytosis

121

946

1.29

1.94

1.9

1.8

4.00

4.64

iu/l

0.40

324

Guillain-Barre syndrome

113

1.89

1.94

1.9

1.8

7.26

6.80

iu/l

—

Placental disorders

2.01

1.94

2.6

2.3

4.71

4.70

iu/l

0.00

Melanocytic naevi of trunk

133

1054

1.27

1.92

1.8

1.9

4.52

4.73

iu/l

0.09

396

Other specified and unspecified disorders of eye and adnexa

307

1.51

1.92

2.2

1.9

2.37

5.40

iu/l

3.33

106

Renal cell carcinoma of kidney

165

1.71

1.92

1.6

1.5

2.95

5.67

iu/l

—

Other congenital malformations

109

842

1.30

1.92

2.5

2.0

5.14

4.31

iu/l

0.32

319

Alcohol use disorder, ICD-based

393

3438

1.15

1.91

1.7

1.8

4.51

9.17

iu/l

0.71

124

1232

Postprocedural disorders of nervous system

102

782

1.31

1.91

1.9

2.1

2.74

4.38

iu/l

4.20

311

Mental and behavioural disorders due to alcohol, excluding acute intoxication

424

3724

1.14

1.91

1.7

1.8

4.48

8.83

iu/l

0.72

132

1335

Carcinoma in situ of other and unspecified digestive organs

128

1.82

1.91

1.3

1.7

2.05

4.62

iu/l

—

Sequelae of injuries of lower limb

105

808

1.31

1.91

2.0

1.9

196.87

4.31

iu/l

0.49

301

Other viral diseases, not elsewhere classified

205

1698

1.21

1.91

1.9

4.16

4.40

iu/l

0.15

656

Congenital malformations of eye, ear, face and neck

618

1.35

1.90

1.8

1.9

3.78

4.74

iu/l

0.67

229

Oral leukoplakia and related diseases

390

1.45

1.89

1.8

3.42

4.54

iu/l

0.48

120

Emergency coronary revascularization (for ACS)

348

2880

0.87

1.89

1.4

1.6

30.81

4.48

iu/l

0.49

116

855

Other and unspecified disorders of skin and subcutaneous tissue

516

1.39

1.89

1.9

4.68

4.63

iu/l

0.02

184

Acute pancreatitis (for exclusion)

178

1459

1.22

1.89

1.7

3.89

4.52

iu/l

0.36

502

Hyphaema and other vascular disorders of iris and ciliary body

114

1.87

1.89

2.6

1.8

5.18

7.30

iu/l

—

Hernia of abdominal wall

456

4033

1.13

1.89

1.7

1.8

4.52

8.69

iu/l

0.74

138

1426

Gout

197

1486

1.21

1.87

1.6

5.10

4.36

iu/l

0.27

472

Carcinoma in situ of other and unspecified digestive organs

129

1.81

1.87

1.3

1.5

2.06

5.98

iu/l

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

285

1.53

1.87

1.9

2.0

3.11

4.02

iu/l

0.76

128

Malignant neoplasm of head and neck

466

1.40

1.87

1.6

1.7

4.77

4.31

iu/l

0.09

140

Other and unspecified disorders of white blood cells

301

1.51

1.86

1.8

1.9

4.10

5.31

iu/l

0.37

102

Other congenital malformations of face and neck

253

1.56

1.86

1.9

5.10

5.35

iu/l

0.06

Allergic colitis

182

1.67

1.86

2.0

1.9

8.61

5.70

iu/l

0.30

Benign neoplasm: Rectum, anus and anal canal

173

1417

1.23

1.86

1.7

4.94

4.63

iu/l

0.12

464

Inguinal or femoral hernia, bilateral

517

1.38

1.86

1.5

1.7

4.09

4.58

iu/l

0.21

156

Other disorders of kidney and ureter

116

908

1.28

1.86

1.7

1.8

5.80

4.78

iu/l

0.23

299

Wide developmental disorders, excluding more controls

211

1.61

1.85

1.8

2.0

3.08

4.80

iu/l

—

Calculus of kidney and ureter

262

2230

1.18

1.85

1.8

1.7

3.97

4.50

iu/l

0.41

748

Examination and encounter for administrative purposes

269

1.54

1.85

2.3

1.8

3.46

5.41

iu/l

—

Hypertrophic scar

527

1.38

1.85

2.0

4.91

5.01

iu/l

0.02

204

Psoriatic and enteropathic arthropathies

131

1042

1.26

1.84

1.6

1.9

2.98

4.23

iu/l

2.37

408

Benign neoplasm of thyroid gland

286

1.52

1.84

1.8

2.0

2.24

5.32

iu/l

4.03

102

Vascular diseases of the intestine

198

1.63

1.84

1.4

1.6

3.67

5.02

iu/l

—

Allergic urticaria

103

796

1.30

1.83

2.0

1.9

3.76

4.44

iu/l

0.53

302

Hallux valgus (acquired)

432

2756

1.14

1.83

1.8

4.76

13.43

iu/l

0.99

145

1041

Drug-induced neutropenia

571

1.36

1.82

1.6

1.9

3.98

5.21

iu/l

0.57

200

MS-disease / Multiple Sclerosis

100

771

1.31

1.82

2.3

2.0

7.69

4.22

iu/l

1.52

300

COPD, hospital admissions 1, only main diagnosis

283

2065

1.17

1.81

1.8

1.6

42.04

4.70

iu/l

0.47

641

Pilonidal cyst

736

1.31

1.81

1.8

1.9

3.52

4.70

iu/l

1.15

284

Sequelae of injuries, of poisoning and of other consequences of external causes

247

2098

1.18

1.81

1.8

93.59

4.33

iu/l

0.50

786

Unspecified/other endometriosis

142

1145

1.25

1.80

1.9

2.0

3.17

4.46

iu/l

2.09

486

Cysts of oral region, not elsewhere classified

312

1.49

1.79

2.2

1.9

3.34

4.90

iu/l

1.35

105

Spondylopathies (FG)

161

1316

1.23

1.78

1.6

2.0

3.78

4.14

iu/l

0.19

538

Disorders of optic nerve and visual pathways

110

861

1.29

1.78

2.2

2.0

4.91

4.46

iu/l

0.13

312

Plantar fascial fibromatosis

117

923

1.28

1.78

1.7

2.0

3.76

13.15

iu/l

0.58

373

Secondary parkinsonism+Parkinsonism in other disease

139

1.74

1.77

1.6

1.7

2.65

6.14

iu/l

—

Hyperaldosteronism

193

1.63

1.76

1.5

1.8

5.15

5.64

iu/l

—

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

522

3808

0.89

1.76

1.8

1.9

21.52

13.76

iu/l

0.18

195

1494

Right bundle-branch block

185

1.64

1.76

1.6

1.8

2.64

5.24

iu/l

—

Congenital malformations of genital organs

134

1070

1.25

1.76

1.8

2.1

3.31

4.43

iu/l

1.48

430

Anterior Iridocyclitis

215

1810

1.19

1.76

1.8

4.26

4.41

iu/l

0.07

673

Certain conditions originating in the perinatal period

106

732

1.29

1.75

2.2

2.0

4.69

4.33

iu/l

0.12

289

Acne

136

1094

1.25

1.75

1.6

2.1

2.53

4.22

iu/l

4.92

455

Other benign neoplasm of uterus: Other parts/unspecified

306

1.49

1.74

1.4

1.6

4.82

4.28

iu/l

0.09

Other and unspecified vascular occlusions

584

1.34

1.74

1.6

1.8

2.69

4.25

iu/l

2.16

178

Other infectious diseases

550

1.35

1.73

2.1

1.9

3.63

4.60

iu/l

0.62

188

Other local infections of skin and subcutaneous tissue

101

785

1.29

1.73

1.8

1.9

3.57

4.94

iu/l

0.77

277

Other disorders of nervous system

465

1.39

1.73

1.5

1.9

2.87

5.00

iu/l

2.40

158

Acute nasopharyngitis (common cold)

109

850

1.28

1.73

1.8

1.9

5.67

4.36

iu/l

0.37

306

Benign neoplasm: Stomach

759

1.30

1.73

1.9

1.8

152.25

4.44

iu/l

0.50

255

Other disorders of penis

397

1.42

1.73

1.7

3.13

3.96

iu/l

0.59

126

Other disorders starting during childhood or adolecense, excluding more controls

375

1.42

1.73

1.7

2.2

5.38

4.87

iu/l

0.09

169

Benign neoplasm: Other parts of oropharynx

2.11

1.73

2.0

1.9

5.17

7.06

iu/l

—

Symptoms and signs involving emotional state

258

1.53

1.72

1.9

3.44

5.30

iu/l

0.65

Pollen allergy

249

2104

1.18

1.72

1.7

2.1

39.24

4.32

iu/l

0.49

869

Other mental disorders due to brain damage and dysfunction and to physical disease

724

1.30

1.72

1.6

1.8

3.36

4.54

iu/l

0.94

224

Mental and behavioural disorders due to alcohol

508

4428

1.12

1.72

1.7

1.8

4.23

9.96

iu/l

1.04

165

1581

Artificial opening status

323

1.47

1.72

1.9

3.23

5.94

iu/l

1.60

Lichen simplex chronicus

250

1.54

1.72

1.7

1.9

2.63

5.08

iu/l

1.68

Other disorders of white blood cells

415

1.41

1.72

1.9

5.98

4.94

iu/l

0.30

144

Endocrine disorders, other/unspecified

179

1.65

1.72

2.0

1.8

2.41

5.47

iu/l

2.61

Lung diseases due to external agents

103

803

1.29

1.72

1.4

1.8

3.16

4.40

iu/l

0.72

254

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

523

3808

0.89

1.71

1.8

1.9

21.52

13.76

iu/l

0.18

195

1494

Idiopathic urticaria

187

1.63

1.71

2.0

1.9

2.46

5.14

iu/l

—

195

1.61

1.71

2.5

1.9

3.36

5.29

iu/l

0.83

Oral leukoplakia, including avohilmo

187

1.62

1.71

1.6

1.7

5.45

4.67

iu/l

—

Use of pramipexole

221

1872

1.19

1.69

1.6

1.8

4.38

4.78

iu/l

0.19

647

Glaucoma secondary to other eye disorders

267

1.51

1.69

2.5

1.8

3.15

4.71

iu/l

0.93

Visual field defects

587

1.34

1.69

1.9

1.8

6.63

5.05

iu/l

0.34

193

Melanocytic naevi of lower limb, including hip

383

1.42

1.69

1.5

2.0

2.60

5.14

iu/l

3.96

142

Secondary parkinsonism

141

1.72

1.69

1.6

1.7

2.65

5.58

iu/l

—

Abnormalities of gait and mobility

100

779

1.29

1.69

1.8

4.71

4.54

iu/l

0.06

242

Foreign body in respiratory tract

425

1.40

1.69

1.7

1.9

6.24

5.20

iu/l

0.15

150

Other endocrine disorders

433

1.39

1.69

2.0

1.9

2.33

4.62

iu/l

4.55

151

Cramp and spasm

375

1.43

1.68

1.7

1.9

2.41

5.28

iu/l

3.06

127

Abrasion of teeth

332

2130

1.15

1.67

2.0

1.9

172.84

4.53

iu/l

0.49

118

832

Mental and behavioural disorders due to opioids

301

1.48

1.66

1.6

2.0

3.52

5.01

iu/l

0.79

113

Other papulosquamous disorders

2.01

1.66

1.7

1.6

3.79

5.43

iu/l

—

Other disorders of optic [2nd] nerve and visual pathways

503

1.36

1.66

2.2

1.9

4.42

5.09

iu/l

0.20

172

Pruritus

123

986

1.25

1.66

1.7

1.9

4.25

4.59

iu/l

0.16

369

Orchitis and epididymitis

376

1.41

1.64

1.4

1.7

4.84

4.05

iu/l

—

123

Open wound of forearm

686

1.30

1.64

1.4

1.9

3.35

4.79

iu/l

1.05

254

Progressive vascular leukoencephalopathy

150

1.68

1.64

1.7

1.5

4.37

5.23

iu/l

—

Iron deficiency anaemia secondary to blood loss (chronic)

154

1266

1.22

1.64

1.8

4.40

4.53

iu/l

0.05

437

Other surgical follow-up care

286

1.48

1.63

1.8

1.9

2.65

5.03

iu/l

2.41

103

Malignant neoplasm of pancreas

328

0.58

1.63

1.5

1.7

2.45

4.61

iu/l

—

106

Ethmoidectomy

140

1141

1.23

1.63

2.0

1.9

4.61

4.63

iu/l

0.01

434

Alcoholic liver disease

571

0.68

1.63

1.7

1.8

3.58

4.63

iu/l

1.28

186

Beningn neoplasm: Meninges, unspecified

113

1.80

1.62

2.0

1.6

3.09

5.72

iu/l

—

Other and unspecified local infections of skin and subcutaneous tissue

749

1.29

1.62

1.8

1.9

3.63

4.58

iu/l

0.50

260

Suggestive for eosinophilic asthma

714

1.30

1.62

2.0

1.8

5.60

4.85

iu/l

0.23

254

Fracture of skull and facial bones

209

1770

1.18

1.62

1.8

4.94

4.30

iu/l

0.30

657

Malnutrition

128

1.74

1.62

1.3

1.6

3.69

6.62

iu/l

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

262

1.50

1.62

1.6

2.0

2.91

4.86

iu/l

1.96

Phlebitis and thrombophlebitis (not including DVT)

236

2020

1.17

1.61

1.6

1.8

5.34

8.79

iu/l

0.37

733

Arthropathic psoriasis

117

936

1.26

1.61

1.6

1.9

3.12

5.03

iu/l

2.78

347

Transport accidents

597

4800

1.10

1.61

1.9

4.21

27.12

iu/l

1.22

215

1867

Dermatitis due to ingested food

276

1.48

1.61

2.1

1.9

6.03

4.91

iu/l

0.15

Other and unspecified abdominal hernia

287

1.48

1.61

1.7

1.8

3.06

4.88

iu/l

0.96

101

Acute and subacute iridocyclitis

201

1699

1.19

1.60

1.8

1.9

4.44

4.40

iu/l

0.02

635

Conductive and sensorineural hearing loss

882

5632

1.09

1.60

1.7

1.8

4.38

14.61

iu/l

1.37

300

1972

Maltreatment syndromes

507

1.35

1.60

2.0

3.69

4.62

iu/l

0.62

203

Dermatopolymyositis (FG)

1.85

1.59

1.4

1.6

3.80

5.09

iu/l

—

Eating disorder

140

1144

1.23

1.59

1.7

2.2

2.18

4.22

iu/l

8.92

479

Coxarthrosis, primary, with hip surgery

429

3628

1.12

1.59

1.6

1.7

75.64

9.81

iu/l

0.46

111

1174

Use of disulfiram, acamprosate or naltrexone

629

1.31

1.58

1.5

1.9

3.19

4.87

iu/l

1.82

244

Dermatitis due to substances taken internally

448

1.37

1.57

2.6

1.9

7.96

4.72

iu/l

0.80

152

Whooping cough

2.09

1.57

2.4

1.9

2.96

6.80

iu/l

—

Visual impairment including blindness (binocular or monocular)

448

1.37

1.57

2.2

1.8

3.87

5.21

iu/l

0.51

153

Benign neoplasm: Caecum

691

1.30

1.57

1.7

1.8

2.73

4.50

iu/l

3.56

225

Retinoschisis and retinal cysts

137

1.70

1.56

1.8

1.6

3.78

5.11

iu/l

—

Chronic ulcer of skin, not elsewhere classified

440

1.37

1.56

1.5

1.8

3.68

4.99

iu/l

0.72

144

Other benign neoplasm of uterus: Other parts/unspecified

314

1.45

1.56

1.4

1.7

4.82

4.80

iu/l

0.00

Melanocytic naevi of lower limb, including hip

390

1.40

1.55

1.5

2.0

2.60

5.04

iu/l

4.02

147

Benign neoplasm: Skin of other and unspecified parts of face

103

816

1.27

1.55

1.7

1.8

5.12

4.52

iu/l

0.18

285

Haematosalpinx/Haematoma of broad ligament

3.50

1.55

1.0

1.9

—

4.90

—

Secondary uncertain malignant neoplasm

101

799

1.27

1.54

1.4

1.8

5.33

4.49

iu/l

0.19

249

Bitten or struck by other mammals

135

1105

1.23

1.53

1.8

2.0

3.40

4.16

iu/l

0.80

443

Dementia in other diseases classified elsewhere

249

1.50

1.53

2.4

1.7

3.63

5.83

iu/l

—

Diabetic neuropathy

716

1.28

1.53

1.5

1.6

4.13

3.99

iu/l

0.07

227

Benign lipomatous neoplasm of other sites/unspecified

624

1.30

1.52

1.6

1.8

4.05

4.78

iu/l

0.51

206

Intestinal malabsorption

366

1.41

1.52

2.0

1.9

6.54

4.73

iu/l

0.41

126

Gout, idiopatic and unspecified

162

1350

1.20

1.52

1.6

5.30

4.11

iu/l

0.39

389

Other interventions on the root canals of the tooth

154

1.65

1.52

1.5

1.9

3.06

5.46

iu/l

—

Other hearing loss

238

2015

1.16

1.51

1.6

1.7

3.80

4.52

iu/l

0.82

637

Benign neoplasm: Other parts of oropharynx

1.99

1.51

2.0

1.8

5.17

7.41

iu/l

—

Psoriasis vulgaris

183

1544

1.19

1.51

1.6

1.8

2.66

4.65

iu/l

6.44

572

Motor disorders, excluding more controls

1.88

1.51

2.4

1.8

2.42

6.52

iu/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

120

973

1.24

1.51

1.7

2.2

3.28

4.34

iu/l

1.59

415

Coronary artery bypass grafting

137

1268

0.82

1.50

1.4

1.6

100.16

4.36

iu/l

0.48

350

Diffuse large B-cell lymphoma, helper endpoint

242

1.50

2.0

1.9

7.82

4.26

iu/l

—

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

242

1.50

2.0

1.9

7.82

4.26

iu/l

—

Alcohol abuse, main dg, excluding more controls

136

1116

1.22

1.50

1.8

2.0

3.48

4.47

iu/l

0.77

441

Premenstrual syndrome

124

1.73

1.50

2.4

2.1

3.13

4.83

iu/l

—

L04AD Calcineurin inhibitors

107

856

1.26

1.50

1.5

1.9

3.81

4.93

iu/l

0.56

312

Neovascular glaucoma

267

1.47

1.49

2.3

1.8

3.15

5.01

iu/l

1.13

Other and unspecified intracranial injuries

194

1.56

1.49

1.5

1.8

5.43

5.45

iu/l

—

Chalazion

112

901

1.25

1.49

2.0

1.7

4.41

4.69

iu/l

0.09

325

Enthesopathies of lower limb, excluding foot

249

2156

1.16

1.49

1.8

1.9

39.88

4.97

iu/l

0.47

831

Scoliosis

104

830

1.26

1.49

1.6

2.0

3.59

5.16

iu/l

1.09

311

Unspecified urinary incontinence

777

1.27

1.49

1.9

1.8

6.97

4.93

iu/l

0.63

263

Rosacea

130

1064

1.23

1.48

2.0

2.80

4.51

iu/l

3.34

422

Specific development disorders of scholastic skills

372

1.39

1.48

1.9

2.0

4.53

4.59

iu/l

0.01

144

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

251

1.48

1.7

5.48

4.07

iu/l

0.18

Other epidermal thickening

326

1.42

1.48

2.3

1.9

3.05

5.20

iu/l

1.51

117

Ingrowing nail

445

1.36

1.48

1.6

1.9

4.15

5.26

iu/l

0.53

161

Inflammatory disorders of breast

770

1.27

1.47

1.8

2.1

3.14

4.33

iu/l

0.91

295

Hodgkin lymphoma

195

1.55

1.47

1.5

1.8

1.51

5.37

iu/l

—

Beningn neoplasm: Meninges, unspecified

117

1.74

1.47

2.0

1.7

3.09

4.53

iu/l

—

Other prurigo

1.91

1.46

1.5

1.6

2.59

6.80

iu/l

—

Disorders of eyelid in diseases classified elsewhere

252

1.48

1.46

2.4

1.7

3.01

5.13

iu/l

1.60

Other benign neoplasms of skin

395

3530

1.12

1.46

1.8

4.73

6.94

iu/l

0.41

140

1240

Other and specified injuries of hip and thigh

140

1.66

1.46

1.7

1.72

5.30

iu/l

—

Selective deficiency of immunoglobulin G [IgG] subclasses

2.09

1.46

2.5

1.6

2.74

5.69

iu/l

—

Airway disease due to specific organic dust

3.24

1.45

1.0

1.8

—

2.56

—

Benign neoplasm: Transverse colon

655

1.29

1.45

2.2

1.7

7.54

4.38

iu/l

0.87

199

Other enthesopathies

357

3173

1.13

1.45

1.7

1.9

3.29

16.10

iu/l

1.11

125

1224

Fasciculation

1.82

1.45

2.4

2.1

4.31

5.72

iu/l

—

Primary open-angle glaucoma

271

2305

1.15

1.45

1.6

4.11

4.77

iu/l

0.44

712

Childhood asthma (age<16), excluding more controls

180

1205

1.19

1.45

2.3

2.2

295.52

3.98

iu/l

0.50

528

Malignant neoplasm of breast, HER2-negative

562

4534

0.91

1.45

1.8

1.9

21.05

12.83

iu/l

0.20

200

1679

Von Willebrand disease

141

1.66

1.44

1.8

2.0

2.00

6.02

iu/l

2.76

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

236

1.49

1.44

1.5

1.7

2.79

4.36

iu/l

—

Diabetic retinopathy

318

1766

1.14

1.44

1.8

1.6

4.25

14.62

iu/l

0.76

583

Sensorineural hearing loss

809

5231

1.08

1.44

1.7

1.8

4.53

15.60

iu/l

1.35

272

1809

Coronary revascularization (ANGIO or CABG)

317

2506

0.88

1.44

1.4

1.7

33.68

4.74

iu/l

0.48

105

780

Pure hyperglyceridaemia

110

1.74

1.44

1.7

1.6

2.81

5.85

iu/l

—

Varicella [chickenpox]

328

1.41

1.43

2.0

1.8

2.90

5.43

iu/l

1.68

123

Vitiligo

1.85

1.43

2.0

1.9

1.91

5.30

iu/l

—

Arterial embolism and thrombosis of lower extremity artery

180

1.57

1.43

1.6

2.91

5.37

iu/l

—

Toxic effect of ethanol

337

1.41

1.43

1.7

1.9

6.11

5.25

iu/l

0.14

122

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

287

1.44

1.42

1.6

1.8

2.62

4.62

iu/l

2.09

103

Fissure and fistula of anal and rectal regions

253

2203

1.15

1.42

1.7

1.8

3.07

8.36

iu/l

0.77

810

Metatarsalgia

112

908

1.24

1.41

1.5

2.0

2.70

13.54

iu/l

0.69

362

L02BA Anti-estrogens

152

1811

0.84

1.41

1.7

1.8

6.09

9.04

iu/l

0.27

681

Other noninfective disorders of lymphatic vessels and lymph nodes

296

1.43

1.41

1.3

2.0

2.80

4.46

iu/l

—

108

Endocarditis

165

1.59

1.41

1.8

1.9

2.98

5.48

iu/l

1.34

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

432

1.35

1.40

1.6

2.0

3.78

4.70

iu/l

0.63

177

Dissocial personality disorder

111

1.73

1.40

2.4

1.9

3.59

5.33

iu/l

—

Long labour

384

3000

1.12

1.40

2.0

4.47

17.17

iu/l

0.98

170

1267

Malignant neoplasm of breast

584

4609

0.91

1.40

1.8

1.9

20.28

12.70

iu/l

0.19

209

1711

Other and unspecified iridocyclitis

347

1.40

1.7

2.0

2.83

5.20

iu/l

2.56

123

Bursitis of shoulder

198

1.53

1.39

1.8

1.9

3.76

5.87

iu/l

—

Childhood asthma (age<16)

180

1211

1.18

1.39

2.3

2.1

295.52

3.98

iu/l

0.50

528

Dementia

255

2018

0.87

1.39

1.6

2.89

4.81

iu/l

5.55

578

Fracture of forearm

671

5781

1.09

1.39

1.8

1.9

3.81

12.55

iu/l

1.30

231

2124

Benign neoplasm: Spinal cord

104

1.76

1.38

2.4

1.7

4.49

5.96

iu/l

—

Ulcer of oesophagus

407

1.36

1.38

1.6

1.7

3.99

4.92

iu/l

0.33

111

Umbilical hernia

245

2133

1.15

1.38

1.6

1.8

4.36

4.32

iu/l

0.01

780

Chronic suppurative otitis media

511

1.32

1.38

1.6

1.9

4.37

5.10

iu/l

0.29

184

Presence of other devices

192

1640

1.17

1.38

1.7

4.57

4.36

iu/l

0.09

529

Malignant neoplasm of rectum

550

0.71

1.37

1.7

1.8

6.62

4.49

iu/l

0.29

173

Biological medicines for asthma

112

1.73

1.37

2.0

4.67

6.19

iu/l

—

Habitual aborter

240

1.48

1.36

2.4

2.2

3.17

4.14

iu/l

0.49

109

Unspecified nephritic syndrome

143

1.63

1.36

2.7

1.8

3.74

6.37

iu/l

—

Other congenital malformations of peripheral vascular system

120

1.70

1.36

2.8

1.8

2.02

5.59

iu/l

—

Olecranon bursitis

340

1.39

1.36

1.4

1.9

2.94

5.02

iu/l

1.85

123

Malignant neoplasm of breast, HER-positive

350

3861

0.89

1.36

1.7

1.8

29.38

14.80

iu/l

0.25

133

1371

Disorders of breast

734

6290

1.08

1.36

1.9

4.17

13.62

iu/l

1.47

260

2460

Immunodeficiencies

409

1.36

1.9

2.84

4.73

iu/l

1.92

146

Seronegative rheumatoid arthritis

129

1067

1.21

1.35

1.6

1.8

3.41

4.37

iu/l

0.54

393

Correction of physiology of bite - very demanding therapy visit

282

1.43

1.35

1.8

2.0

4.02

4.94

iu/l

0.27

111

Exposure to other specified factors

911

7962

1.07

1.35

1.9

3.96

13.93

iu/l

1.96

318

2990

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

136

1132

1.21

1.35

1.7

2.1

3.25

4.30

iu/l

1.67

461

Malignant neoplasm of nasal cavity and middle ear, excluding all cancers (controls excluding all cancers)

2.19

1.35

1.3

1.8

—

5.32

—

Herpesviral keratitis and keratoconjunctivitis

324

1.40

1.35

2.1

1.9

2.73

5.09

iu/l

2.84

115

Benign neoplasm: Rectum, anus and anal canal

173

1470

1.18

1.35

1.7

4.94

4.55

iu/l

0.15

476

Use of fingolimod

113

1.72

1.34

3.5

2.1

12.36

5.52

iu/l

—

Fall on and from ladder

435

1.34

1.5

1.7

3.29

4.48

iu/l

0.81

139

Ehlers-Danlos syndrome

113

1.72

1.34

1.8

2.0

2.84

6.32

iu/l

—

Other disorders of optic disc

1.76

1.33

1.6

1.9

5.43

5.53

iu/l

—

Dystonia

489

1.32

1.6

1.9

138.88

5.45

iu/l

0.48

171

Hernia

1156

7365

1.07

1.32

1.8

1.9

4.17

13.80

iu/l

1.67

377

2709

Other disorders of veins

464

4209

1.10

1.32

1.8

1.9

5.64

13.47

iu/l

0.75

143

1560

Benign neoplasm: Oesophagus

1.87

1.31

1.6

1.7

3.16

5.83

iu/l

—

Injuries to the hip and thigh

450

3731

1.11

1.31

1.6

1.8

4.31

6.91

iu/l

0.52

148

1269

Cerebral palsy and other paralytic syndromes

114

935

1.22

1.31

1.7

1.9

3.52

4.44

iu/l

0.60

333

Other lesions of median nerve

201

1.51

1.31

1.8

1.6

2.45

5.00

iu/l

1.90

Hodgkin lymphoma, hilmo

201

1.51

1.31

1.5

1.8

1.51

6.27

iu/l

—

Bicipital tendinitis

343

1.38

1.31

2.1

2.0

4.78

5.15

iu/l

0.07

124

Other juvenile arthritis

386

1.36

1.30

1.7

2.1

3.75

5.27

iu/l

0.80

163

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

145

1.61

1.30

2.5

1.9

4.29

6.39

iu/l

—

Emphysema

377

1.36

1.30

1.9

1.8

3.84

5.24

iu/l

0.48

117

Amblyopia ex anopsia

335

1.38

1.30

1.8

3.11

4.57

iu/l

1.23

118

Postmenopausal atrophic vaginitis

332

1777

1.13

1.30

1.9

1.8

34.52

21.02

iu/l

0.17

108

672

Benign neoplasm of breast

155

1311

1.19

1.30

1.8

1.9

68.16

4.48

iu/l

0.50

484

Inguinal hernia

466

3461

0.91

1.29

1.6

1.8

24.83

6.71

iu/l

0.40

146

1198

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

276

1.42

1.29

1.6

1.9

2.91

5.32

iu/l

2.30

Benign neoplasm: Rectosigmoid junction

226

1.47

1.29

1.8

1.9

3.76

4.46

iu/l

—

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

447

1.33

1.29

1.6

1.8

4.70

4.69

iu/l

0.00

148

Vascular dementia

315

1.38

1.29

1.3

1.5

2.98

4.85

iu/l

—

Secondary hypertension

503

1.31

1.29

1.6

1.9

3.00

4.57

iu/l

2.31

187

Infections of genitourinary tract in pregnancy

137

1147

1.20

1.29

2.0

3.72

4.38

iu/l

0.46

450

Infectious mononucleosis

109

892

1.23

1.29

1.7

2.1

3.78

4.35

iu/l

0.36

360

Other inflammatory liver diseases

526

1.30

1.29

2.0

1.9

5.70

4.93

iu/l

0.16

184

Other and unspecified injuries of head

465

1.32

1.28

1.5

1.9

5.03

4.79

iu/l

0.04

163

Overexertion and strenuous or repetitive movements

103

838

1.23

1.28

2.0

1.9

3.88

4.52

iu/l

0.29

313

Diseases of spleen

130

1.64

1.28

1.7

1.6

2.08

7.15

iu/l

—

Abdominal aortic aneurysm (AAA)

358

1.36

1.28

1.6

2.92

4.13

iu/l

0.69

103

Dermatophytosis

114

938

1.22

1.27

1.9

1.8

3.56

4.59

iu/l

0.98

320

Acne vulgaris

103

839

1.23

1.27

1.6

2.1

2.50

4.25

iu/l

4.27

346

Injury of unspecified body region

571

1.29

1.27

1.7

1.8

2.27

4.89

iu/l

4.69

196

Injuries to unspecified part of trunk, limb or body region

767

1.24

1.27

1.6

1.9

2.31

4.98

iu/l

6.77

268

Palmar fascial fibromatosis [Dupuytren]

111

911

1.22

1.27

1.4

1.6

7.12

4.66

iu/l

0.53

277

Rheumatoid arthritis

361

2946

1.12

1.26

1.8

4.32

13.10

iu/l

1.08

108

1090

Guttate psoriasis

115

1.68

1.26

1.4

2.0

1.94

6.31

iu/l

—

Benign mammary dysplasia

184

1583

1.17

1.26

1.7

1.8

6.23

4.57

iu/l

0.41

569

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

459

0.69

1.26

1.8

2.99

4.34

iu/l

0.83

137

Other bursopathies

127

1058

1.20

1.26

1.7

1.8

71.61

4.84

iu/l

0.49

389

Malignant neoplasm of nasal cavity and middle ear

2.45

1.25

1.2

1.8

—

3.46

—

Use of anticholinesterases

170

1608

0.85

1.25

1.4

1.6

2.69

4.54

iu/l

5.03

439

N06DA Anticholinesterases

170

1608

0.85

1.25

1.4

1.6

2.69

4.54

iu/l

5.03

439

Contact with and exposure to communicable diseases

432

3905

1.10

1.25

2.0

2.1

3.59

11.68

iu/l

1.17

234

1585

Eating disorders

156

1324

1.18

1.25

1.7

2.1

2.26

4.25

iu/l

8.69

530

Ménière disease

796

1.24

1.25

1.8

3.36

4.65

iu/l

1.78

270

Hypotension due to drugs

1.88

1.25

1.9

1.6

2.38

6.95

iu/l

—

Parkinson's disease, strict definition, excluding more controls

727

1.24

1.25

1.3

1.6

3.50

5.01

iu/l

0.88

225

Biguanides

1172

6799

1.06

1.25

1.7

1.9

19.95

11.19

iu/l

0.33

389

2521

Stroke, excluding SAH

553

3766

1.09

1.24

1.7

4.22

7.18

iu/l

0.60

156

1235

Otalgia

716

1.25

1.24

1.7

1.9

4.00

4.45

iu/l

0.22

262

Lagophthalmos

1.93

1.24

1.7

1.5

2.00

4.32

iu/l

—

Generalized skin eruption due to drugs and medicaments

330

1.38

1.23

2.2

1.9

5.55

5.38

iu/l

0.04

118

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

654

1.26

1.23

1.4

1.9

3.26

4.62

iu/l

0.61

236

Speech and linguistic disorders

713

1.24

1.23

1.7

2.0

4.68

4.36

iu/l

0.09

273

Galactorrhea

132

1.63

1.23

1.7

2.0

4.47

5.62

iu/l

—

Inflammatory bowel disease

357

3212

1.11

1.23

1.8

1.9

3.69

6.88

iu/l

0.66

128

1216

Transplanted organ and tissue status

663

1.26

1.23

1.5

1.8

4.88

4.92

iu/l

0.01

230

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

834

6349

1.07

1.22

2.0

1.9

20.37

19.47

iu/l

0.02

340

2457

Malignant neoplasm of gum

2.69

1.22

1.0

1.8

—

2.80

—

Benign neoplasm: Oesophagus

1.82

1.22

1.6

1.5

3.16

6.14

iu/l

—

Gout, FINNGEN

197

1707

1.16

1.22

1.6

5.10

4.41

iu/l

0.25

501

Stroke, including SAH

596

4060

1.09

1.22

1.7

4.14

11.52

iu/l

1.19

171

1368

Benign lipomatous neoplasm of other sites/unspecified

646

1.26

1.22

1.6

1.9

4.05

4.57

iu/l

0.34

211

Redundant prepuce, phimosis and paraphimosis

116

957

1.21

1.6

1.7

6.80

3.93

iu/l

0.79

305

Other enthesopathy of foot (+metatarsalgia)

118

981

1.21

1.5

2.0

2.72

12.95

iu/l

0.72

397

Benign neoplasm: Spinal cord

109

1.68

1.20

2.4

1.7

4.49

6.50

iu/l

—

Other diseases of biliary tract

576

1.27

1.20

1.7

1.8

3.81

5.10

iu/l

1.15

183

Scar conditions and fibrosis of skin

375

1.34

1.20

2.5

1.9

9.19

4.85

iu/l

0.37

138

Other degenerative diseases of the nervous system

266

1783

1.13

1.20

1.8

5.60

4.73

iu/l

0.51

644

Oesophageal obstruction

189

1.49

1.19

1.8

1.7

2.31

5.00

iu/l

2.05

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

462

1.30

1.19

1.6

1.7

4.35

4.84

iu/l

0.10

143

Hydronephrosis

101

828

1.22

1.19

1.5

1.9

4.89

4.48

iu/l

0.08

289

Parkinson's disease, excluding more controls

100

798

1.22

1.18

1.3

1.7

3.46

5.14

iu/l

1.14

260

Psoriatic arthropathies

104

856

1.22

1.18

1.6

1.9

3.30

4.30

iu/l

1.11

337

Benign neoplasm: Pancreas

157

1.54

1.18

1.7

1.8

4.20

4.71

iu/l

—

Enteropathic arthropathies

198

1.48

1.18

1.6

2.1

2.28

5.41

iu/l

3.03

Colorectal adenocarcinoma

104

1258

0.82

1.18

1.7

7.72

4.50

iu/l

0.79

384

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

567

0.74

1.17

1.8

6.37

4.48

iu/l

0.27

173

Arthropathy in ulcerative colitis

110

1.66

1.17

1.7

1.8

2.36

4.93

iu/l

—

Lumbosacral root disorders, not elsewhere classified

1.75

1.16

1.6

1.7

6.02

6.35

iu/l

—

Acute generalized exanthematous pustulosis

377

1.34

1.16

2.1

1.9

5.15

5.05

iu/l

0.02

134

Diffuse large B-cell lymphoma

257

1.41

1.16

2.0

1.8

7.82

4.63

iu/l

—

Other embolism and thrombosis

121

1013

1.20

1.16

1.7

1.8

3.12

4.66

iu/l

1.76

368

Mixed disorders of conduct and emotions

249

1.42

1.16

1.9

2.1

4.76

4.95

iu/l

0.04

105

Unattended death

0.00

1.16

0.0

1.9

—

8.54

—

Erosion of teeth

134

1.59

1.15

1.3

2.0

11.68

4.68

iu/l

—

Erythema intertrigo

158

1.53

1.15

1.5

1.7

8.42

5.88

iu/l

—

Endometriosis ASRM stages 3,4

331

2980

1.11

1.15

2.0

1.9

4.51

7.15

iu/l

0.48

127

1169

Other puerperal infections

122

1025

1.20

1.14

2.6

2.1

3.33

4.11

iu/l

0.85

430

Corneal scars and opacities

183

1.49

1.14

1.8

1.9

2.74

5.89

iu/l

—

Retinal detachment with retinal break

105

869

1.21

1.14

1.7

5.34

4.84

iu/l

0.16

278

Sacroiliitis, not elsewhere classified

466

1.30

1.14

1.8

2.1

2.73

5.03

iu/l

3.76

189

Flat foot [pes planus] (acquired)

107

888

1.21

1.13

1.7

1.8

4.36

14.13

iu/l

0.52

330

Benign neoplasm: Rectosigmoid junction

233

1.43

1.13

1.8

1.7

3.76

5.34

iu/l

—

Memory loss

599

1.26

1.13

1.5

1.8

4.34

4.37

iu/l

0.01

189

Malignant neoplasm of nasal cavity and sinuses

2.04

1.13

2.5

1.6

—

4.59

—

Inguinal hernia, bilateral

510

1.28

1.13

1.5

1.7

4.32

4.41

iu/l

0.03

152

Dyshidrosis [pompholyx]

127

1.59

1.13

1.6

1.9

3.48

6.24

iu/l

—

Disorders of synovium and tendon in diseases classified elsewhere

151

1.54

1.12

1.5

1.9

285.06

4.71

iu/l

0.46

Injury of muscle and tendon at forearm level

119

1.61

1.12

1.6

1.9

4.42

5.86

iu/l

—

Crushed, pushed or stepped on by crowd or human stampede

609

1.25

1.12

1.8

1.9

4.80

4.58

iu/l

0.06

227

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

663

1.24

1.12

1.4

1.9

3.26

5.24

iu/l

0.93

230

Somnolence, stupor and coma

293

1.37

1.12

1.5

1.9

2.39

5.23

iu/l

3.43

106

Peripheral arterial reconstruction

105

871

1.21

1.11

1.6

3.09

4.29

iu/l

1.19

244

Erosion and ectropion of cervix uteri

260

1.40

1.10

1.9

1.8

4.40

4.72

iu/l

0.11

Convergence insufficiency and excess

144

1.55

1.10

1.9

2.1

1.99

5.22

iu/l

—

Benign neoplasm: Pancreas

160

1.51

1.10

1.7

1.6

4.20

5.68

iu/l

—

Atopic dermatitis, strict definition with reimbursement

404

3571

1.10

2.0

5.08

12.27

iu/l

0.87

174

1465

Hemiplegia

398

1.31

1.10

1.7

1.9

2.84

4.60

iu/l

1.75

133

Adenocarcinoma and papilloma adenocarcinoma of rectum

549

0.74

1.10

1.8

6.37

4.30

iu/l

0.30

171

Other disorders of cornea

755

1.22

1.10

1.8

1.9

4.55

4.47

iu/l

0.02

265

Intestinal adhesions without obstruction

575

1.26

1.10

1.3

1.8

5.38

5.36

iu/l

0.00

200

Infections specific to the perinatal period

1.84

1.10

1.8

1.6

4.03

4.96

iu/l

—

Benign neoplasm: Skin of eyelid, including canthus

144

1232

1.17

1.09

1.9

1.8

4.89

4.59

iu/l

0.12

435

Sequelae of intentional self-harm, assault and events of undetermined intent

1.91

1.09

2.4

2.1

2.74

5.76

iu/l

—

Gestational [pregnancy-induced] hypertension

402

3661

1.10

1.08

2.0

2.1

3.33

27.43

iu/l

1.05

167

1515

Primary_lymphoid and hematopoietic malignant neoplasms

194

1697

1.15

1.08

1.7

6.92

4.40

iu/l

0.96

568

Oligomenorrhoea

382

1.32

1.08

2.5

2.0

2.88

4.78

iu/l

1.61

165

Other congenital malformations of nervous system

105

1.65

1.08

1.8

2.1

9.61

6.25

iu/l

—

Xerosis cutis

1.67

1.08

2.8

1.7

2.75

6.51

iu/l

—

Embolic stroke

227

1.42

1.07

1.4

1.6

2.78

5.12

iu/l

—

Parapsoriasis

153

1.52

1.07

2.3

1.8

2.04

6.25

iu/l

—

Other encephalitis

211

1.43

1.07

1.9

8.66

5.77

iu/l

0.59

Other specified/unspecified spondylopathies

153

1.52

1.07

1.7

535.15

4.65

iu/l

—

Achalasia of cardia

105

1.64

1.07

2.1

1.8

445.19

6.70

iu/l

—

Alzheimer’s disease (Early onset)

217

0.60

1.06

1.5

1.6

2.00

5.22

iu/l

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

903

0.81

1.06

1.5

1.8

4.05

4.87

iu/l

0.28

295

Immunodeficiency with predominantly antibody defects

220

1.42

1.06

2.1

1.9

3.09

4.92

iu/l

1.12

Family history of certain disabilities and chronic diseases leading to disablement

463

1.28

1.05

1.7

2.0

3.44

4.58

iu/l

0.53

180

Radial styloid tenosynovitis [de Quervain]

570

1.25

1.05

2.3

2.0

3.72

4.73

iu/l

0.52

239

Chronic iridocyclitis

410

1.30

1.05

2.2

1.9

5.22

4.79

iu/l

0.08

146

Intussusception

162

1.50

1.05

1.8

1.7

4.05

5.26

iu/l

—

Superficial injury of hip and thigh

131

1116

1.18

1.05

1.8

5.64

4.61

iu/l

0.23

385

Striking against or struck by other objects

325

2939

1.11

1.05

1.7

1.9

3.99

4.16

iu/l

0.11

112

1100

ILD, hospital admission 2, with pulmonary infections

534

1.26

1.05

1.6

1.7

4.32

4.25

iu/l

0.02

173

Exposure to other and unspecified animate mechanical forces

263

1.38

1.04

2.0

1.9

2.47

4.50

iu/l

2.42

Problems related to social environment

212

1.43

1.04

2.0

1.8

4.44

5.26

iu/l

0.22

Other specified and unspecified retinal disorders

229

1.41

1.04

1.5

1.8

7.62

4.91

iu/l

0.42

Anorexia

138

1.54

1.04

1.4

1.9

1.93

5.97

iu/l

—

Postpartum hemorraghe, parous women as controls

434

3487

1.09

1.04

2.2

2.1

4.00

30.61

iu/l

1.11

174

1491

Conotruncal defects

106

1.62

1.04

2.3

1.9

3.06

5.29

iu/l

—

Other acquired deformities of musculoskeletal system and connective tissue

367

1.32

1.04

1.8

1.9

3.66

4.91

iu/l

0.55

120

Bulimia nervosa (incl. atypical)

429

1.29

1.04

1.8

2.1

2.26

4.72

iu/l

3.61

186

Eustachian salpingitis and obstruction

779

1.21

1.04

2.1

2.0

4.77

4.43

iu/l

0.12

288

Embolic stroke with flimmer

1.64

1.03

1.6

2.86

7.19

iu/l

—

Event of undetermined intent

500

1.27

1.03

1.7

1.9

2.64

5.09

iu/l

2.43

189

Cerebral aneurysm, nonruptured

725

1.22

1.03

1.9

1.8

2.75

4.93

iu/l

3.41

267

Alcohol use disorder, Swedish definition

529

4544

1.08

1.03

1.7

1.8

22.88

7.98

iu/l

0.37

166

1629

Diseases of tongue

509

1.26

1.03

1.8

1.9

3.54

4.53

iu/l

0.34

183

Pedal cyclist injured in other and unspecified transport accidents

943

0.81

1.03

1.8

1.9

2.61

4.75

iu/l

2.47

341

Benign neoplasm of breast

155

1343

1.16

1.02

1.8

68.16

4.63

iu/l

0.50

498

Bell's palsy

117

991

1.18

1.02

1.8

1.9

6.18

4.62

iu/l

0.53

382

Polyarthritis, unspecified

290

1.35

1.02

2.0

3.08

4.97

iu/l

1.03

109

Stenosis and insufficiency of lacrimal passages

735

1.22

1.02

2.0

1.6

5.43

5.04

iu/l

0.12

251

Other complications of labour and delivery, not elsewhere classified

179

1511

1.15

1.01

2.1

289.78

17.06

iu/l

0.46

658

Suppurative and unspecified otitis media

462

3773

1.09

1.01

1.8

2.0

117.76

9.79

iu/l

0.46

176

1519

Benign neoplasm: Skin of other and unspecified parts of face

103

864

1.20

1.00

1.7

1.8

5.12

4.57

iu/l

0.16

301

Hypertrophy of breast in women and men

203

2292

0.88

1.00

2.0

1.9

3.90

8.02

iu/l

0.62

898

Cyst of kidney

422

1.29

1.00

1.4

1.8

2.76

4.46

iu/l

1.65

135

SLE (Finngen)

248

1.38

1.00

2.1

1.6

9.26

3.34

iu/l

0.90

Chronic periodontitis, complicated

664

1.22

1.00

1.5

1.9

2.97

4.77

iu/l

1.70

230

Female infertility, associated with anovulation

126

1077

1.18

1.00

2.2

3.25

4.30

iu/l

2.08

478

Oesophageal varices

237

0.63

0.99

1.5

1.9

2.68

4.83

iu/l

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

240

1.39

0.99

2.4

1.9

4.26

4.86

iu/l

0.14

Granulosa cell carcinoma of ovary

0.00

0.99

0.0

1.4

—

8.90

—

Behçet disease

0.00

0.99

0.0

1.7

—

5.17

—

Cleft lip

0.00

0.99

0.0

1.8

—

5.98

—

Dementia, including avohilmo

285

2180

0.90

0.99

1.6

2.82

4.78

iu/l

6.49

629

Acidosis

1.68

0.98

1.6

3.90

5.13

iu/l

—

Other specified/unspecified diseases of inner ear

0.00

0.98

0.0

1.7

—

5.35

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

459

1.27

0.98

1.5

1.9

4.10

4.63

iu/l

0.18

157

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

102

857

1.19

0.98

1.8

8.18

4.71

iu/l

0.87

271

Unspecified misadventure during surgical and medical care

406

1.29

0.98

2.0

1.9

3.30

5.15

iu/l

1.35

144

Optic atrophy

132

1.53

0.98

2.4

1.8

2.68

5.77

iu/l

—

Unspecified fall

511

4699

1.08

0.98

1.8

23.49

4.44

iu/l

0.47

157

1671

Benign neoplasm: Skin of lip

100

1.62

0.98

1.4

1.8

10.68

6.25

iu/l

—

Unspecific neurodegenerative disorder

240

1851

0.89

0.97

1.5

1.6

3.04

4.55

iu/l

3.12

519

Granulomatous disorders of skin and subcutaneous tissue

241

1.38

0.97

1.9

3.02

5.07

iu/l

1.50

Monoplegia

108

1.59

0.97

1.3

1.8

3.14

5.63

iu/l

—

Other maltreatment syndromes

258

1.37

0.97

1.8

2.0

3.45

4.46

iu/l

0.54

Epileptic seizures related to alcohol

0.00

0.97

0.0

1.7

—

4.73

—

Other disorders of pigmentation

354

1.31

0.97

1.9

1.8

215.85

4.59

iu/l

0.47

119

Effects of foreign body entering through natural orifice

217

1931

1.13

0.97

1.6

1.8

4.65

4.18

iu/l

0.20

689

216

1.40

0.96

1.9

2.17

6.11

iu/l

3.08

Defect, injury or illness of lumbar spine

0.00

0.96

0.0

1.7

—

3.49

—

Myocardial infarction

448

2963

1.09

0.96

1.5

1.7

26.64

7.97

iu/l

0.37

134

931

Acute alcohol intoxication ICD-9

199

1.42

0.96

1.6

1.8

2.38

4.59

iu/l

—

Glomerular diseases

156

1360

1.15

0.95

1.7

1.8

58.91

4.68

iu/l

0.48

473

LSIL lesion of the vulva

303

1.33

0.95

2.1

2.0

2.81

4.77

iu/l

2.05

124

Background retinopathy and retinal vascular changes

125

1.53

0.94

1.9

1.6

2.55

5.43

iu/l

—

Alcohol-induced chronic pancreatitis

364

1.30

0.94

1.7

1.8

166.33

5.26

iu/l

0.47

127

Pedal cyclist injured in noncollision transport accidents

965

0.83

0.94

2.0

1.9

3.86

4.53

iu/l

0.20

373

Filling of root of tooth

260

1.36

0.94

1.6

1.8

3.68

4.92

iu/l

—

Colorectal cancer, excluding all cancers (controls excluding all cancers)

169

1858

0.88

0.94

1.6

1.7

6.60

4.46

iu/l

0.65

610

Colorectal cancer

139

1601

0.87

0.93

1.6

1.7

6.86

4.56

iu/l

0.64

500

Macular cyst

150

1.48

0.93

2.0

1.7

4.23

4.21

iu/l

—

569

4872

1.07

0.93

1.7

1.8

21.04

7.79

iu/l

0.36

183

1750

Other/unspecified enthesopathies of lower limb, excluding foot

653

1.22

0.92

2.0

3.41

5.09

iu/l

1.87

251

Injury of muscle and tendon at lower leg level

1158

0.84

0.92

1.9

1.8

6.52

4.33

iu/l

0.75

425

Other specified disorders of muscle

218

1.39

0.92

1.3

1.9

8.00

5.85

iu/l

0.20

Hypersomnia

118

1.54

0.92

1.7

2.0

1.65

6.54

iu/l

—

Acute posthaemorrhagic anaemia

201

1.40

0.91

1.6

1.7

5.38

5.93

iu/l

—

Toxic effect of other and unspecified substances

110

1.56

0.91

1.5

2.1

5.08

6.36

iu/l

—

Endometriosis diagnosis and infertility diagnosis occurring together

152

1329

1.15

0.91

2.0

2.1

4.54

4.39

iu/l

0.07

548

Early lumbar disc prolapse, operated

111

947

1.18

0.91

1.9

2.0

3.99

4.75

iu/l

0.54

408

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

1.64

0.91

1.5

1.7

1.67

4.64

iu/l

—

Benign neoplasm: Skin of lip

102

1.59

0.91

1.4

1.7

10.68

7.44

iu/l

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

565

0.78

0.91

1.8

1.7

6.37

4.49

iu/l

0.27

171

Mixed specific developmental disorders

148

1.46

0.91

1.9

8.22

4.62

iu/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

127

1096

1.16

0.91

1.6

1.9

5.40

4.43

iu/l

0.37

416

Cellulitis

202

1799

1.13

0.91

1.7

1.8

3.23

4.59

iu/l

2.52

653

Wide developmental disorders

253

1.35

0.90

1.8

3.08

5.49

iu/l

—

Degenerative diseases of the nervous system

184

1564

0.88

0.90

1.6

3.95

4.22

iu/l

0.14

442

LeFortI or BSSRO operation

417

0.74

0.90

2.0

4.63

5.03

iu/l

0.16

168

L04AC Interleukin inhibitors

417

0.74

0.90

1.3

2.0

2.55

4.77

iu/l

—

151

Gluteal tendinitis

332

1.30

0.90

1.9

2.0

3.18

5.04

iu/l

1.24

123

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

465

1.25

0.90

1.5

1.9

4.10

4.90

iu/l

0.29

158

Polypectomy (DHB20)

456

1.26

0.90

1.6

1.8

3.24

5.10

iu/l

1.14

156

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

741

0.81

0.90

1.7

1.8

7.33

4.64

iu/l

0.46

230

Other localized connective tissue disorders

160

1.45

0.90

2.3

1.8

3.64

5.25

iu/l

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

503

1.24

0.90

1.7

2.0

5.77

4.43

iu/l

0.27

204

Malignant neoplasm of other connective and soft tissue

135

1.49

0.89

1.9

1.7

8.16

5.34

iu/l

—

Familial hypercholesterolemia, with ischemic heart disease

501

1.24

0.89

1.5

1.6

5.03

4.59

iu/l

0.07

152

Sequelae of other external causes

403

1.27

0.89

1.7

2.0

2.48

4.92

iu/l

3.90

150

Seropositive rheumatoid arthritis

272

2460

1.11

0.89

1.8

4.49

7.85

iu/l

0.48

909

Other and unspecified haemorrhagic conditions

119

1.53

0.89

1.9

1.7

3.80

6.45

iu/l

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

729

1.20

0.89

2.1

1.9

3.61

4.94

iu/l

1.19

268

Otosclerosis

651

0.80

0.89

1.6

1.8

2.76

4.87

iu/l

3.82

221

Disorders of globe

152

1.46

0.88

2.3

1.7

7.02

6.40

iu/l

—

Chronic suppurative otitis media, including avohilmo

629

1.21

0.88

1.6

1.9

4.20

5.01

iu/l

0.37

228

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

357

3152

0.92

0.88

1.7

1.9

28.85

15.95

iu/l

0.22

136

1211

Alzheimer’s disease (Early onset), excluding more controls

194

0.63

0.88

1.5

1.6

2.00

4.53

iu/l

—

Acute lymphadenitis

548

1.23

0.88

1.9

3.57

4.94

iu/l

0.86

200

Other and unspecified rosacea

767

1.19

0.88

2.0

2.55

4.80

iu/l

4.17

294

Normotensive glaucoma

557

1.23

0.87

1.6

1.7

3.67

4.48

iu/l

0.48

171

Other orthopaedic follow-up care

449

1.25

0.87

2.1

1.8

5.55

4.93

iu/l

0.17

158

Kidney transplant status

369

0.73

0.87

1.3

2.0

2.30

4.98

iu/l

—

134

Other abnormal findings of blood chemistry

334

1.30

0.87

1.6

2.0

2.44

4.88

iu/l

2.65

119

Other specified/unspecified bacterial intestinal infections

504

1.24

0.86

1.8

1.9

2.61

4.88

iu/l

2.76

171

Congenital deformities of hip

153

1.45

0.86

1.8

5.22

6.01

iu/l

—

Other and unspecified psoriasis

495

1.24

0.86

1.5

2.0

2.44

5.05

iu/l

3.85

173

Motorcycle rider injured in noncollision transport accidents

221

1.37

0.86

2.5

1.9

2.14

6.24

iu/l

3.52

Other diseases of peritoneum

388

1.27

0.85

1.6

2.0

3.55

4.99

iu/l

0.60

139

Other infective otitis externa

496

1.24

0.85

1.7

1.9

4.68

4.76

iu/l

0.02

176

Other and unspecified mononeuropathies of upper limb

239

1.35

0.85

1.4

2.0

3.37

5.48

iu/l

0.96

Family history of malignant neoplasm

127

1104

1.15

0.84

1.6

2.0

4.24

4.40

iu/l

0.08

443

Lichen planus

124

1076

1.16

0.84

1.9

1.8

6.01

4.87

iu/l

0.31

368

Other and unspecified injuries of abdomen, lower back and pelvis

129

1.49

0.84

2.7

1.9

3.21

5.99

iu/l

—

Behavioural disorders, excluding more controls

179

1.41

0.84

2.6

1.9

3.66

5.03

iu/l

—

Primary coxarthrosis, bilateral

243

2199

1.11

0.84

1.7

107.08

4.58

iu/l

0.50

707

Carcinoma in situ of skin of other and unspecified parts of face

371

1.27

0.84

1.2

1.7

12.61

4.72

iu/l

—

112

Other benign neoplasms of uterus

452

1.25

0.84

1.4

1.7

4.52

4.24

iu/l

0.06

138

Benign neoplasm: Descending colon

407

1.26

0.84

1.9

1.8

5.09

4.23

iu/l

0.19

131

Autism spe, excluding more controls

171

1.41

0.83

1.6

2.0

2.95

5.01

iu/l

—

Alcohol dependence

220

1981

1.11

0.83

1.8

4.70

4.39

iu/l

0.17

675

Diseases of middle ear and mastoid

740

5726

1.06

0.83

1.8

2.0

76.47

11.04

iu/l

0.43

276

2207

Other specified/unspecified hearing loss

570

1.22

0.83

1.5

1.9

3.39

4.54

iu/l

0.58

187

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

545

0.79

0.82

1.8

6.37

4.52

iu/l

0.26

169

Benign neoplasm: Other and unspecified parts of mouth

249

1.33

0.82

1.8

2.0

2.56

4.76

iu/l

—

Varicose veins

713

5086

1.06

0.82

1.7

1.8

4.35

13.85

iu/l

1.18

270

1833

Other arterial embolism and thrombosis

155

1.43

0.81

1.4

1.5

3.40

5.75

iu/l

—

Juvenile arthritis (FINNGEN)

463

1.24

0.81

1.7

2.0

3.79

5.04

iu/l

0.73

194

Urethral stricture

258

1.32

0.81

1.7

214.71

5.18

iu/l

0.49

Benign neoplasm: Choroid

427

1.25

0.81

1.9

3.34

4.61

iu/l

0.55

143

Lichen ruber planus, wide definition including periferal and oral lichen planus

214

1929

1.11

0.81

1.8

4.91

9.29

iu/l

0.47

688

Perioral dermatitis

224

1.35

0.81

2.1

2.0

3.29

4.54

iu/l

0.73

Secondary and unspecified malignant neoplasm of lymph nodes

563

1.21

0.81

1.5

1.8

6.46

4.71

iu/l

0.31

185

Abnormal findings in secretions and smears from cervix uteri vagina vulva

774

5760

1.06

0.81

2.1

2.0

21.40

20.55

iu/l

0.02

320

2296

Colectomy operation

139

1221

1.14

0.80

1.6

1.8

6.62

4.65

iu/l

0.63

402

Benign neoplasm: Pineal gland

0.00

0.80

0.0

2.6

—

5.22

—

Other inflammation of vagina/vulva

437

1.24

0.80

2.9

2.1

4.02

4.60

iu/l

0.21

184

Recurrent cholesteatoma of postmastoidectomy cavity

0.00

0.80

0.0

1.9

—

6.58

—

Fracture of femur

204

1674

1.11

0.80

1.5

1.7

4.58

4.65

iu/l

0.03

517

Alopecia areata

268

1.32

0.80

2.8

1.9

6.72

4.39

iu/l

0.44

107

Other benign neoplasms of uterus

455

1.24

0.80

1.4

1.8

4.52

4.97

iu/l

0.10

139

Alzheimer disease

155

1320

0.88

0.80

1.5

3.11

4.26

iu/l

1.38

365

Pedal cyclist injured in transport accident

184

2054

0.89

0.80

1.9

4.05

4.35

iu/l

0.13

768

Lumbosacral plexus disorders

0.00

0.80

0.0

1.8

—

3.43

—

Congenital malformations and deformations of the musculoskeletal system

101

863

1.17

0.80

1.8

1.9

3.16

4.34

iu/l

1.29

328

Drowning and submersion while in natural water

0.00

0.80

0.0

2.0

—

8.65

—

Granulosa cell carcinoma of ovary, excluding all cancers (controls excluding all cancers)

0.00

0.79

0.0

1.5

—

7.23

—

Congenital malformations of uterus and cervix

251

1.33

0.79

1.7

2.1

3.06

4.97

iu/l

—

107

Other diseases of gallbladder

321

1.28

0.79

1.9

1.8

3.25

5.06

iu/l

1.03

101

Hypertrophy of bone

0.00

0.79

0.0

2.7

—

4.47

—

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

173

1.40

0.79

1.7

1.8

5.93

4.61

iu/l

—

Conductive hearing loss, unspecified

702

1.19

0.79

1.9

2.74

5.14

iu/l

3.73

252

Benign neoplasm: Other and unspecified parts of mouth

251

1.32

0.79

1.8

2.56

5.03

iu/l

—

Invasive ventilation

492

1.22

0.79

1.5

1.9

3.32

4.71

iu/l

0.68

169

Myocardial infarction, with ST-elevation

107

924

1.16

0.78

1.4

1.6

3.91

4.46

iu/l

0.30

264

Other disorders of choroid

1.60

0.78

1.2

1.7

1.78

8.18

iu/l

—

Uterine polyps

119

1037

1.15

0.78

1.8

1.9

3.93

23.65

iu/l

0.52

405

Crohn disease

138

1215

1.14

0.78

1.4

1.9

4.03

4.59

iu/l

0.30

465

Contusion of ankle

349

1.27

0.78

1.5

1.9

6.63

5.22

iu/l

0.30

128

Hypertrophy of breast

193

2143

0.90

0.77

2.1

1.9

3.96

8.19

iu/l

0.60

851

Dipeptidyl peptidase 4 (DPP-4) inhibitors

796

1.17

0.77

2.0

1.7

5.76

4.67

iu/l

0.29

251

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

104

1201

0.86

0.77

1.7

7.72

4.34

iu/l

0.84

361

Bullous disorders

394

1.25

0.77

1.8

2.98

4.89

iu/l

0.91

131

Persistent delusional disorders

594

1.20

0.77

1.5

1.9

4.00

4.84

iu/l

0.29

202

Drug-induced hypoglycaemia without coma

107

1.51

0.77

2.3

1.8

8.63

7.30

iu/l

—

Benign neoplasm: Small intestine

261

1.31

0.77

1.9

1.8

4.06

4.21

iu/l

0.04

Hydrocele

457

1.23

0.77

1.8

1.6

2.86

3.97

iu/l

1.29

136

Lyme disease

260

2376

1.10

0.76

1.7

1.8

4.52

8.24

iu/l

0.50

859

HSIL lesion of the cervix uteri, vagina or vulva

293

2693

1.09

0.76

2.4

2.1

45.46

9.92

iu/l

0.41

133

1137

Benign neoplasm: Choroid

431

1.24

0.76

1.9

3.34

4.72

iu/l

0.62

142

Inflammatory disease of cervix uteri

678

1.19

0.76

2.4

1.9

5.66

4.76

iu/l

0.20

249

Abnormal spermatozoa

494

0.79

0.76

1.4

1.5

4.45

4.05

iu/l

0.09

136

Motor disorders

107

1.50

0.76

2.4

2.0

2.42

6.41

iu/l

—

Other aneurysm

288

1.29

0.75

2.1

1.8

5.02

5.07

iu/l

0.01

Residual foreign body in soft tissue

381

0.76

0.75

1.6

1.9

2.68

5.45

iu/l

3.34

149

Other appendicitis

771

1.17

0.75

1.7

1.9

3.07

5.02

iu/l

2.44

290

Other otitis externa (chronic)

532

1.21

0.75

1.7

2.0

4.58

4.81

iu/l

0.05

195

Other female pelvic inflammatory diseases

215

1950

1.11

0.74

1.8

1.9

3.63

8.69

iu/l

0.64

746

Other (seronegative) rheumatoid arthritis, wide

198

1788

1.11

0.74

1.7

1.8

3.70

4.48

iu/l

0.50

630

Other facial nerve disorders

245

1.32

0.74

1.7

1.8

6.61

5.41

iu/l

—

Haemangioma, any site

707

1.18

0.74

1.9

3.14

4.59

iu/l

0.99

259

Asthma mixed form (mode), excluding more controls

414

1.24

0.74

1.9

2.33

4.96

iu/l

2.92

162

Benign neoplasm: Skin of eyelid, including canthus

144

1277

1.13

0.74

1.9

1.8

4.89

4.60

iu/l

0.11

442

Superficial injury of ankle and foot

129

1136

1.14

0.74

1.7

2.0

4.09

4.14

iu/l

0.02

438

Toxic effects of substances chiefly nonmedicinal as to source

110

958

1.15

0.74

1.6

1.9

3.48

4.59

iu/l

0.84

355

Congenital malformations of ovaries, fallopian tubes and broad ligaments

680

1.18

0.74

1.8

2.1

3.68

4.32

iu/l

0.46

276

Oral lichen ruber planus

193

1.36

0.74

1.9

1.8

2.59

5.21

iu/l

—

Migraine without aura, drug-induced

125

1.46

0.74

1.4

1.9

2.12

5.63

iu/l

—

Haemangioma and lymphangioma, any site

754

1.17

0.73

1.9

3.14

4.51

iu/l

0.93

277

Atrophic disorders of skin

163

1458

1.12

0.73

2.0

1.8

5.93

4.31

iu/l

0.47

533

Other superficial mycoses

176

1.38

0.73

1.6

1.9

4.40

5.56

iu/l

—

Benign neoplasm: Hypopharynx

2.03

0.73

1.2

1.5

—

6.49

—

Other congenital malformations of circulatory system

202

1.35

0.73

2.0

1.9

1.89

5.18

iu/l

—

Benign neoplasm: Pharynx, unspecified

1.63

0.73

1.2

1.8

—

9.15

—

Ulcerative colitis

261

2392

1.09

0.73

2.0

1.9

3.68

7.66

iu/l

0.60

905

Other specified congenital malformation syndromes affecting multiple systems

142

1.42

0.73

2.5

1.9

4.11

5.49

iu/l

—

Deficiency of other B group vitamins

142

1.42

0.73

2.0

1.7

4.10

5.55

iu/l

—

Other spirochaetal diseases

262

2402

1.09

0.73

1.7

1.8

4.46

8.18

iu/l

0.51

870

Liposarcoma, excluding all cancers (controls excluding all cancers)

1.69

0.73

2.3

1.4

8.04

4.56

iu/l

—

Colonic or urogenital fistula

269

2469

1.09

0.73

1.7

1.8

3.05

7.82

iu/l

0.77

893

Flatulence and related conditions

1.64

0.72

1.5

1.9

2.35

6.73

iu/l

—

Adalimumab

839

0.84

0.72

1.3

2.0

4.43

4.42

iu/l

0.00

333

Impacted teeth

243

2067

1.10

0.72

2.1

4.39

4.00

iu/l

0.21

836

Urethritis and urethral syndrome

194

1.35

0.72

2.5

1.8

4.14

5.26

iu/l

0.33

LSIL lesion of the cervix uteri

161

1442

1.12

0.72

2.3

2.1

4.09

4.30

iu/l

0.13

604

Foreign body or object entering through skin

489

1.21

0.72

1.6

1.9

4.45

5.10

iu/l

0.16

190

Other follicular disorders

636

1.18

0.71

2.3

2.0

4.27

4.41

iu/l

0.03

248

Other disorders starting during childhood or adolescence

449

1.22

0.71

1.7

2.0

5.38

4.56

iu/l

0.15

182

Haemorrhage, not elsewhere classified

194

1.35

0.71

1.8

1.6

4.83

5.01

iu/l

—

Livedoid vasculitis

1.96

0.71

1.0

2.1

—

4.43

—

LSIL lesion of the cervix uteri, vagina or vulva

201

1823

1.11

0.71

2.2

2.0

3.83

4.36

iu/l

0.50

753

Fitting and adjustment of other devices

261

2643

0.92

0.71

1.5

1.7

5.43

8.23

iu/l

0.36

890

Fracture of lower leg, including ankle

619

5835

1.06

0.70

1.9

1.8

4.04

14.00

iu/l

1.45

225

2104

Benign neoplasm: Pharynx, unspecified

1.57

0.70

1.2

1.8

—

9.09

—

Opening and dilatation of root channel of tooth

573

1.19

0.70

1.9

2.0

3.03

4.98

iu/l

1.51

217

Injuries to the head

1429

8971

1.04

0.70

1.8

1.9

10.93

18.84

iu/l

0.39

482

3342

Tic and related disorders

1.52

0.70

2.7

1.8

3.05

7.29

iu/l

—

Puerperal sepsis

170

1530

1.11

0.70

2.0

1.9

4.10

9.66

iu/l

0.52

581

Algoneurodystrophy

310

1.27

0.70

1.7

2.0

4.48

4.65

iu/l

0.05

117

Benign neoplasm of ovary

210

1911

1.10

0.70

1.7

1.9

2.91

8.83

iu/l

0.76

713

Endometriosis of fallopian tube

1.58

0.69

2.2

1.8

1.60

5.16

iu/l

—

1.58

0.69

1.5

1.8

1.98

6.42

iu/l

—

Failed attempted abortion

161

1.38

0.69

1.8

2.3

4.75

5.00

iu/l

0.05

ILD-related respiratory insufficiency

152

1.39

0.69

1.9

1.6

3.38

4.92

iu/l

—

Anisometropia and aniseikonia

248

1.30

0.69

2.0

1.8

2.60

4.55

iu/l

—

Dementia in Alzheimer disease

752

0.85

0.69

1.6

1.5

2.71

4.33

iu/l

2.08

196

Unspecified maternal hypertension

144

1.41

0.69

2.1

2.3

2.40

5.93

iu/l

—

Other obstructed labour

102

890

1.15

0.69

2.1

1.9

5.59

4.05

iu/l

0.83

353

Chronic myeloid leukaemia

1.88

0.69

1.4

1.9

—

3.36

—

Malignant neoplasm of mesothelium and soft tissue

248

1.30

0.69

1.7

6.25

5.21

iu/l

0.17

Mumps

204

0.68

0.69

2.1

1.8

5.08

5.12

iu/l

—

Rhinophyma

1.87

0.69

1.0

1.7

—

7.69

—

Iridocyclitis in diseases classified elsewhere

127

1.43

0.68

1.3

1.9

2.00

6.98

iu/l

—

Benign neoplasm: Descending colon

419

1.22

0.68

1.9

1.8

5.09

4.47

iu/l

0.13

136

123

1.43

0.68

1.7

1.8

2.71

4.87

iu/l

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

338

1.25

0.68

1.8

2.0

1.88

4.88

iu/l

4.02

129

Assault by blunt object

102

1.48

0.68

1.6

2.1

3.03

6.06

iu/l

—

Exclusion endpoint for clefts

170

1.36

0.68

2.5

1.9

4.22

5.22

iu/l

—

Artificial joint re-operation

456

1.21

0.68

1.5

1.7

4.45

4.18

iu/l

0.06

137

Lesion of sciatic nerve

258

1.28

0.67

1.7

6.06

4.75

iu/l

—

Occupational exposure to risk-factors

214

1.32

0.67

1.5

2.0

2.32

5.92

iu/l

—

Impacted cerumen

659

1.17

0.67

1.8

1.9

3.98

4.38

iu/l

0.14

215

Parkinson's disease, including avohilmo

105

920

1.14

0.67

1.3

1.7

4.56

4.18

iu/l

0.13

268

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

128

1.42

0.66

2.2

2.0

5.43

5.54

iu/l

—

Tularaemia

1.53

0.66

2.2

1.7

3.18

4.68

iu/l

—

Other keratitis

111

977

1.14

0.66

2.0

3.88

4.61

iu/l

0.47

372

Acute poliomyelitis

1.53

0.66

1.5

1.6

5.63

4.89

iu/l

—

Multiple delivery

111

978

1.14

0.66

2.2

2.0

4.49

12.63

iu/l

0.51

390

Specific developmental disorder of motor function

109

1.45

0.66

2.4

1.9

2.42

5.43

iu/l

—

Complications following abortion and ectopic and molar pregnancy

349

1.24

0.65

1.9

4.21

6.00

iu/l

0.43

120

Dislocation of lens

1.58

0.65

2.5

1.7

2.78

6.07

iu/l

—

Aortic valve malfunction, age under 60 years

661

1.17

0.65

2.2

1.9

3.66

4.96

iu/l

1.11

240

Optic neuritis

422

1.22

0.65

1.9

2.0

5.65

4.61

iu/l

0.16

162

Major coronary heart disease event excluding revascularizations

593

3877

1.06

0.65

1.5

1.7

38.72

7.11

iu/l

0.70

181

1229

Ankylosing spondylitis

745

1.16

0.65

1.5

2.0

3.88

4.96

iu/l

0.63

284

Alcohol abuse, main dg

136

1215

1.12

0.65

1.8

1.9

3.48

4.41

iu/l

0.75

463

Status epilepticus

242

1.29

0.64

2.0

1.9

3.43

5.16

iu/l

0.99

Benign neoplasm: Skin of ear and external auricular canal

242

1.29

0.64

1.7

1.8

3.03

5.18

iu/l

—

Other overlap syndromes

146

1.38

0.64

1.8

1.9

4.23

5.23

iu/l

—

Disturbances of smell and taste

332

1.24

0.64

1.7

1.9

2.98

4.74

iu/l

1.25

118

Embedded and impacted teeth

345

2736

1.07

0.64

2.1

4.06

22.49

iu/l

0.50

145

1084

603

5126

1.05

0.63

1.7

1.8

19.97

13.44

iu/l

0.16

195

1862

Unequal limb length (acquired)

1.54

0.63

1.8

2.29

6.48

iu/l

—

Diabetic nephropathy, excluding more controls

124

920

1.13

0.63

1.7

1.6

4.12

24.26

iu/l

0.78

308

Ulcer of vagina/vulva

270

1.27

0.63

1.9

2.0

4.20

5.01

iu/l

0.31

105

Parkinson's disease

100

878

1.14

0.63

1.3

1.7

3.46

4.20

iu/l

0.40

259

Wegener granulomatosis

104

1.45

0.63

1.6

1.7

5.33

7.35

iu/l

—

Medicines for HER+ breast cancer

393

4077

0.94

0.63

1.7

1.8

26.89

14.13

iu/l

0.24

148

1458

Bronchiectasis

534

1.18

0.62

1.8

1.9

5.28

4.73

iu/l

0.10

169

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

270

1.26

0.62

1.4

1.9

4.44

4.34

iu/l

—

Drug-induced cataract

173

1.34

0.62

2.7

1.8

2.57

4.80

iu/l

—

Granuloma annulare

130

1.40

0.62

2.6

1.8

2.85

5.13

iu/l

1.10

Benign neoplasm: Hypopharynx

1.69

0.62

1.2

1.6

—

8.59

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

156

1.36

0.62

1.8

1.9

2.88

5.97

iu/l

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Thyrotropin receptor Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS